{ "company_details": [ { "company_id": "0001206942", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001206942.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001206942.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001206942.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001206942_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001206942_main_keyfigs.svg", "name": "Golden Grain Energy", "rank": 1, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001206942.svg", "report_text": "The relative strengths and weaknesses of Golden Grain Energy are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Golden Grain Energy compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 138% points.The greatest weakness of Golden Grain Energy is the variable Other Expenses, reducing the Economic Capital Ratio by 227% points.

The company's Economic Capital Ratio, given in the ranking table, is 210%, being 86% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001206942_2012_Golden_Grain_Energy.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "17.4", "Liabilities": "107", "Stockholders Equity": "1.45", "ECR before LimitedLiability": "101", "Liabilities, Noncurrent": "49.4", "Liabilities, Current": "69.1", "Assets, Current": "5.12", "Assets": "5.85", "Other Assets": "0.387", "Assets, Noncurrent": "-0.806", "Intangible Assets": "1.90", "Selling, General and Administrative Expense": "31.9", "Expenses": "-94.5", "Revenues": "138", "Net Income": "65.5", "Other Expenses": "-227", "Cost of Revenues": "60.9", "Other Revenues": "138", "Comprehensive Net Income": "65.2", "Other Net Income": "2.52", "Economic Capital Ratio": "86.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001206942_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "23,749", "Assets, Noncurrent": "24,096", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "6,739", "Liabilities, Noncurrent": "2,069", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "303,577", "Other Liabilities": "0", "Other Net Income": "5,474", "Other Revenues": "324,928", "Property, Plant and Equipment, Net": "72,558", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "8,808", "Assets": "120,403", "Expenses": "303,577", "Revenues": "324,928", "Stockholders Equity": "111,596", "Net Income": "26,825", "Comprehensive Net Income": "26,825", "BaseVar": "381,595", "ECR before LimitedLiability": "181%", "Economic Capital Ratio": "210%" } } }, "top_rated": true, "trend": null, "value": 2.0975949177127373, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001206942.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001206942.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001206942.svg" }, { "company_id": "0001366744", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001366744.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001366744.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001366744.jpg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001366744_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001366744_main_keyfigs.svg", "name": "Homeland Energy Solutions LLC", "rank": 2, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001366744.svg", "report_text": "The relative strengths and weaknesses of Homeland Energy Solutions LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Homeland Energy Solutions LLC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 132% points.The greatest weakness of Homeland Energy Solutions LLC is the variable Other Expenses, reducing the Economic Capital Ratio by 201% points.

The company's Economic Capital Ratio, given in the ranking table, is 204%, being 80% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001366744_2012_Homeland_Energy_Solutions_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-4.49", "Liabilities": "98.1", "ECR before LimitedLiability": "94.7", "Liabilities, Noncurrent": "47.8", "Liabilities, Current": "70.7", "Assets, Current": "2.74", "Assets": "2.96", "Assets, Noncurrent": "0.763", "Intangible Assets": "0.960", "Property, Plant and Equipment, Net": "-1.83", "Selling, General and Administrative Expense": "27.9", "Expenses": "-80.7", "Net Income": "63.8", "Other Expenses": "-201", "Cost of Revenues": "57.7", "Other Revenues": "132", "Revenues": "132", "Comprehensive Net Income": "63.5", "Other Compr. Net Income": "-0.286", "Other Net Income": "-4.01", "Economic Capital Ratio": "79.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001366744_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "23,320", "Assets, Noncurrent": "875", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "0", "Liabilities, Noncurrent": "246", "Other Assets": "2,097", "Other Compr. Net Income": "0", "Other Expenses": "379,166", "Other Liabilities": "16,571", "Other Net Income": "-1,028", "Other Revenues": "419,313", "Property, Plant and Equipment, Net": "131,218", "Selling, General and Administrative Expense": "2,764" }, "output_variables": { "Liabilities": "16,818", "Assets": "157,510", "Expenses": "381,930", "Revenues": "419,313", "Stockholders Equity": "140,692", "Net Income": "36,354", "Comprehensive Net Income": "36,354", "BaseVar": "488,300", "ECR before LimitedLiability": "172%", "Economic Capital Ratio": "204%" } } }, "top_rated": true, "trend": null, "value": 2.0352409475437865, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001366744.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001366744.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001366744.svg" }, { "company_id": "0001352081", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001352081.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001352081.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001352081.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001352081_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001352081_main_keyfigs.svg", "name": "Cardinal Ethanol LLC", "rank": 3, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001352081.svg", "report_text": "The relative strengths and weaknesses of Cardinal Ethanol LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Cardinal Ethanol LLC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 96% points.The greatest weakness of Cardinal Ethanol LLC is the variable Other Expenses, reducing the Economic Capital Ratio by 126% points.

The company's Economic Capital Ratio, given in the ranking table, is 193%, being 70% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001352081_2012_Cardinal_Ethanol_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "11.8", "Liabilities": "76.7", "Stockholders Equity": "19.7", "ECR before LimitedLiability": "84.4", "Liabilities, Noncurrent": "37.1", "Liabilities, Current": "43.0", "Assets, Current": "-0.793", "Assets": "-0.820", "Assets, Noncurrent": "-0.282", "Intangible Assets": "-0.344", "Property, Plant and Equipment, Net": "0.895", "Selling, General and Administrative Expense": "23.0", "Expenses": "-40.4", "Revenues": "95.7", "Net Income": "44.8", "Other Expenses": "-126", "Cost of Revenues": "44.4", "Other Revenues": "95.7", "Comprehensive Net Income": "44.6", "Other Net Income": "-5.58", "Economic Capital Ratio": "69.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001352081_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "49,830", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "18,628", "Liabilities, Noncurrent": "0", "Other Assets": "877", "Other Compr. Net Income": "0", "Other Expenses": "306,941", "Other Liabilities": "0", "Other Net Income": "-4,570", "Other Revenues": "337,020", "Property, Plant and Equipment, Net": "125,170", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "18,628", "Assets": "175,877", "Expenses": "306,941", "Revenues": "337,020", "Stockholders Equity": "157,248", "Net Income": "25,509", "Comprehensive Net Income": "25,509", "BaseVar": "421,518", "ECR before LimitedLiability": "157%", "Economic Capital Ratio": "193%" } } }, "top_rated": true, "trend": null, "value": 1.9317482004445543, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001352081.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001352081.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001352081.svg" }, { "company_id": "0001371451", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001371451.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001371451.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001371451.jpg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001371451_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001371451_main_keyfigs.svg", "name": "Highwater Ethanol LLC", "rank": 4, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001371451.svg", "report_text": "The relative strengths and weaknesses of Highwater Ethanol LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Highwater Ethanol LLC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 68% points.The greatest weakness of Highwater Ethanol LLC is the variable Other Expenses, reducing the Economic Capital Ratio by 95% points.

The company's Economic Capital Ratio, given in the ranking table, is 192%, being 69% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001371451_2012_Highwater_Ethanol_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "9.91", "Liabilities": "68.4", "Stockholders Equity": "37.3", "ECR before LimitedLiability": "83.7", "Liabilities, Noncurrent": "31.8", "Liabilities, Current": "39.1", "Assets, Current": "-1.03", "Assets": "-0.380", "Assets, Noncurrent": "-0.191", "Intangible Assets": "-0.356", "Property, Plant and Equipment, Net": "2.80", "Selling, General and Administrative Expense": "19.2", "Expenses": "-26.7", "Revenues": "62.1", "Net Income": "32.8", "Other Expenses": "-94.6", "Cost of Revenues": "36.9", "Other Revenues": "62.1", "Comprehensive Net Income": "32.6", "Other Net Income": "-2.00", "Economic Capital Ratio": "68.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001371451_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "15,695", "Assets, Noncurrent": "3,422", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "7,742", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "151,303", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "160,374", "Property, Plant and Equipment, Net": "91,812", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "7,742", "Assets": "110,929", "Expenses": "151,303", "Revenues": "160,374", "Stockholders Equity": "103,188", "Net Income": "9,071", "Comprehensive Net Income": "9,071", "BaseVar": "215,174", "ECR before LimitedLiability": "156%", "Economic Capital Ratio": "192%" } } }, "top_rated": true, "trend": null, "value": 1.924727209937772, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001371451.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001371451.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001371451.svg" }, { "company_id": "0001101302", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001101302.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001101302.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001101302.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001101302_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001101302_main_keyfigs.svg", "name": "Entegris INC", "rank": 5, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001101302.svg", "report_text": "The relative strengths and weaknesses of Entegris INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Entegris INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 64% points.The greatest weakness of Entegris INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 44% points.

The company's Economic Capital Ratio, given in the ranking table, is 192%, being 69% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001101302_2012_Entegris_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "7.43", "Liabilities": "45.3", "Assets": "0.544", "Stockholders Equity": "41.6", "ECR before LimitedLiability": "83.3", "Liabilities, Noncurrent": "24.4", "Liabilities, Current": "19.7", "Assets, Current": "1.43", "Assets, Noncurrent": "-0.210", "Property, Plant and Equipment, Net": "-0.399", "Selling, General and Administrative Expense": "-16.8", "Expenses": "4.58", "Revenues": "33.5", "Net Income": "37.0", "Other Expenses": "64.2", "Cost of Revenues": "-44.3", "Other Revenues": "33.5", "Comprehensive Net Income": "36.9", "Other Net Income": "-1.08", "Other Compr. Net Income": "-0.134", "Economic Capital Ratio": "68.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001101302_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "502,999", "Assets, Noncurrent": "5,707", "Cost of Revenues": "423,329", "Intangible Assets": "56,453", "Liabilities, Current": "92,594", "Liabilities, Noncurrent": "0", "Other Assets": "28,950", "Other Compr. Net Income": "0", "Other Expenses": "15,328", "Other Liabilities": "0", "Other Net Income": "2,471", "Other Revenues": "749,259", "Property, Plant and Equipment, Net": "130,554", "Selling, General and Administrative Expense": "188,827" }, "output_variables": { "Liabilities": "92,594", "Assets": "724,663", "Expenses": "627,484", "Revenues": "749,259", "Stockholders Equity": "632,069", "Net Income": "124,246", "Comprehensive Net Income": "124,246", "BaseVar": "1,098,236", "ECR before LimitedLiability": "156%", "Economic Capital Ratio": "192%" } } }, "top_rated": true, "trend": null, "value": 1.9216855311886938, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001101302.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001101302.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001101302.svg" }, { "company_id": "0000915913", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000915913.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000915913.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000915913.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000915913_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000915913_main_keyfigs.svg", "name": "Albemarle CORP", "rank": 6, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000915913.svg", "report_text": "The relative strengths and weaknesses of Albemarle CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Albemarle CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 45% points.The greatest weakness of Albemarle CORP is the variable Other Expenses, reducing the Economic Capital Ratio by 16% points.

The company's Economic Capital Ratio, given in the ranking table, is 190%, being 66% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000915913_2012_Albemarle_CORP.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "3.81", "Liabilities": "35.0", "Stockholders Equity": "44.1", "ECR before LimitedLiability": "56.4", "Liabilities, Noncurrent": "23.8", "Liabilities, Current": "10.5", "Assets, Current": "1.16", "Assets": "2.44", "Property, Plant and Equipment, Net": "0.922", "Other Assets": "0.489", "Assets, Noncurrent": "-0.232", "Other Expenses": "-29.8", "Expenses": "4.55", "Revenues": "5.80", "Net Income": "12.3", "Selling, General and Administrative Expense": "6.85", "Cost of Revenues": "26.4", "Other Revenues": "5.80", "Comprehensive Net Income": "12.5", "Other Net Income": "1.96", "Economic Capital Ratio": "54.0" }, "2011": { "Other Liabilities": "6.79", "Liabilities": "41.2", "Stockholders Equity": "45.5", "ECR before LimitedLiability": "80.7", "Liabilities, Noncurrent": "22.5", "Liabilities, Current": "17.0", "Assets, Current": "0.297", "Assets": "1.44", "Other Assets": "0.306", "Intangible Assets": "0.310", "Property, Plant and Equipment, Net": "0.507", "Selling, General and Administrative Expense": "-1.11", "Expenses": "8.36", "Revenues": "23.9", "Net Income": "32.6", "Other Expenses": "-16.2", "Cost of Revenues": "25.2", "Other Revenues": "23.9", "Comprehensive Net Income": "32.5", "Other Net Income": "0.266", "Economic Capital Ratio": "65.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000915913_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "1,348,198", "Assets, Noncurrent": "125,878", "Cost of Revenues": "0", "Intangible Assets": "407,002", "Liabilities, Current": "364,177", "Liabilities, Noncurrent": "0", "Other Assets": "180,690", "Other Compr. Net Income": "0", "Other Expenses": "1,742,052", "Other Liabilities": "0", "Other Net Income": "40,763", "Other Revenues": "2,362,764", "Property, Plant and Equipment, Net": "1,006,313", "Selling, General and Administrative Expense": "324,116" }, "output_variables": { "Liabilities": "364,177", "Assets": "3,068,081", "Expenses": "2,066,168", "Revenues": "2,362,764", "Stockholders Equity": "2,703,904", "Net Income": "337,359", "Comprehensive Net Income": "337,359", "BaseVar": "3,950,976", "ECR before LimitedLiability": "147%", "Economic Capital Ratio": "187%" } }, "2011": { "input_variables": { "Assets, Current": "1,355,620", "Assets, Noncurrent": "116,871", "Cost of Revenues": "0", "Intangible Assets": "403,426", "Liabilities, Current": "401,178", "Liabilities, Noncurrent": "0", "Other Assets": "198,427", "Other Compr. Net Income": "0", "Other Expenses": "2,059,534", "Other Liabilities": "0", "Other Net Income": "44,111", "Other Revenues": "2,869,005", "Property, Plant and Equipment, Net": "1,129,480", "Selling, General and Administrative Expense": "389,219" }, "output_variables": { "Liabilities": "401,178", "Assets": "3,203,824", "Expenses": "2,448,753", "Revenues": "2,869,005", "Stockholders Equity": "2,802,646", "Net Income": "464,363", "Comprehensive Net Income": "464,363", "BaseVar": "4,483,436", "ECR before LimitedLiability": "152%", "Economic Capital Ratio": "190%" } } }, "top_rated": true, "trend": -5.0, "value": 1.8950503831245196, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000915913.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000915913.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000915913.svg" }, { "company_id": "0001156174", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001156174.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001156174.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001156174.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001156174_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001156174_main_keyfigs.svg", "name": "Lake Area Corn Processors LLC", "rank": 7, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001156174.svg", "report_text": "The relative strengths and weaknesses of Lake Area Corn Processors LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Lake Area Corn Processors LLC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 114% points.The greatest weakness of Lake Area Corn Processors LLC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 207% points.

The company's Economic Capital Ratio, given in the ranking table, is 188%, being 64% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001156174_2012_Lake_Area_Corn_Processors_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "11.6", "Liabilities": "68.7", "Assets": "-2.55", "Stockholders Equity": "2.83", "ECR before LimitedLiability": "79.2", "Liabilities, Noncurrent": "36.0", "Liabilities, Current": "33.5", "Assets, Current": "-1.70", "Assets, Noncurrent": "-0.467", "Property, Plant and Equipment, Net": "-0.809", "Selling, General and Administrative Expense": "23.3", "Expenses": "-39.7", "Revenues": "109", "Net Income": "57.2", "Other Expenses": "114", "Cost of Revenues": "-207", "Other Revenues": "109", "Comprehensive Net Income": "57.0", "Other Net Income": "-2.42", "Other Compr. Net Income": "-0.218", "Economic Capital Ratio": "64.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001156174_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "27,400", "Assets, Noncurrent": "3,123", "Cost of Revenues": "126,627", "Intangible Assets": "10,396", "Liabilities, Current": "13,209", "Liabilities, Noncurrent": "489", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "3,246", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "146,965", "Property, Plant and Equipment, Net": "26,474", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "13,698", "Assets": "67,393", "Expenses": "129,873", "Revenues": "146,965", "Stockholders Equity": "53,695", "Net Income": "17,092", "Comprehensive Net Income": "17,092", "BaseVar": "178,964", "ECR before LimitedLiability": "149%", "Economic Capital Ratio": "188%" } } }, "top_rated": true, "trend": null, "value": 1.879872015999373, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001156174.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001156174.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001156174.svg" }, { "company_id": "0000082166", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000082166.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000082166.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000082166_main_keyfigs.svg", "name": "Raven Industries INC", "rank": 8, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000082166.svg", "report_text": "The relative strengths and weaknesses of Raven Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Raven Industries INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 72% points.The greatest weakness of Raven Industries INC is the variable Other Expenses, reducing the Economic Capital Ratio by 62% points.

The company's Economic Capital Ratio, given in the ranking table, is 187%, being 64% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000082166_2012_Raven_Industries_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "9.69", "Liabilities": "57.2", "Stockholders Equity": "17.5", "ECR before LimitedLiability": "78.5", "Liabilities, Noncurrent": "31.3", "Liabilities, Current": "25.3", "Assets, Current": "0.838", "Assets": "-1.53", "Assets, Noncurrent": "-0.470", "Intangible Assets": "-0.388", "Property, Plant and Equipment, Net": "-1.32", "Selling, General and Administrative Expense": "0.511", "Expenses": "-19.7", "Revenues": "72.0", "Net Income": "47.9", "Other Expenses": "-62.0", "Cost of Revenues": "37.4", "Other Revenues": "72.0", "Comprehensive Net Income": "47.7", "Other Net Income": "-1.68", "Economic Capital Ratio": "63.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000082166_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "128,181", "Assets, Noncurrent": "5,695", "Cost of Revenues": "0", "Intangible Assets": "12,362", "Liabilities, Current": "34,335", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "81", "Other Expenses": "243,024", "Other Liabilities": "0", "Other Net Income": "530", "Other Revenues": "314,708", "Property, Plant and Equipment, Net": "41,522", "Selling, General and Administrative Expense": "31,677" }, "output_variables": { "Liabilities": "34,335", "Assets": "187,760", "Expenses": "274,701", "Revenues": "314,708", "Stockholders Equity": "153,425", "Net Income": "40,537", "Comprehensive Net Income": "40,618", "BaseVar": "406,058", "ECR before LimitedLiability": "148%", "Economic Capital Ratio": "187%" } } }, "top_rated": true, "trend": null, "value": 1.873659078915421, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000082166.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000082166.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000082166.svg" }, { "company_id": "0001282637", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001282637.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001282637.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001282637.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001282637_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001282637_main_keyfigs.svg", "name": "Newmarket CORP", "rank": 9, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001282637.svg", "report_text": "The relative strengths and weaknesses of Newmarket CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Newmarket CORP compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 94% points.The greatest weakness of Newmarket CORP is the variable Cost of Revenues, reducing the Economic Capital Ratio by 130% points.

The company's Economic Capital Ratio, given in the ranking table, is 186%, being 63% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001282637_2012_Newmarket_CORP.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "5.82", "Liabilities": "52.0", "Stockholders Equity": "6.56", "ECR before LimitedLiability": "49.7", "Liabilities, Noncurrent": "35.1", "Liabilities, Current": "17.0", "Assets": "-3.53", "Property, Plant and Equipment, Net": "-1.05", "Other Assets": "0.910", "Intangible Assets": "-2.90", "Assets, Noncurrent": "-0.915", "Other Expenses": "53.4", "Expenses": "-33.6", "Revenues": "52.8", "Net Income": "17.3", "Selling, General and Administrative Expense": "7.22", "Cost of Revenues": "-103", "Other Revenues": "52.8", "Comprehensive Net Income": "17.6", "Other Net Income": "-0.420", "Economic Capital Ratio": "47.3" }, "2011": { "Other Liabilities": "10.4", "Liabilities": "62.5", "Stockholders Equity": "13.1", "ECR before LimitedLiability": "77.4", "Liabilities, Noncurrent": "33.4", "Liabilities, Current": "29.1", "Assets, Current": "-0.478", "Assets": "-2.28", "Other Assets": "0.430", "Intangible Assets": "-0.992", "Property, Plant and Equipment, Net": "-1.23", "Selling, General and Administrative Expense": "-3.18", "Expenses": "-29.0", "Revenues": "78.1", "Net Income": "48.6", "Other Expenses": "93.8", "Cost of Revenues": "-130", "Other Revenues": "78.1", "Comprehensive Net Income": "48.4", "Other Net Income": "3.17", "Economic Capital Ratio": "62.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001282637_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "602,775", "Assets, Noncurrent": "48,893", "Cost of Revenues": "1,281,933", "Intangible Assets": "0", "Liabilities, Current": "206,387", "Liabilities, Noncurrent": "0", "Other Assets": "77,097", "Other Compr. Net Income": "0", "Other Expenses": "100,132", "Other Liabilities": "0", "Other Net Income": "-10,047", "Other Revenues": "1,797,392", "Property, Plant and Equipment, Net": "333,976", "Selling, General and Administrative Expense": "228,155" }, "output_variables": { "Liabilities": "206,387", "Assets": "1,062,741", "Expenses": "1,610,220", "Revenues": "1,797,392", "Stockholders Equity": "856,354", "Net Income": "177,125", "Comprehensive Net Income": "177,125", "BaseVar": "2,343,394", "ECR before LimitedLiability": "137%", "Economic Capital Ratio": "180%" } }, "2011": { "input_variables": { "Assets, Current": "679,731", "Assets, Noncurrent": "73,619", "Cost of Revenues": "1,590,531", "Intangible Assets": "0", "Liabilities, Current": "216,024", "Liabilities, Noncurrent": "0", "Other Assets": "85,346", "Other Compr. Net Income": "0", "Other Expenses": "115,630", "Other Liabilities": "0", "Other Net Income": "56,704", "Other Revenues": "2,149,558", "Property, Plant and Equipment, Net": "352,966", "Selling, General and Administrative Expense": "257,098" }, "output_variables": { "Liabilities": "216,024", "Assets": "1,191,662", "Expenses": "1,963,259", "Revenues": "2,149,558", "Stockholders Equity": "975,638", "Net Income": "243,003", "Comprehensive Net Income": "243,003", "BaseVar": "2,788,604", "ECR before LimitedLiability": "147%", "Economic Capital Ratio": "186%" } } }, "top_rated": true, "trend": -7.0, "value": 1.8624927431320637, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001282637.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001282637.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001282637.svg" }, { "company_id": "0001425715", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001425715.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001425715.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001425715_main_keyfigs.svg", "name": "Guanwei Recycling Corp", "rank": 10, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001425715.svg", "report_text": "The relative strengths and weaknesses of Guanwei Recycling Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Guanwei Recycling Corp compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Guanwei Recycling Corp is the variable Other Expenses, reducing the Economic Capital Ratio by 48% points.

The company's Economic Capital Ratio, given in the ranking table, is 183%, being 60% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001425715_2012_Guanwei_Recycling_Corp.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "7.89", "Liabilities": "37.0", "Assets": "-0.976", "Stockholders Equity": "15.2", "ECR before LimitedLiability": "74.3", "Liabilities, Noncurrent": "26.0", "Liabilities, Current": "6.37", "Assets, Current": "3.73", "Intangible Assets": "-1.01", "Property, Plant and Equipment, Net": "-1.76", "Selling, General and Administrative Expense": "16.0", "Expenses": "1.57", "Revenues": "49.8", "Net Income": "50.0", "Other Expenses": "-47.6", "Cost of Revenues": "30.9", "Other Revenues": "49.8", "Comprehensive Net Income": "52.6", "Other Net Income": "-1.44", "Other Compr. Net Income": "2.31", "Economic Capital Ratio": "59.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001425715_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "35,871", "Assets, Noncurrent": "205", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "12,069", "Liabilities, Noncurrent": "0", "Other Assets": "848", "Other Compr. Net Income": "1,067", "Other Expenses": "50,895", "Other Liabilities": "0", "Other Net Income": "88", "Other Revenues": "63,601", "Property, Plant and Equipment, Net": "8,151", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "12,069", "Assets": "45,076", "Expenses": "50,895", "Revenues": "63,601", "Stockholders Equity": "33,007", "Net Income": "12,793", "Comprehensive Net Income": "13,860", "BaseVar": "86,398", "ECR before LimitedLiability": "142%", "Economic Capital Ratio": "183%" } } }, "top_rated": true, "trend": null, "value": 1.8312744368618374, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001425715.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001425715.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001425715.svg" }, { "company_id": "0001410056", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001410056.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001410056.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001410056_main_keyfigs.svg", "name": "Greenhunter Resources Inc", "rank": 11, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001410056.svg", "report_text": "The relative strengths and weaknesses of Greenhunter Resources Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Greenhunter Resources Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 109% points.The greatest weakness of Greenhunter Resources Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 67% points.

The company's Economic Capital Ratio, given in the ranking table, is 183%, being 59% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001410056_2012_Greenhunter_Resources_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-5.20", "Liabilities": "-29.5", "Stockholders Equity": "-12.7", "ECR before LimitedLiability": "74.1", "Liabilities, Noncurrent": "18.0", "Liabilities, Current": "-52.9", "Selling, General and Administrative Expense": "-14.4", "Expenses": "51.8", "Net Income": "100", "Other Expenses": "44.9", "Cost of Revenues": "20.4", "Other Revenues": "-67.5", "Revenues": "-67.5", "Assets, Current": "-2.72", "Other Assets": "0.456", "Assets, Noncurrent": "-0.568", "Intangible Assets": "-0.701", "Property, Plant and Equipment, Net": "6.57", "Comprehensive Net Income": "100", "Other Net Income": "109", "Economic Capital Ratio": "59.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001410056_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "571", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "14,273", "Liabilities, Noncurrent": "0", "Other Assets": "1,702", "Other Compr. Net Income": "0", "Other Expenses": "1,339", "Other Liabilities": "2,076", "Other Net Income": "30,186", "Other Revenues": "1,105", "Property, Plant and Equipment, Net": "20,893", "Selling, General and Administrative Expense": "7,455" }, "output_variables": { "Liabilities": "16,349", "Assets": "23,166", "Expenses": "8,793", "Revenues": "1,105", "Stockholders Equity": "6,817", "Net Income": "22,498", "Comprehensive Net Income": "22,498", "BaseVar": "39,800", "ECR before LimitedLiability": "142%", "Economic Capital Ratio": "183%" } } }, "top_rated": true, "trend": null, "value": 1.8295457187648612, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001410056.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001410056.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001410056.svg" }, { "company_id": "0001286964", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001286964.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001286964.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001286964.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001286964_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001286964_main_keyfigs.svg", "name": "Heron Lake Bioenergy LLC", "rank": 12, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001286964.svg", "report_text": "The relative strengths and weaknesses of Heron Lake Bioenergy LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Heron Lake Bioenergy LLC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 104% points.The greatest weakness of Heron Lake Bioenergy LLC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 181% points.

The company's Economic Capital Ratio, given in the ranking table, is 182%, being 58% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001286964_2012_Heron_Lake_Bioenergy_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "10.2", "Liabilities": "71.0", "Stockholders Equity": "31.8", "ECR before LimitedLiability": "73.2", "Liabilities, Noncurrent": "32.4", "Liabilities, Current": "40.4", "Assets, Current": "-4.09", "Assets": "-2.36", "Assets, Noncurrent": "-0.999", "Intangible Assets": "-1.39", "Property, Plant and Equipment, Net": "9.71", "Selling, General and Administrative Expense": "20.8", "Expenses": "-36.1", "Revenues": "70.4", "Net Income": "25.2", "Other Expenses": "104", "Cost of Revenues": "-181", "Other Revenues": "70.4", "Comprehensive Net Income": "25.0", "Other Net Income": "-5.45", "Economic Capital Ratio": "58.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001286964_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "14,238", "Assets, Noncurrent": "1,303", "Cost of Revenues": "157,164", "Intangible Assets": "0", "Liabilities, Current": "7,808", "Liabilities, Noncurrent": "109", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "3,613", "Other Liabilities": "-109", "Other Net Income": "-2,800", "Other Revenues": "164,120", "Property, Plant and Equipment, Net": "88,593", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "7,808", "Assets": "104,134", "Expenses": "160,777", "Revenues": "164,120", "Stockholders Equity": "96,326", "Net Income": "543", "Comprehensive Net Income": "543", "BaseVar": "219,820", "ECR before LimitedLiability": "140%", "Economic Capital Ratio": "182%" } } }, "top_rated": true, "trend": null, "value": 1.819981081782199, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001286964.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001286964.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001286964.svg" }, { "company_id": "0000310142", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000310142.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000310142.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000310142.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000310142_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000310142_main_keyfigs.svg", "name": "Sensient Technologies CORP", "rank": 13, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000310142.svg", "report_text": "The relative strengths and weaknesses of Sensient Technologies CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Sensient Technologies CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 46% points.The greatest weakness of Sensient Technologies CORP is the variable Other Expenses, reducing the Economic Capital Ratio by 15% points.

The company's Economic Capital Ratio, given in the ranking table, is 181%, being 57% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000310142_2012_Sensient_Technologies_CORP.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "3.84", "Liabilities": "35.2", "Stockholders Equity": "40.8", "ECR before LimitedLiability": "49.6", "Liabilities, Noncurrent": "24.1", "Liabilities, Current": "10.1", "Assets, Current": "1.29", "Assets": "3.11", "Property, Plant and Equipment, Net": "0.387", "Intangible Assets": "2.09", "Assets, Noncurrent": "-0.692", "Other Expenses": "-32.9", "Expenses": "-1.28", "Revenues": "7.99", "Net Income": "7.11", "Selling, General and Administrative Expense": "3.12", "Cost of Revenues": "27.9", "Other Revenues": "7.99", "Comprehensive Net Income": "7.28", "Other Net Income": "0.407", "Economic Capital Ratio": "47.2" }, "2011": { "Other Liabilities": "6.43", "Liabilities": "39.6", "Stockholders Equity": "46.5", "ECR before LimitedLiability": "72.2", "Liabilities, Noncurrent": "21.5", "Liabilities, Current": "16.1", "Assets, Current": "0.756", "Assets": "3.30", "Other Assets": "-0.184", "Assets, Noncurrent": "-0.500", "Intangible Assets": "3.28", "Selling, General and Administrative Expense": "-5.28", "Expenses": "4.48", "Revenues": "20.8", "Net Income": "24.1", "Other Expenses": "-15.4", "Cost of Revenues": "25.2", "Other Revenues": "20.8", "Comprehensive Net Income": "23.9", "Other Net Income": "-1.34", "Economic Capital Ratio": "57.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000310142_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "672,305", "Assets, Noncurrent": "36,093", "Cost of Revenues": "0", "Intangible Assets": "458,334", "Liabilities, Current": "205,063", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "987,254", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "1,328,180", "Property, Plant and Equipment, Net": "432,536", "Selling, General and Administrative Expense": "233,782" }, "output_variables": { "Liabilities": "205,063", "Assets": "1,599,268", "Expenses": "1,221,036", "Revenues": "1,328,180", "Stockholders Equity": "1,394,205", "Net Income": "107,144", "Comprehensive Net Income": "107,144", "BaseVar": "2,176,774", "ECR before LimitedLiability": "137%", "Economic Capital Ratio": "180%" } }, "2011": { "input_variables": { "Assets, Current": "706,870", "Assets, Noncurrent": "38,730", "Cost of Revenues": "0", "Intangible Assets": "457,025", "Liabilities, Current": "207,275", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,051,476", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "1,430,789", "Property, Plant and Equipment, Net": "451,539", "Selling, General and Administrative Expense": "258,829" }, "output_variables": { "Liabilities": "207,275", "Assets": "1,654,164", "Expenses": "1,310,305", "Revenues": "1,430,789", "Stockholders Equity": "1,446,889", "Net Income": "120,484", "Comprehensive Net Income": "120,484", "BaseVar": "2,301,266", "ECR before LimitedLiability": "139%", "Economic Capital Ratio": "181%" } } }, "top_rated": true, "trend": -10.0, "value": 1.8100621722555323, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000310142.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000310142.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000310142.svg" }, { "company_id": "0000084748", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000084748.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000084748.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000084748.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000084748_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000084748_main_keyfigs.svg", "name": "Rogers CORP", "rank": 14, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000084748.svg", "report_text": "The relative strengths and weaknesses of Rogers CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Rogers CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 49% points.The greatest weakness of Rogers CORP is the variable Other Expenses, reducing the Economic Capital Ratio by 9.5% points.

The company's Economic Capital Ratio, given in the ranking table, is 180%, being 57% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000084748_2012_Rogers_CORP.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "6.26", "Liabilities": "39.4", "Stockholders Equity": "49.3", "ECR before LimitedLiability": "71.6", "Liabilities, Noncurrent": "21.0", "Liabilities, Current": "16.4", "Assets, Current": "0.432", "Assets": "4.00", "Other Assets": "6.57", "Intangible Assets": "-0.985", "Property, Plant and Equipment, Net": "-0.625", "Selling, General and Administrative Expense": "-9.22", "Expenses": "5.76", "Revenues": "17.8", "Net Income": "21.6", "Other Expenses": "-9.53", "Cost of Revenues": "24.6", "Other Revenues": "17.8", "Comprehensive Net Income": "21.4", "Other Net Income": "-2.05", "Economic Capital Ratio": "56.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000084748_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "265,632", "Assets, Noncurrent": "32,167", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "78,797", "Liabilities, Noncurrent": "0", "Other Assets": "231,647", "Other Compr. Net Income": "0", "Other Expenses": "385,989", "Other Liabilities": "0", "Other Net Income": "-4,270", "Other Revenues": "553,150", "Property, Plant and Equipment, Net": "148,182", "Selling, General and Administrative Expense": "125,836" }, "output_variables": { "Liabilities": "78,797", "Assets": "677,628", "Expenses": "511,825", "Revenues": "553,150", "Stockholders Equity": "598,831", "Net Income": "37,055", "Comprehensive Net Income": "37,055", "BaseVar": "912,835", "ECR before LimitedLiability": "138%", "Economic Capital Ratio": "180%" } } }, "top_rated": true, "trend": null, "value": 1.8046529216089093, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000084748.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000084748.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000084748.svg" }, { "company_id": "0000060714", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000060714.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000060714.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000060714.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000060714_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000060714_main_keyfigs.svg", "name": "LSB Industries INC", "rank": 15, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000060714.svg", "report_text": "The relative strengths and weaknesses of LSB Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of LSB Industries INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 81% points.The greatest weakness of LSB Industries INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 105% points.

The company's Economic Capital Ratio, given in the ranking table, is 180%, being 56% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000060714_2012_LSB_Industries_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "9.09", "Liabilities": "53.5", "Stockholders Equity": "17.4", "ECR before LimitedLiability": "71.3", "Liabilities, Noncurrent": "29.7", "Liabilities, Current": "22.1", "Assets, Current": "1.19", "Assets": "-2.53", "Other Assets": "-0.280", "Assets, Noncurrent": "-1.00", "Intangible Assets": "-1.41", "Property, Plant and Equipment, Net": "-1.13", "Expenses": "-19.7", "Revenues": "66.7", "Net Income": "41.8", "Other Expenses": "80.6", "Cost of Revenues": "-105", "Other Revenues": "66.7", "Comprehensive Net Income": "41.6", "Other Net Income": "-1.87", "Economic Capital Ratio": "56.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000060714_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "328,106", "Assets, Noncurrent": "7,632", "Cost of Revenues": "582,238", "Intangible Assets": "1,724", "Liabilities, Current": "97,149", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "57,036", "Other Liabilities": "0", "Other Net Income": "265", "Other Revenues": "809,194", "Property, Plant and Equipment, Net": "164,547", "Selling, General and Administrative Expense": "86,343" }, "output_variables": { "Liabilities": "97,149", "Assets": "502,009", "Expenses": "725,617", "Revenues": "809,194", "Stockholders Equity": "404,860", "Net Income": "83,842", "Comprehensive Net Income": "83,842", "BaseVar": "1,067,117", "ECR before LimitedLiability": "137%", "Economic Capital Ratio": "180%" } } }, "top_rated": true, "trend": null, "value": 1.8007415388988481, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000060714.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000060714.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000060714.svg" }, { "company_id": "0001181749", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001181749.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001181749.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001181749.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001181749_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001181749_main_keyfigs.svg", "name": "Granite Falls Energy LLC", "rank": 16, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001181749.svg", "report_text": "The relative strengths and weaknesses of Granite Falls Energy LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Granite Falls Energy LLC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 108% points.The greatest weakness of Granite Falls Energy LLC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 251% points.

The company's Economic Capital Ratio, given in the ranking table, is 179%, being 56% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001181749_2012_Granite_Falls_Energy_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "17.8", "Liabilities": "74.2", "Stockholders Equity": "-6.53", "ECR before LimitedLiability": "70.6", "Liabilities, Noncurrent": "34.5", "Liabilities, Current": "36.0", "Assets, Current": "-3.92", "Assets": "-6.24", "Other Assets": "-0.399", "Assets, Noncurrent": "-1.65", "Intangible Assets": "-2.01", "Selling, General and Administrative Expense": "26.1", "Expenses": "-57.2", "Revenues": "107", "Net Income": "54.2", "Other Expenses": "108", "Cost of Revenues": "-251", "Other Revenues": "107", "Comprehensive Net Income": "53.9", "Other Net Income": "-2.44", "Economic Capital Ratio": "55.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001181749_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "27,542", "Assets, Noncurrent": "0", "Cost of Revenues": "142,353", "Intangible Assets": "0", "Liabilities, Current": "13,680", "Liabilities, Noncurrent": "2,517", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "2,003", "Other Liabilities": "-2,517", "Other Net Income": "126", "Other Revenues": "156,521", "Property, Plant and Equipment, Net": "35,899", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "13,680", "Assets": "63,441", "Expenses": "144,356", "Revenues": "156,521", "Stockholders Equity": "49,761", "Net Income": "12,292", "Comprehensive Net Income": "12,292", "BaseVar": "189,063", "ECR before LimitedLiability": "136%", "Economic Capital Ratio": "179%" } } }, "top_rated": true, "trend": null, "value": 1.793837189003082, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001181749.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001181749.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001181749.svg" }, { "company_id": "0001426780", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001426780.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001426780.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001426780_main_keyfigs.svg", "name": "Soy Energy LLC", "rank": 17, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001426780.svg", "report_text": "The relative strengths and weaknesses of Soy Energy LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Soy Energy LLC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 83% points.The greatest weakness of Soy Energy LLC is the variable Other Revenues, reducing the Economic Capital Ratio by 37% points.

The company's Economic Capital Ratio, given in the ranking table, is 178%, being 54% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001426780_2012_Soy_Energy_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "2.91", "Liabilities": "15.4", "Stockholders Equity": "82.6", "ECR before LimitedLiability": "68.9", "Liabilities, Noncurrent": "10.1", "Liabilities, Current": "2.93", "Assets, Current": "0.155", "Assets": "28.6", "Assets, Noncurrent": "1.24", "Intangible Assets": "-0.552", "Property, Plant and Equipment, Net": "24.6", "Selling, General and Administrative Expense": "5.89", "Expenses": "35.8", "Revenues": "-37.3", "Net Income": "4.47", "Other Expenses": "17.8", "Cost of Revenues": "11.3", "Other Revenues": "-37.3", "Comprehensive Net Income": "4.41", "Other Net Income": "5.78", "Economic Capital Ratio": "54.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001426780_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "4,671", "Assets, Noncurrent": "2,585", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "2,206", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "2,018", "Other Liabilities": "0", "Other Net Income": "1,428", "Other Revenues": "34", "Property, Plant and Equipment, Net": "19,973", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "2,206", "Assets": "27,229", "Expenses": "2,018", "Revenues": "34", "Stockholders Equity": "25,023", "Net Income": "-556", "Comprehensive Net Income": "-556", "BaseVar": "16,458", "ECR before LimitedLiability": "134%", "Economic Capital Ratio": "178%" } } }, "top_rated": true, "trend": null, "value": 1.7776176611418484, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001426780.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001426780.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001426780.svg" }, { "company_id": "0000100790", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000100790.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000100790.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000100790.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000100790_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000100790_main_keyfigs.svg", "name": "Union Carbide CORP NEW", "rank": 18, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000100790.svg", "report_text": "The relative strengths and weaknesses of Union Carbide CORP NEW are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Union Carbide CORP NEW compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 103% points.The greatest weakness of Union Carbide CORP NEW is the variable Other Revenues, reducing the Economic Capital Ratio by 90% points.

The company's Economic Capital Ratio, given in the ranking table, is 175%, being 52% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000100790_2012_Union_Carbide_CORP_NEW.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "6.52", "Liabilities": "41.4", "Stockholders Equity": "45.8", "ECR before LimitedLiability": "66.6", "Liabilities, Noncurrent": "21.9", "Liabilities, Current": "17.5", "Assets, Current": "3.27", "Assets": "3.64", "Other Assets": "5.79", "Intangible Assets": "-1.37", "Property, Plant and Equipment, Net": "-1.86", "Other Revenues": "-89.6", "Revenues": "-89.6", "Net Income": "20.3", "Cost of Revenues": "-78.2", "Comprehensive Net Income": "18.6", "Other Compr. Net Income": "-1.73", "Selling, General and Administrative Expense": "13.5", "Other Net Income": "103", "Other Expenses": "63.9", "Economic Capital Ratio": "51.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000100790_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "4,207,000", "Assets, Noncurrent": "185,000", "Cost of Revenues": "6,493,000", "Intangible Assets": "8,000", "Liabilities, Current": "951,000", "Liabilities, Noncurrent": "0", "Other Assets": "2,005,000", "Other Compr. Net Income": "-106,000", "Other Expenses": "200,000", "Other Liabilities": "0", "Other Net Income": "6,786,000", "Other Revenues": "186,000", "Property, Plant and Equipment, Net": "1,354,000", "Selling, General and Administrative Expense": "10,000" }, "output_variables": { "Liabilities": "951,000", "Assets": "7,759,000", "Expenses": "6,703,000", "Revenues": "186,000", "Stockholders Equity": "6,808,000", "Net Income": "269,000", "Comprehensive Net Income": "163,000", "BaseVar": "11,245,500", "ECR before LimitedLiability": "130%", "Economic Capital Ratio": "175%" } } }, "top_rated": true, "trend": null, "value": 1.7541154149603588, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000100790.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000100790.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000100790.svg" }, { "company_id": "0001306830", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001306830.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001306830.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001306830.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001306830_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001306830_main_keyfigs.svg", "name": "Celanese Corp", "rank": 19, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001306830.svg", "report_text": "The relative strengths and weaknesses of Celanese Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Celanese Corp compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Celanese Corp is the variable Cost of Revenues, reducing the Economic Capital Ratio by 49% points.

The company's Economic Capital Ratio, given in the ranking table, is 174%, being 51% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001306830_2012_Celanese_Corp.pdf", "shrinked_graph_json": { "2009": { "Liabilities, Current": "-6.26", "Liabilities": "28.7", "Assets": "4.71", "Stockholders Equity": "35.8", "ECR before LimitedLiability": "38.0", "Liabilities, Noncurrent": "27.3", "Other Liabilities": "7.55", "Other Assets": "5.79", "Assets, Current": "2.55", "Assets, Noncurrent": "-2.32", "Cost of Revenues": "-27.7", "Expenses": "-1.71", "Revenues": "2.15", "Net Income": "2.31", "Selling, General and Administrative Expense": "1.04", "Other Expenses": "25.6", "Other Revenues": "2.15", "Comprehensive Net Income": "1.38", "Other Net Income": "1.88", "Other Compr. Net Income": "-0.936", "Economic Capital Ratio": "39.8" }, "2010": { "Other Liabilities": "3.33", "Liabilities": "23.7", "Stockholders Equity": "35.9", "ECR before LimitedLiability": "37.6", "Liabilities, Noncurrent": "21.4", "Liabilities, Current": "-0.597", "Assets": "6.18", "Property, Plant and Equipment, Net": "3.49", "Other Assets": "4.11", "Intangible Assets": "-0.695", "Assets, Noncurrent": "-0.808", "Other Expenses": "32.2", "Expenses": "3.34", "Revenues": "-2.12", "Net Income": "4.44", "Selling, General and Administrative Expense": "10.9", "Cost of Revenues": "-38.8", "Other Revenues": "-2.12", "Comprehensive Net Income": "4.60", "Other Net Income": "3.22", "Economic Capital Ratio": "35.2" }, "2011": { "Other Liabilities": "5.95", "Liabilities": "32.6", "Stockholders Equity": "42.3", "ECR before LimitedLiability": "65.7", "Liabilities, Noncurrent": "20.1", "Liabilities, Current": "9.29", "Assets, Current": "-0.931", "Assets": "4.82", "Other Assets": "2.80", "Intangible Assets": "0.707", "Property, Plant and Equipment, Net": "2.36", "Selling, General and Administrative Expense": "4.06", "Expenses": "7.18", "Revenues": "13.1", "Net Income": "23.1", "Other Expenses": "53.5", "Cost of Revenues": "-48.8", "Other Revenues": "13.1", "Comprehensive Net Income": "23.0", "Other Net Income": "2.55", "Economic Capital Ratio": "50.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001306830_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "2,856,000", "Assets, Noncurrent": "311,000", "Cost of Revenues": "4,079,000", "Intangible Assets": "1,092,000", "Liabilities, Current": "1,607,000", "Liabilities, Noncurrent": "0", "Other Assets": "1,354,000", "Other Compr. Net Income": "0", "Other Expenses": "177,000", "Other Liabilities": "0", "Other Net Income": "206,000", "Other Revenues": "5,082,000", "Property, Plant and Equipment, Net": "2,797,000", "Selling, General and Administrative Expense": "544,000" }, "output_variables": { "Liabilities": "1,607,000", "Assets": "8,410,000", "Expenses": "4,800,000", "Revenues": "5,082,000", "Stockholders Equity": "6,803,000", "Net Income": "488,000", "Comprehensive Net Income": "488,000", "BaseVar": "10,052,500", "ECR before LimitedLiability": "120%", "Economic Capital Ratio": "168%" } }, "2010": { "input_variables": { "Assets, Current": "2,668,000", "Assets, Noncurrent": "289,000", "Cost of Revenues": "4,738,000", "Intangible Assets": "1,026,000", "Liabilities, Current": "1,542,000", "Liabilities, Noncurrent": "0", "Other Assets": "1,281,000", "Other Compr. Net Income": "0", "Other Expenses": "439,000", "Other Liabilities": "0", "Other Net Income": "211,000", "Other Revenues": "5,918,000", "Property, Plant and Equipment, Net": "3,017,000", "Selling, General and Administrative Expense": "575,000" }, "output_variables": { "Liabilities": "1,542,000", "Assets": "8,281,000", "Expenses": "5,752,000", "Revenues": "5,918,000", "Stockholders Equity": "6,739,000", "Net Income": "377,000", "Comprehensive Net Income": "377,000", "BaseVar": "10,852,000", "ECR before LimitedLiability": "119%", "Economic Capital Ratio": "168%" } }, "2011": { "input_variables": { "Assets, Current": "2,703,000", "Assets, Noncurrent": "344,000", "Cost of Revenues": "5,329,000", "Intangible Assets": "957,000", "Liabilities, Current": "1,385,000", "Liabilities, Noncurrent": "0", "Other Assets": "1,245,000", "Other Compr. Net Income": "0", "Other Expenses": "483,000", "Other Liabilities": "0", "Other Net Income": "288,000", "Other Revenues": "6,763,000", "Property, Plant and Equipment, Net": "3,269,000", "Selling, General and Administrative Expense": "632,000" }, "output_variables": { "Liabilities": "1,385,000", "Assets": "8,518,000", "Expenses": "6,444,000", "Revenues": "6,763,000", "Stockholders Equity": "7,133,000", "Net Income": "607,000", "Comprehensive Net Income": "607,000", "BaseVar": "11,699,000", "ECR before LimitedLiability": "129%", "Economic Capital Ratio": "174%" } } }, "top_rated": true, "trend": -14.0, "value": 1.7447637775672624, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001306830.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001306830.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001306830.svg" }, { "company_id": "0001041577", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001041577.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001041577.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001041577_main_keyfigs.svg", "name": "ATMI INC", "rank": 20, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001041577.svg", "report_text": "The relative strengths and weaknesses of ATMI INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of ATMI INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 56% points.The greatest weakness of ATMI INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 24% points.

The company's Economic Capital Ratio, given in the ranking table, is 174%, being 51% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001041577_2012_ATMI_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "6.12", "Liabilities": "42.3", "Stockholders Equity": "56.0", "ECR before LimitedLiability": "65.5", "Liabilities, Noncurrent": "20.6", "Liabilities, Current": "20.1", "Assets, Current": "4.12", "Assets": "6.20", "Other Assets": "0.634", "Intangible Assets": "1.95", "Property, Plant and Equipment, Net": "-0.654", "Selling, General and Administrative Expense": "-19.6", "Expenses": "-0.917", "Revenues": "12.9", "Net Income": "10.4", "Other Expenses": "44.7", "Cost of Revenues": "-24.2", "Other Revenues": "12.9", "Comprehensive Net Income": "10.3", "Other Net Income": "-1.47", "Economic Capital Ratio": "50.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001041577_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "271,188", "Assets, Noncurrent": "20,638", "Cost of Revenues": "205,957", "Intangible Assets": "83,117", "Liabilities, Current": "44,956", "Liabilities, Noncurrent": "0", "Other Assets": "22,468", "Other Compr. Net Income": "0", "Other Expenses": "66,251", "Other Liabilities": "0", "Other Net Income": "-644", "Other Revenues": "390,087", "Property, Plant and Equipment, Net": "116,275", "Selling, General and Administrative Expense": "137,254" }, "output_variables": { "Liabilities": "44,956", "Assets": "513,686", "Expenses": "409,462", "Revenues": "390,087", "Stockholders Equity": "468,730", "Net Income": "-20,019", "Comprehensive Net Income": "-20,019", "BaseVar": "679,418", "ECR before LimitedLiability": "129%", "Economic Capital Ratio": "174%" } } }, "top_rated": true, "trend": null, "value": 1.7435408947897022, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001041577.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001041577.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001041577.svg" }, { "company_id": "0001350420", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001350420.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001350420.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001350420.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001350420_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001350420_main_keyfigs.svg", "name": "Lincolnway Energy LLC", "rank": 21, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001350420.svg", "report_text": "The relative strengths and weaknesses of Lincolnway Energy LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Lincolnway Energy LLC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 111% points.The greatest weakness of Lincolnway Energy LLC is the variable Other Expenses, reducing the Economic Capital Ratio by 234% points.

The company's Economic Capital Ratio, given in the ranking table, is 173%, being 50% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001350420_2012_Lincolnway_Energy_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "17.2", "Liabilities": "95.7", "Stockholders Equity": "-10.5", "ECR before LimitedLiability": "64.3", "Liabilities, Noncurrent": "37.2", "Liabilities, Current": "60.8", "Assets, Current": "-8.55", "Assets": "-10.6", "Assets, Noncurrent": "-2.39", "Intangible Assets": "-3.28", "Property, Plant and Equipment, Net": "1.34", "Selling, General and Administrative Expense": "32.7", "Expenses": "-102", "Revenues": "111", "Net Income": "40.9", "Other Expenses": "-234", "Cost of Revenues": "67.2", "Other Revenues": "111", "Comprehensive Net Income": "40.6", "Other Net Income": "-4.37", "Economic Capital Ratio": "49.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001350420_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "15,275", "Assets, Noncurrent": "1,230", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "4,871", "Liabilities, Noncurrent": "4,368", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "172,467", "Other Liabilities": "-1,180", "Other Net Income": "-584", "Other Revenues": "173,951", "Property, Plant and Equipment, Net": "44,693", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "8,059", "Assets": "61,199", "Expenses": "172,467", "Revenues": "173,951", "Stockholders Equity": "53,139", "Net Income": "900", "Comprehensive Net Income": "900", "BaseVar": "208,130", "ECR before LimitedLiability": "127%", "Economic Capital Ratio": "173%" } } }, "top_rated": true, "trend": null, "value": 1.7312771111715208, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001350420.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001350420.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001350420.svg" }, { "company_id": "0001122976", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001122976.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001122976.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001122976.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001122976_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001122976_main_keyfigs.svg", "name": "Avient CORP", "rank": 22, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001122976.svg", "report_text": "The relative strengths and weaknesses of Avient CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Avient CORP compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 46% points.The greatest weakness of Avient CORP is the variable Other Expenses, reducing the Economic Capital Ratio by 50% points.

The company's Economic Capital Ratio, given in the ranking table, is 168%, being 44% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001122976_2012_Avient_CORP.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "8.05", "Liabilities": "46.0", "Stockholders Equity": "18.6", "ECR before LimitedLiability": "59.0", "Liabilities, Noncurrent": "26.8", "Liabilities, Current": "16.0", "Assets, Current": "-2.87", "Assets": "-3.27", "Assets, Noncurrent": "-0.981", "Intangible Assets": "7.23", "Property, Plant and Equipment, Net": "-4.14", "Selling, General and Administrative Expense": "-2.41", "Expenses": "-17.8", "Revenues": "44.4", "Net Income": "31.0", "Other Expenses": "-50.3", "Cost of Revenues": "35.4", "Other Revenues": "44.4", "Comprehensive Net Income": "30.8", "Other Net Income": "6.15", "Economic Capital Ratio": "44.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001122976_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "843,500", "Assets, Noncurrent": "95,400", "Cost of Revenues": "0", "Intangible Assets": "739,200", "Liabilities, Current": "442,400", "Liabilities, Noncurrent": "0", "Other Assets": "8,800", "Other Compr. Net Income": "0", "Other Expenses": "2,460,600", "Other Liabilities": "0", "Other Net Income": "151,400", "Other Revenues": "2,863,500", "Property, Plant and Equipment, Net": "393,600", "Selling, General and Administrative Expense": "381,700" }, "output_variables": { "Liabilities": "442,400", "Assets": "2,080,500", "Expenses": "2,842,300", "Revenues": "2,863,500", "Stockholders Equity": "1,638,100", "Net Income": "172,600", "Comprehensive Net Income": "172,600", "BaseVar": "4,190,050", "ECR before LimitedLiability": "119%", "Economic Capital Ratio": "168%" } } }, "top_rated": true, "trend": null, "value": 1.6783542859271248, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001122976.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001122976.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001122976.svg" }, { "company_id": "0000896622", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000896622.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000896622.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000896622.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000896622_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000896622_main_keyfigs.svg", "name": "Aptargroup INC", "rank": 23, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000896622.svg", "report_text": "The relative strengths and weaknesses of Aptargroup INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Aptargroup INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 60% points.The greatest weakness of Aptargroup INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 51% points.

The company's Economic Capital Ratio, given in the ranking table, is 164%, being 40% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000896622_2012_Aptargroup_INC.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "3.95", "Liabilities": "29.7", "Stockholders Equity": "24.2", "ECR before LimitedLiability": "38.6", "Liabilities, Noncurrent": "25.0", "Liabilities, Current": "1.85", "Assets, Current": "3.33", "Assets": "1.09", "Property, Plant and Equipment, Net": "1.75", "Intangible Assets": "-1.53", "Assets, Noncurrent": "-1.68", "Other Expenses": "33.5", "Expenses": "-5.92", "Revenues": "15.0", "Net Income": "8.62", "Selling, General and Administrative Expense": "6.05", "Cost of Revenues": "-44.9", "Other Revenues": "15.0", "Comprehensive Net Income": "8.81", "Other Net Income": "-0.290", "Economic Capital Ratio": "36.2" }, "2011": { "Other Liabilities": "6.45", "Liabilities": "30.5", "Stockholders Equity": "25.3", "ECR before LimitedLiability": "55.1", "Liabilities, Noncurrent": "21.8", "Liabilities, Current": "4.00", "Assets, Current": "2.35", "Assets": "1.26", "Other Assets": "-0.381", "Assets, Noncurrent": "-1.62", "Intangible Assets": "0.499", "Property, Plant and Equipment, Net": "0.625", "Other Revenues": "29.3", "Revenues": "29.3", "Net Income": "27.0", "Cost of Revenues": "-51.2", "Comprehensive Net Income": "26.8", "Selling, General and Administrative Expense": "-2.99", "Other Net Income": "-2.06", "Other Expenses": "59.7", "Economic Capital Ratio": "40.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000896622_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "1,063,983", "Assets, Noncurrent": "10,627", "Cost of Revenues": "1,378,792", "Intangible Assets": "232,271", "Liabilities, Current": "423,322", "Liabilities, Noncurrent": "0", "Other Assets": "853", "Other Compr. Net Income": "0", "Other Expenses": "213,848", "Other Liabilities": "0", "Other Net Income": "-13,629", "Other Revenues": "2,076,719", "Property, Plant and Equipment, Net": "724,984", "Selling, General and Administrative Expense": "296,861" }, "output_variables": { "Liabilities": "423,322", "Assets": "2,032,718", "Expenses": "1,889,501", "Revenues": "2,076,719", "Stockholders Equity": "1,609,396", "Net Income": "173,589", "Comprehensive Net Income": "173,589", "BaseVar": "3,217,944", "ECR before LimitedLiability": "120%", "Economic Capital Ratio": "169%" } }, "2011": { "input_variables": { "Assets, Current": "1,143,950", "Assets, Noncurrent": "18,755", "Cost of Revenues": "1,568,286", "Intangible Assets": "238,063", "Liabilities, Current": "518,849", "Liabilities, Noncurrent": "0", "Other Assets": "3,812", "Other Compr. Net Income": "0", "Other Expenses": "225,484", "Other Liabilities": "0", "Other Net Income": "-12,154", "Other Revenues": "2,337,183", "Property, Plant and Equipment, Net": "754,715", "Selling, General and Administrative Expense": "347,629" }, "output_variables": { "Liabilities": "518,849", "Assets": "2,159,295", "Expenses": "2,141,399", "Revenues": "2,337,183", "Stockholders Equity": "1,640,446", "Net Income": "183,630", "Comprehensive Net Income": "183,630", "BaseVar": "3,584,440", "ECR before LimitedLiability": "113%", "Economic Capital Ratio": "164%" } } }, "top_rated": false, "trend": -19.0, "value": 1.6390984238811726, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000896622.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000896622.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000896622.svg" }, { "company_id": "0001473597", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001473597.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001473597.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001473597.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001473597_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001473597_main_keyfigs.svg", "name": "STR Holdings INC", "rank": 24, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001473597.svg", "report_text": "The relative strengths and weaknesses of STR Holdings INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of STR Holdings INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 45% points.The greatest weakness of STR Holdings INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 23% points.

The company's Economic Capital Ratio, given in the ranking table, is 163%, being 40% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001473597_2012_STR_Holdings_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-14.3", "Liabilities": "25.5", "Stockholders Equity": "45.4", "ECR before LimitedLiability": "54.3", "Liabilities, Noncurrent": "17.0", "Liabilities, Current": "21.5", "Assets, Current": "-1.75", "Assets": "10.3", "Assets, Noncurrent": "-1.47", "Intangible Assets": "25.0", "Property, Plant and Equipment, Net": "-2.37", "Selling, General and Administrative Expense": "2.90", "Expenses": "8.73", "Revenues": "-5.16", "Net Income": "2.41", "Other Expenses": "30.3", "Cost of Revenues": "-23.0", "Other Revenues": "-5.16", "Comprehensive Net Income": "12.8", "Other Compr. Net Income": "10.3", "Economic Capital Ratio": "39.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001473597_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "110,306", "Assets, Noncurrent": "650", "Cost of Revenues": "160,446", "Intangible Assets": "226,436", "Liabilities, Current": "20,827", "Liabilities, Noncurrent": "2,174", "Other Assets": "1,225", "Other Compr. Net Income": "36,552", "Other Expenses": "81,413", "Other Liabilities": "48,585", "Other Net Income": "394", "Other Revenues": "232,431", "Property, Plant and Equipment, Net": "63,474", "Selling, General and Administrative Expense": "30,394" }, "output_variables": { "Liabilities": "71,586", "Assets": "402,091", "Expenses": "272,253", "Revenues": "232,431", "Stockholders Equity": "330,505", "Net Income": "-39,428", "Comprehensive Net Income": "-2,876", "BaseVar": "507,654", "ECR before LimitedLiability": "112%", "Economic Capital Ratio": "163%" } } }, "top_rated": false, "trend": null, "value": 1.6316295007977937, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001473597.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001473597.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001473597.svg" }, { "company_id": "0001337298", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001337298.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001337298.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001337298.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001337298_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001337298_main_keyfigs.svg", "name": "Futurefuel Corp", "rank": 25, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001337298.svg", "report_text": "The relative strengths and weaknesses of Futurefuel Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Futurefuel Corp compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 31% points.The greatest weakness of Futurefuel Corp is the variable Other Expenses, reducing the Economic Capital Ratio by 20% points.

The company's Economic Capital Ratio, given in the ranking table, is 163%, being 39% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001337298_2012_Futurefuel_Corp.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "6.44", "Liabilities": "19.6", "Stockholders Equity": "31.5", "ECR before LimitedLiability": "54.2", "Liabilities, Noncurrent": "-4.52", "Liabilities, Current": "17.7", "Assets, Current": "8.68", "Assets": "6.45", "Other Assets": "-7.73", "Assets, Noncurrent": "11.1", "Intangible Assets": "-1.93", "Property, Plant and Equipment, Net": "2.65", "Selling, General and Administrative Expense": "9.14", "Expenses": "12.1", "Revenues": "11.2", "Net Income": "24.3", "Other Expenses": "-19.7", "Cost of Revenues": "23.5", "Other Revenues": "11.2", "Comprehensive Net Income": "24.6", "Economic Capital Ratio": "39.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001337298_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "242,525", "Assets, Noncurrent": "142,719", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "35,799", "Liabilities, Noncurrent": "64,230", "Other Assets": "-140,517", "Other Compr. Net Income": "1,278", "Other Expenses": "266,396", "Other Liabilities": "-3,023", "Other Net Income": "6,431", "Other Revenues": "304,614", "Property, Plant and Equipment, Net": "140,517", "Selling, General and Administrative Expense": "10,140" }, "output_variables": { "Liabilities": "97,006", "Assets": "385,244", "Expenses": "276,536", "Revenues": "304,614", "Stockholders Equity": "288,238", "Net Income": "34,509", "Comprehensive Net Income": "35,787", "BaseVar": "535,554", "ECR before LimitedLiability": "112%", "Economic Capital Ratio": "163%" } } }, "top_rated": false, "trend": null, "value": 1.6306181153153458, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001337298.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001337298.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001337298.svg" }, { "company_id": "0000029915", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000029915.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000029915.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000029915.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000029915_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000029915_main_keyfigs.svg", "name": "DOW Chemical CO DE", "rank": 26, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000029915.svg", "report_text": "The relative strengths and weaknesses of DOW Chemical CO DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of DOW Chemical CO DE compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 59% points.The greatest weakness of DOW Chemical CO DE is the variable Cost of Revenues, reducing the Economic Capital Ratio by 58% points.

The company's Economic Capital Ratio, given in the ranking table, is 163%, being 39% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000029915_2012_DOW_Chemical_CO_DE.pdf", "shrinked_graph_json": { "2009": { "Liabilities, Current": "-5.08", "Liabilities": "31.6", "Stockholders Equity": "31.6", "ECR before LimitedLiability": "32.3", "Liabilities, Noncurrent": "29.0", "Other Liabilities": "8.00", "Other Assets": "3.96", "Assets": "2.97", "Property, Plant and Equipment, Net": "-2.65", "Intangible Assets": "4.34", "Assets, Noncurrent": "-2.54", "Cost of Revenues": "-37.2", "Expenses": "-9.93", "Revenues": "4.76", "Net Income": "-3.36", "Selling, General and Administrative Expense": "4.81", "Other Expenses": "23.3", "Other Revenues": "4.76", "Comprehensive Net Income": "-3.59", "Other Net Income": "1.90", "Economic Capital Ratio": "34.1" }, "2010": { "Other Liabilities": "3.40", "Liabilities": "23.8", "Stockholders Equity": "32.4", "ECR before LimitedLiability": "33.4", "Liabilities, Noncurrent": "21.9", "Liabilities, Current": "-1.22", "Assets": "5.48", "Property, Plant and Equipment, Net": "0.180", "Other Assets": "2.02", "Intangible Assets": "3.16", "Assets, Noncurrent": "-0.262", "Other Expenses": "33.3", "Expenses": "0.490", "Net Income": "3.03", "Selling, General and Administrative Expense": "15.5", "Cost of Revenues": "-46.7", "Other Revenues": "0.0246", "Revenues": "0.0246", "Comprehensive Net Income": "2.37", "Other Compr. Net Income": "-0.659", "Other Net Income": "2.51", "Economic Capital Ratio": "30.9" }, "2011": { "Other Liabilities": "5.91", "Liabilities": "30.1", "Stockholders Equity": "36.3", "ECR before LimitedLiability": "54.1", "Liabilities, Noncurrent": "20.1", "Liabilities, Current": "5.98", "Assets, Current": "-1.53", "Assets": "5.03", "Other Assets": "2.34", "Intangible Assets": "5.95", "Property, Plant and Equipment, Net": "-1.06", "Selling, General and Administrative Expense": "8.71", "Expenses": "4.22", "Revenues": "15.9", "Net Income": "20.5", "Other Expenses": "58.6", "Cost of Revenues": "-57.9", "Other Revenues": "15.9", "Comprehensive Net Income": "17.6", "Other Compr. Net Income": "-2.75", "Economic Capital Ratio": "39.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000029915_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "19,560,000", "Assets, Noncurrent": "4,016,000", "Cost of Revenues": "39,148,000", "Intangible Assets": "19,080,000", "Liabilities, Current": "13,106,000", "Liabilities, Noncurrent": "0", "Other Assets": "5,140,000", "Other Compr. Net Income": "469,000", "Other Expenses": "4,234,000", "Other Liabilities": "0", "Other Net Income": "1,670,000", "Other Revenues": "44,875,000", "Property, Plant and Equipment, Net": "18,141,000", "Selling, General and Administrative Expense": "2,487,000" }, "output_variables": { "Liabilities": "13,106,000", "Assets": "65,937,000", "Expenses": "45,869,000", "Revenues": "44,875,000", "Stockholders Equity": "52,831,000", "Net Income": "676,000", "Comprehensive Net Income": "1,145,000", "BaseVar": "85,963,000", "ECR before LimitedLiability": "111%", "Economic Capital Ratio": "163%" } }, "2010": { "input_variables": { "Assets, Current": "23,781,000", "Assets, Noncurrent": "4,413,000", "Cost of Revenues": "45,780,000", "Intangible Assets": "18,497,000", "Liabilities, Current": "13,896,000", "Liabilities, Noncurrent": "0", "Other Assets": "5,229,000", "Other Compr. Net Income": "-518,000", "Other Expenses": "4,292,000", "Other Liabilities": "0", "Other Net Income": "1,328,000", "Other Revenues": "53,674,000", "Property, Plant and Equipment, Net": "17,668,000", "Selling, General and Administrative Expense": "2,609,000" }, "output_variables": { "Liabilities": "13,896,000", "Assets": "69,588,000", "Expenses": "52,681,000", "Revenues": "53,674,000", "Stockholders Equity": "55,692,000", "Net Income": "2,321,000", "Comprehensive Net Income": "1,803,000", "BaseVar": "95,842,500", "ECR before LimitedLiability": "112%", "Economic Capital Ratio": "164%" } }, "2011": { "input_variables": { "Assets, Current": "23,422,000", "Assets, Noncurrent": "4,129,000", "Cost of Revenues": "51,029,000", "Intangible Assets": "17,991,000", "Liabilities, Current": "13,634,000", "Liabilities, Noncurrent": "0", "Other Assets": "6,383,000", "Other Compr. Net Income": "-1,639,000", "Other Expenses": "4,331,000", "Other Liabilities": "0", "Other Net Income": "947,000", "Other Revenues": "59,985,000", "Property, Plant and Equipment, Net": "17,299,000", "Selling, General and Administrative Expense": "2,788,000" }, "output_variables": { "Liabilities": "13,634,000", "Assets": "69,224,000", "Expenses": "58,148,000", "Revenues": "59,985,000", "Stockholders Equity": "55,590,000", "Net Income": "2,784,000", "Comprehensive Net Income": "1,145,000", "BaseVar": "101,788,500", "ECR before LimitedLiability": "111%", "Economic Capital Ratio": "163%" } } }, "top_rated": false, "trend": -19.0, "value": 1.6291705843429782, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000029915.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000029915.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000029915.svg" }, { "company_id": "0000069488", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000069488.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000069488.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000069488.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000069488_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000069488_main_keyfigs.svg", "name": "Myers Industries INC", "rank": 27, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000069488.svg", "report_text": "The relative strengths and weaknesses of Myers Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Myers Industries INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 75% points.The greatest weakness of Myers Industries INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 107% points.

The company's Economic Capital Ratio, given in the ranking table, is 158%, being 35% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000069488_2012_Myers_Industries_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "8.81", "Liabilities": "49.5", "Stockholders Equity": "5.33", "ECR before LimitedLiability": "49.5", "Liabilities, Noncurrent": "29.4", "Liabilities, Current": "16.4", "Assets, Current": "-3.50", "Assets": "-8.47", "Other Assets": "-4.52", "Assets, Noncurrent": "1.84", "Property, Plant and Equipment, Net": "-3.74", "Selling, General and Administrative Expense": "21.0", "Expenses": "-31.0", "Revenues": "74.6", "Net Income": "31.8", "Other Expenses": "54.1", "Cost of Revenues": "-107", "Other Revenues": "74.6", "Comprehensive Net Income": "31.6", "Other Net Income": "-2.07", "Economic Capital Ratio": "34.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000069488_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "218,452", "Assets, Noncurrent": "69,371", "Cost of Revenues": "557,385", "Intangible Assets": "61,933", "Liabilities, Current": "110,656", "Liabilities, Noncurrent": "0", "Other Assets": "-61,933", "Other Compr. Net Income": "0", "Other Expenses": "173,764", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "755,654", "Property, Plant and Equipment, Net": "140,934", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "110,656", "Assets": "428,757", "Expenses": "731,149", "Revenues": "755,654", "Stockholders Equity": "318,101", "Net Income": "24,505", "Comprehensive Net Income": "24,505", "BaseVar": "1,013,108", "ECR before LimitedLiability": "105%", "Economic Capital Ratio": "158%" } } }, "top_rated": false, "trend": null, "value": 1.5834777366339954, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000069488.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000069488.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000069488.svg" }, { "company_id": "0000072162", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000072162.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000072162.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000072162.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000072162_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000072162_main_keyfigs.svg", "name": "NL Industries INC", "rank": 28, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000072162.svg", "report_text": "The relative strengths and weaknesses of NL Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of NL Industries INC compared to the market average is the variable Assets, Noncurrent, increasing the Economic Capital Ratio by 66% points.The greatest weakness of NL Industries INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 42% points.

The company's Economic Capital Ratio, given in the ranking table, is 153%, being 29% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000072162_2012_NL_Industries_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "3.55", "Liabilities": "-17.2", "Assets": "16.3", "Stockholders Equity": "19.8", "ECR before LimitedLiability": "44.2", "Liabilities, Noncurrent": "-41.6", "Liabilities, Current": "14.1", "Assets, Current": "-5.72", "Assets, Noncurrent": "65.9", "Property, Plant and Equipment, Net": "-4.03", "Selling, General and Administrative Expense": "5.24", "Expenses": "42.2", "Revenues": "-32.5", "Net Income": "20.8", "Other Expenses": "18.2", "Cost of Revenues": "16.2", "Other Revenues": "-32.5", "Comprehensive Net Income": "35.3", "Other Net Income": "15.3", "Other Compr. Net Income": "13.1", "Economic Capital Ratio": "29.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000072162_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "58,304", "Assets, Noncurrent": "651,136", "Cost of Revenues": "0", "Intangible Assets": "47,553", "Liabilities, Current": "40,806", "Liabilities, Noncurrent": "294,444", "Other Assets": "-47,553", "Other Compr. Net Income": "103,105", "Other Expenses": "158,293", "Other Liabilities": "0", "Other Net Income": "126,393", "Other Revenues": "138,835", "Property, Plant and Equipment, Net": "51,802", "Selling, General and Administrative Expense": "24,280" }, "output_variables": { "Liabilities": "335,250", "Assets": "761,242", "Expenses": "182,573", "Revenues": "138,835", "Stockholders Equity": "425,992", "Net Income": "82,655", "Comprehensive Net Income": "185,760", "BaseVar": "823,699", "ECR before LimitedLiability": "97%", "Economic Capital Ratio": "153%" } } }, "top_rated": false, "trend": null, "value": 1.5306480502421889, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000072162.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000072162.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000072162.svg" }, { "company_id": "0000842295", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000842295.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000842295.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000842295.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000842295_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000842295_main_keyfigs.svg", "name": "TOR Minerals International INC", "rank": 29, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000842295.svg", "report_text": "The relative strengths and weaknesses of TOR Minerals International INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of TOR Minerals International INC compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 25% points.The greatest weakness of TOR Minerals International INC is the variable Other Expenses, reducing the Economic Capital Ratio by 14% points.

The company's Economic Capital Ratio, given in the ranking table, is 153%, being 29% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000842295_2012_TOR_Minerals_International_INC.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "15.3", "Stockholders Equity": "24.2", "ECR before LimitedLiability": "44.1", "Liabilities, Noncurrent": "11.5", "Liabilities, Current": "3.68", "Assets, Current": "7.40", "Assets": "5.99", "Assets, Noncurrent": "-2.11", "Intangible Assets": "-2.61", "Property, Plant and Equipment, Net": "5.00", "Selling, General and Administrative Expense": "1.62", "Expenses": "11.2", "Revenues": "13.6", "Net Income": "24.1", "Other Expenses": "-14.1", "Cost of Revenues": "25.0", "Other Revenues": "13.6", "Comprehensive Net Income": "22.3", "Other Net Income": "-1.30", "Other Compr. Net Income": "-1.67", "Economic Capital Ratio": "29.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000842295_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "27,807", "Assets, Noncurrent": "22", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "10,094", "Liabilities, Noncurrent": "2,668", "Other Assets": "0", "Other Compr. Net Income": "-713", "Other Expenses": "32,246", "Other Liabilities": "1,780", "Other Net Income": "-13", "Other Revenues": "41,021", "Property, Plant and Equipment, Net": "20,138", "Selling, General and Administrative Expense": "4,926" }, "output_variables": { "Liabilities": "14,542", "Assets": "47,967", "Expenses": "37,172", "Revenues": "41,021", "Stockholders Equity": "33,425", "Net Income": "3,836", "Comprehensive Net Income": "3,123", "BaseVar": "70,714", "ECR before LimitedLiability": "97%", "Economic Capital Ratio": "153%" } } }, "top_rated": false, "trend": null, "value": 1.5292617021319415, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000842295.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000842295.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000842295.svg" }, { "company_id": "0000922247", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000922247.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000922247.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000922247.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000922247_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000922247_main_keyfigs.svg", "name": "Cyclo Therapeutics Inc", "rank": 30, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000922247.svg", "report_text": "The relative strengths and weaknesses of Cyclo Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Cyclo Therapeutics Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Cyclo Therapeutics Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 14% points.

The company's Economic Capital Ratio, given in the ranking table, is 152%, being 28% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000922247_2012_Cyclo_Therapeutics_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "3.83", "Liabilities": "7.49", "Stockholders Equity": "47.8", "ECR before LimitedLiability": "42.9", "Liabilities, Noncurrent": "13.4", "Liabilities, Current": "-10.7", "Assets, Current": "-5.14", "Assets": "25.3", "Assets, Noncurrent": "10.5", "Intangible Assets": "-1.97", "Property, Plant and Equipment, Net": "25.0", "Selling, General and Administrative Expense": "9.09", "Expenses": "23.7", "Revenues": "-13.8", "Net Income": "6.74", "Other Expenses": "-3.50", "Cost of Revenues": "17.8", "Other Revenues": "-13.8", "Comprehensive Net Income": "6.65", "Other Net Income": "-1.85", "Economic Capital Ratio": "28.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000922247_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "316", "Assets, Noncurrent": "752", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "652", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,106", "Other Liabilities": "0", "Other Net Income": "-24", "Other Revenues": "1,032", "Property, Plant and Equipment, Net": "1,722", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "652", "Assets": "2,790", "Expenses": "1,106", "Revenues": "1,032", "Stockholders Equity": "2,138", "Net Income": "-98", "Comprehensive Net Income": "-98", "BaseVar": "2,802", "ECR before LimitedLiability": "95%", "Economic Capital Ratio": "152%" } } }, "top_rated": false, "trend": null, "value": 1.5176254494958195, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000922247.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000922247.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000922247.svg" }, { "company_id": "0000038264", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000038264.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000038264.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000038264.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000038264_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000038264_main_keyfigs.svg", "name": "Forward Industries Inc", "rank": 31, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000038264.svg", "report_text": "The relative strengths and weaknesses of Forward Industries Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Forward Industries Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 43% points.The greatest weakness of Forward Industries Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 64% points.

The company's Economic Capital Ratio, given in the ranking table, is 152%, being 28% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000038264_2012_Forward_Industries_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "2.56", "Liabilities": "41.5", "Stockholders Equity": "37.1", "ECR before LimitedLiability": "42.8", "Liabilities, Noncurrent": "22.8", "Liabilities, Current": "19.4", "Assets, Current": "43.1", "Assets": "1.63", "Assets, Noncurrent": "-2.61", "Intangible Assets": "-3.38", "Property, Plant and Equipment, Net": "-9.71", "Selling, General and Administrative Expense": "16.3", "Expenses": "-18.3", "Revenues": "24.5", "Net Income": "3.29", "Other Expenses": "-63.7", "Cost of Revenues": "32.5", "Other Revenues": "24.5", "Comprehensive Net Income": "3.14", "Other Net Income": "-1.31", "Economic Capital Ratio": "28.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000038264_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "21,869", "Assets, Noncurrent": "89", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "2,948", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "25,736", "Other Liabilities": "630", "Other Net Income": "58", "Other Revenues": "22,777", "Property, Plant and Equipment, Net": "302", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "3,578", "Assets": "22,260", "Expenses": "25,736", "Revenues": "22,777", "Stockholders Equity": "18,683", "Net Income": "-2,901", "Comprehensive Net Income": "-2,901", "BaseVar": "37,205", "ECR before LimitedLiability": "95%", "Economic Capital Ratio": "152%" } } }, "top_rated": false, "trend": null, "value": 1.516043721360546, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000038264.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000038264.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000038264.svg" }, { "company_id": "0000744187", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000744187.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000744187.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000744187_main_keyfigs.svg", "name": "REX American Resources Corp", "rank": 32, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000744187.svg", "report_text": "The relative strengths and weaknesses of REX American Resources Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of REX American Resources Corp compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 56% points.The greatest weakness of REX American Resources Corp is the variable Cost of Revenues, reducing the Economic Capital Ratio by 52% points.

The company's Economic Capital Ratio, given in the ranking table, is 151%, being 28% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000744187_2012_REX_American_Resources_Corp.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "5.37", "Liabilities": "18.0", "Stockholders Equity": "27.1", "ECR before LimitedLiability": "42.6", "Liabilities, Noncurrent": "-10.3", "Liabilities, Current": "21.8", "Assets, Current": "-2.08", "Assets": "6.44", "Assets, Noncurrent": "5.28", "Intangible Assets": "-2.75", "Property, Plant and Equipment, Net": "6.84", "Selling, General and Administrative Expense": "10.0", "Expenses": "6.45", "Revenues": "8.29", "Net Income": "18.0", "Other Expenses": "56.3", "Cost of Revenues": "-51.5", "Other Revenues": "8.29", "Comprehensive Net Income": "17.9", "Other Net Income": "2.86", "Economic Capital Ratio": "27.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000744187_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "125,849", "Assets, Noncurrent": "73,256", "Cost of Revenues": "270,777", "Intangible Assets": "0", "Liabilities, Current": "24,567", "Liabilities, Noncurrent": "81,191", "Other Assets": "6,806", "Other Compr. Net Income": "0", "Other Expenses": "27,000", "Other Liabilities": "0", "Other Net Income": "14,524", "Other Revenues": "301,717", "Property, Plant and Equipment, Net": "169,811", "Selling, General and Administrative Expense": "9,722" }, "output_variables": { "Liabilities": "105,758", "Assets": "375,722", "Expenses": "307,499", "Revenues": "301,717", "Stockholders Equity": "269,964", "Net Income": "8,742", "Comprehensive Net Income": "8,742", "BaseVar": "552,610", "ECR before LimitedLiability": "94%", "Economic Capital Ratio": "151%" } } }, "top_rated": false, "trend": null, "value": 1.514520364091779, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000744187.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000744187.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000744187.svg" }, { "company_id": "0000812701", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000812701.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000812701.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000812701.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000812701_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000812701_main_keyfigs.svg", "name": "Calgon Carbon Corp", "rank": 33, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000812701.svg", "report_text": "The relative strengths and weaknesses of Calgon Carbon Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Calgon Carbon Corp compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Calgon Carbon Corp is the variable Other Expenses, reducing the Economic Capital Ratio by 15% points.

The company's Economic Capital Ratio, given in the ranking table, is 150%, being 26% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000812701_2012_Calgon_Carbon_Corp.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "-10.1", "Liabilities": "14.6", "Stockholders Equity": "13.5", "ECR before LimitedLiability": "20.9", "Liabilities, Noncurrent": "21.6", "Liabilities, Current": "1.62", "Assets, Current": "5.91", "Assets": "1.45", "Property, Plant and Equipment, Net": "3.30", "Intangible Assets": "-3.77", "Assets, Noncurrent": "-2.51", "Other Expenses": "-33.1", "Expenses": "-1.78", "Revenues": "7.33", "Net Income": "6.60", "Selling, General and Administrative Expense": "3.46", "Cost of Revenues": "30.9", "Other Revenues": "7.33", "Comprehensive Net Income": "6.13", "Other Net Income": "1.08", "Economic Capital Ratio": "18.5" }, "2011": { "Other Liabilities": "-8.61", "Liabilities": "17.9", "Assets": "2.87", "Stockholders Equity": "19.2", "ECR before LimitedLiability": "40.9", "Liabilities, Noncurrent": "19.3", "Liabilities, Current": "6.55", "Assets, Current": "2.69", "Assets, Noncurrent": "-2.28", "Property, Plant and Equipment, Net": "4.32", "Selling, General and Administrative Expense": "-4.59", "Expenses": "5.64", "Revenues": "19.9", "Net Income": "24.7", "Other Expenses": "-15.4", "Cost of Revenues": "27.5", "Other Revenues": "19.9", "Comprehensive Net Income": "22.5", "Other Net Income": "-1.30", "Other Compr. Net Income": "-1.91", "Economic Capital Ratio": "26.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000812701_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "272,048", "Assets, Noncurrent": "4,769", "Cost of Revenues": "0", "Intangible Assets": "35,525", "Liabilities, Current": "105,174", "Liabilities, Noncurrent": "3,721", "Other Assets": "2,387", "Other Compr. Net Income": "-3,068", "Other Expenses": "365,550", "Other Liabilities": "49,430", "Other Net Income": "3,130", "Other Revenues": "482,341", "Property, Plant and Equipment, Net": "186,834", "Selling, General and Administrative Expense": "85,071" }, "output_variables": { "Liabilities": "158,325", "Assets": "501,563", "Expenses": "450,621", "Revenues": "482,341", "Stockholders Equity": "343,238", "Net Income": "34,850", "Comprehensive Net Income": "31,782", "BaseVar": "799,524", "ECR before LimitedLiability": "94%", "Economic Capital Ratio": "151%" } }, "2011": { "input_variables": { "Assets, Current": "277,941", "Assets, Noncurrent": "3,277", "Cost of Revenues": "0", "Intangible Assets": "34,418", "Liabilities, Current": "115,987", "Liabilities, Noncurrent": "1,103", "Other Assets": "2,805", "Other Compr. Net Income": "-9,443", "Other Expenses": "406,859", "Other Liabilities": "58,783", "Other Net Income": "467", "Other Revenues": "541,472", "Property, Plant and Equipment, Net": "234,549", "Selling, General and Administrative Expense": "95,856" }, "output_variables": { "Liabilities": "175,873", "Assets": "552,990", "Expenses": "502,715", "Revenues": "541,472", "Stockholders Equity": "377,117", "Net Income": "39,224", "Comprehensive Net Income": "29,781", "BaseVar": "891,480", "ECR before LimitedLiability": "92%", "Economic Capital Ratio": "150%" } } }, "top_rated": false, "trend": -23.0, "value": 1.4975005665889178, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000812701.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000812701.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000812701.svg" }, { "company_id": "0001384135", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001384135.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001384135.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001384135_main_keyfigs.svg", "name": "Lithium Boron Technology Inc", "rank": 34, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001384135.svg", "report_text": "The relative strengths and weaknesses of Lithium Boron Technology Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Lithium Boron Technology Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 51% points.The greatest weakness of Lithium Boron Technology Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 17% points.

The company's Economic Capital Ratio, given in the ranking table, is 149%, being 25% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001384135_2012_Lithium_Boron_Technology_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "4.11", "Liabilities": "13.5", "Stockholders Equity": "51.2", "ECR before LimitedLiability": "40.0", "Liabilities, Noncurrent": "14.3", "Liabilities, Current": "-5.15", "Assets, Current": "43.9", "Assets": "25.0", "Other Assets": "-6.16", "Assets, Noncurrent": "6.07", "Property, Plant and Equipment, Net": "-5.24", "Selling, General and Administrative Expense": "9.96", "Expenses": "15.9", "Revenues": "-17.5", "Net Income": "-4.30", "Other Expenses": "-12.8", "Cost of Revenues": "19.5", "Other Revenues": "-17.5", "Other Net Income": "-1.82", "Economic Capital Ratio": "25.2", "Other Compr. Net Income": "4.71" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001384135_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "145,580", "Assets, Noncurrent": "31,398", "Cost of Revenues": "0", "Intangible Assets": "17,518", "Liabilities, Current": "36,472", "Liabilities, Noncurrent": "0", "Other Assets": "-28,867", "Other Compr. Net Income": "7,336", "Other Expenses": "88,384", "Other Liabilities": "0", "Other Net Income": "-1,266", "Other Revenues": "65,221", "Property, Plant and Equipment, Net": "11,349", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "36,472", "Assets": "176,978", "Expenses": "88,384", "Revenues": "65,221", "Stockholders Equity": "140,506", "Net Income": "-24,428", "Comprehensive Net Income": "-17,093", "BaseVar": "187,828", "ECR before LimitedLiability": "91%", "Economic Capital Ratio": "149%" } } }, "top_rated": false, "trend": null, "value": 1.4880367538320147, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001384135.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001384135.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001384135.svg" }, { "company_id": "0000891014", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000891014.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000891014.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000891014.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000891014_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000891014_main_keyfigs.svg", "name": "Minerals Technologies INC", "rank": 35, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000891014.svg", "report_text": "The relative strengths and weaknesses of Minerals Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Minerals Technologies INC compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 26% points.The greatest weakness of Minerals Technologies INC is the variable Other Expenses, reducing the Economic Capital Ratio by 18% points.

The company's Economic Capital Ratio, given in the ranking table, is 147%, being 24% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000891014_2012_Minerals_Technologies_INC.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "3.36", "Liabilities": "14.4", "Stockholders Equity": "17.4", "ECR before LimitedLiability": "23.1", "Liabilities, Noncurrent": "1.96", "Liabilities, Current": "9.44", "Assets, Current": "9.60", "Assets": "3.16", "Property, Plant and Equipment, Net": "0.897", "Intangible Assets": "-3.65", "Assets, Noncurrent": "-1.45", "Other Expenses": "-36.3", "Expenses": "0.266", "Revenues": "5.19", "Net Income": "5.93", "Selling, General and Administrative Expense": "10.1", "Cost of Revenues": "29.4", "Other Revenues": "5.19", "Comprehensive Net Income": "6.11", "Other Net Income": "0.462", "Economic Capital Ratio": "20.7" }, "2011": { "Other Liabilities": "5.32", "Liabilities": "12.4", "Stockholders Equity": "19.0", "ECR before LimitedLiability": "38.6", "Liabilities, Noncurrent": "-4.60", "Liabilities, Current": "11.6", "Assets, Current": "9.40", "Assets": "4.91", "Other Assets": "-0.573", "Intangible Assets": "-1.09", "Property, Plant and Equipment, Net": "-1.08", "Selling, General and Administrative Expense": "2.88", "Expenses": "8.80", "Revenues": "14.7", "Net Income": "22.4", "Other Expenses": "-18.2", "Cost of Revenues": "26.0", "Other Revenues": "14.7", "Comprehensive Net Income": "22.3", "Other Net Income": "-1.54", "Economic Capital Ratio": "23.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000891014_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "675,572", "Assets, Noncurrent": "40,580", "Cost of Revenues": "0", "Intangible Assets": "67,156", "Liabilities, Current": "155,237", "Liabilities, Noncurrent": "178,173", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "822,989", "Other Liabilities": "0", "Other Net Income": "572", "Other Revenues": "1,002,354", "Property, Plant and Equipment, Net": "332,797", "Selling, General and Administrative Expense": "110,051" }, "output_variables": { "Liabilities": "333,410", "Assets": "1,116,105", "Expenses": "933,040", "Revenues": "1,002,354", "Stockholders Equity": "782,695", "Net Income": "69,886", "Comprehensive Net Income": "69,886", "BaseVar": "1,692,740", "ECR before LimitedLiability": "97%", "Economic Capital Ratio": "153%" } }, "2011": { "input_variables": { "Assets, Current": "720,289", "Assets, Noncurrent": "61,861", "Cost of Revenues": "0", "Intangible Assets": "64,671", "Liabilities, Current": "180,902", "Liabilities, Noncurrent": "216,033", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "860,613", "Other Liabilities": "0", "Other Net Income": "-2,598", "Other Revenues": "1,044,853", "Property, Plant and Equipment, Net": "318,134", "Selling, General and Administrative Expense": "111,388" }, "output_variables": { "Liabilities": "396,935", "Assets": "1,164,955", "Expenses": "972,001", "Revenues": "1,044,853", "Stockholders Equity": "768,020", "Net Income": "70,254", "Comprehensive Net Income": "70,254", "BaseVar": "1,790,671", "ECR before LimitedLiability": "89%", "Economic Capital Ratio": "147%" } } }, "top_rated": false, "trend": -26.0, "value": 1.4743715940590914, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000891014.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000891014.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000891014.svg" }, { "company_id": "0001463258", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001463258.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001463258.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001463258.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001463258_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001463258_main_keyfigs.svg", "name": "Renewable Energy Group Inc", "rank": 36, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001463258.svg", "report_text": "The relative strengths and weaknesses of Renewable Energy Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Renewable Energy Group Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 74% points.The greatest weakness of Renewable Energy Group Inc is the variable Cost of Revenues, reducing the Economic Capital Ratio by 105% points.

The company's Economic Capital Ratio, given in the ranking table, is 147%, being 23% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001463258_2012_Renewable_Energy_Group_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-33.9", "Liabilities": "24.6", "Stockholders Equity": "-9.09", "ECR before LimitedLiability": "37.8", "Liabilities, Noncurrent": "23.7", "Liabilities, Current": "27.6", "Assets, Current": "-9.23", "Assets": "-9.76", "Other Assets": "3.39", "Assets, Noncurrent": "-3.06", "Intangible Assets": "2.10", "Property, Plant and Equipment, Net": "-2.58", "Selling, General and Administrative Expense": "11.5", "Expenses": "-11.7", "Revenues": "61.4", "Net Income": "43.2", "Other Expenses": "74.4", "Cost of Revenues": "-105", "Other Revenues": "61.4", "Comprehensive Net Income": "43.0", "Economic Capital Ratio": "23.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001463258_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "150,022", "Assets, Noncurrent": "5,963", "Cost of Revenues": "696,820", "Intangible Assets": "89,302", "Liabilities, Current": "59,862", "Liabilities, Noncurrent": "7,262", "Other Assets": "53,769", "Other Compr. Net Income": "0", "Other Expenses": "2,982", "Other Liabilities": "148,968", "Other Net Income": "-881", "Other Revenues": "824,031", "Property, Plant and Equipment, Net": "185,391", "Selling, General and Administrative Expense": "34,479" }, "output_variables": { "Liabilities": "216,092", "Assets": "484,447", "Expenses": "734,281", "Revenues": "824,031", "Stockholders Equity": "268,355", "Net Income": "88,869", "Comprehensive Net Income": "88,869", "BaseVar": "1,129,866", "ECR before LimitedLiability": "87%", "Economic Capital Ratio": "147%" } } }, "top_rated": false, "trend": null, "value": 1.4658163352473292, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001463258.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001463258.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001463258.svg" }, { "company_id": "0001200375", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001200375.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001200375.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001200375.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001200375_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001200375_main_keyfigs.svg", "name": "Codexis INC", "rank": 37, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001200375.svg", "report_text": "The relative strengths and weaknesses of Codexis INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Codexis INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Codexis INC is the variable Selling, General and Administrative Expense, reducing the Economic Capital Ratio by 66% points.

The company's Economic Capital Ratio, given in the ranking table, is 145%, being 22% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001200375_2012_Codexis_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "6.03", "Liabilities": "31.5", "Stockholders Equity": "34.4", "ECR before LimitedLiability": "36.5", "Liabilities, Noncurrent": "20.7", "Liabilities, Current": "6.58", "Assets, Current": "8.23", "Assets": "4.47", "Other Assets": "3.41", "Assets, Noncurrent": "-2.64", "Intangible Assets": "2.71", "Property, Plant and Equipment, Net": "-5.25", "Selling, General and Administrative Expense": "-66.3", "Expenses": "-10.5", "Revenues": "15.7", "Net Income": "3.22", "Other Expenses": "32.6", "Cost of Revenues": "30.3", "Other Revenues": "15.7", "Comprehensive Net Income": "2.76", "Economic Capital Ratio": "21.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001200375_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "79,232", "Assets, Noncurrent": "972", "Cost of Revenues": "0", "Intangible Assets": "19,683", "Liabilities, Current": "28,292", "Liabilities, Noncurrent": "0", "Other Assets": "11,859", "Other Compr. Net Income": "-373", "Other Expenses": "42,697", "Other Liabilities": "0", "Other Net Income": "273", "Other Revenues": "123,865", "Property, Plant and Equipment, Net": "24,176", "Selling, General and Administrative Expense": "97,991" }, "output_variables": { "Liabilities": "28,292", "Assets": "135,922", "Expenses": "140,688", "Revenues": "123,865", "Stockholders Equity": "107,630", "Net Income": "-16,550", "Comprehensive Net Income": "-16,923", "BaseVar": "214,706", "ECR before LimitedLiability": "86%", "Economic Capital Ratio": "145%" } } }, "top_rated": false, "trend": null, "value": 1.4527820771861928, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001200375.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001200375.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001200375.svg" }, { "company_id": "0001311230", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001311230.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001311230.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001311230_main_keyfigs.svg", "name": "Terravia Holdings Inc", "rank": 38, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001311230.svg", "report_text": "The relative strengths and weaknesses of Terravia Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Terravia Holdings Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 73% points.The greatest weakness of Terravia Holdings Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 31% points.

The company's Economic Capital Ratio, given in the ranking table, is 145%, being 22% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001311230_2012_Terravia_Holdings_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "3.26", "Liabilities": "10.9", "Stockholders Equity": "71.3", "ECR before LimitedLiability": "36.4", "Liabilities, Noncurrent": "3.73", "Liabilities, Current": "4.18", "Assets, Current": "72.9", "Assets": "52.5", "Assets, Noncurrent": "-1.56", "Intangible Assets": "-1.99", "Property, Plant and Equipment, Net": "-2.97", "Selling, General and Administrative Expense": "-28.0", "Expenses": "21.6", "Revenues": "-30.6", "Net Income": "-13.3", "Other Expenses": "38.0", "Cost of Revenues": "15.6", "Other Revenues": "-30.6", "Comprehensive Net Income": "-13.4", "Other Net Income": "-2.25", "Economic Capital Ratio": "21.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001311230_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "258,893", "Assets, Noncurrent": "346", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "29,212", "Liabilities, Noncurrent": "15,454", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "2,420", "Other Liabilities": "0", "Other Net Income": "-3,408", "Other Revenues": "38,966", "Property, Plant and Equipment, Net": "25,985", "Selling, General and Administrative Expense": "87,039" }, "output_variables": { "Liabilities": "44,666", "Assets": "285,224", "Expenses": "89,459", "Revenues": "38,966", "Stockholders Equity": "240,558", "Net Income": "-53,901", "Comprehensive Net Income": "-53,901", "BaseVar": "230,862", "ECR before LimitedLiability": "85%", "Economic Capital Ratio": "145%" } } }, "top_rated": false, "trend": null, "value": 1.4519767361888394, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001311230.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001311230.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001311230.svg" }, { "company_id": "0000717605", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000717605.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000717605.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000717605.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000717605_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000717605_main_keyfigs.svg", "name": "Hexcel CORP DE", "rank": 39, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000717605.svg", "report_text": "The relative strengths and weaknesses of Hexcel CORP DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Hexcel CORP DE compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Hexcel CORP DE is the variable Other Expenses, reducing the Economic Capital Ratio by 19% points.

The company's Economic Capital Ratio, given in the ranking table, is 142%, being 18% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000717605_2012_Hexcel_CORP_DE.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "-2.59", "Liabilities": "-3.78", "Stockholders Equity": "-1.68", "ECR before LimitedLiability": "0.818", "Liabilities, Noncurrent": "-8.91", "Liabilities, Current": "7.30", "Assets, Current": "-0.582", "Assets": "0.577", "Property, Plant and Equipment, Net": "10.3", "Other Assets": "5.54", "Intangible Assets": "-8.14", "Assets, Noncurrent": "-3.20", "Other Expenses": "-31.7", "Expenses": "4.15", "Revenues": "1.50", "Net Income": "5.59", "Selling, General and Administrative Expense": "9.34", "Cost of Revenues": "31.4", "Other Revenues": "1.50", "Comprehensive Net Income": "5.78", "Economic Capital Ratio": "-1.61" }, "2011": { "Liabilities": "7.38", "Stockholders Equity": "8.42", "ECR before LimitedLiability": "32.8", "Liabilities, Noncurrent": "-2.89", "Liabilities, Current": "10.6", "Assets, Current": "-2.67", "Assets": "1.66", "Other Assets": "2.81", "Assets, Noncurrent": "-2.40", "Intangible Assets": "-3.53", "Property, Plant and Equipment, Net": "9.57", "Selling, General and Administrative Expense": "2.29", "Expenses": "8.93", "Revenues": "19.6", "Net Income": "27.5", "Other Expenses": "-18.7", "Cost of Revenues": "27.6", "Other Revenues": "19.6", "Comprehensive Net Income": "27.3", "Other Net Income": "-1.74", "Economic Capital Ratio": "18.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000717605_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "497,700", "Assets, Noncurrent": "22,400", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "205,900", "Liabilities, Noncurrent": "330,900", "Other Assets": "139,700", "Other Compr. Net Income": "0", "Other Expenses": "940,600", "Other Liabilities": "61,900", "Other Net Income": "-6,300", "Other Revenues": "1,173,600", "Property, Plant and Equipment, Net": "598,300", "Selling, General and Administrative Expense": "149,300" }, "output_variables": { "Liabilities": "598,700", "Assets": "1,258,100", "Expenses": "1,089,900", "Revenues": "1,173,600", "Stockholders Equity": "659,400", "Net Income": "77,400", "Comprehensive Net Income": "77,400", "BaseVar": "2,063,300", "ECR before LimitedLiability": "66%", "Economic Capital Ratio": "131%" } }, "2011": { "input_variables": { "Assets, Current": "524,300", "Assets, Noncurrent": "17,600", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "247,500", "Liabilities, Noncurrent": "257,900", "Other Assets": "112,100", "Other Compr. Net Income": "0", "Other Expenses": "1,100,500", "Other Liabilities": "68,500", "Other Net Income": "-4,900", "Other Revenues": "1,392,400", "Property, Plant and Equipment, Net": "722,100", "Selling, General and Administrative Expense": "153,100" }, "output_variables": { "Liabilities": "573,900", "Assets": "1,376,100", "Expenses": "1,253,600", "Revenues": "1,392,400", "Stockholders Equity": "802,200", "Net Income": "133,900", "Comprehensive Net Income": "133,900", "BaseVar": "2,300,450", "ECR before LimitedLiability": "80%", "Economic Capital Ratio": "142%" } } }, "top_rated": false, "trend": -27.0, "value": 1.4160526400347342, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000717605.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000717605.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000717605.svg" }, { "company_id": "0001257640", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001257640.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001257640.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001257640.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001257640_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001257640_main_keyfigs.svg", "name": "Kronos Worldwide INC", "rank": 40, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001257640.svg", "report_text": "The relative strengths and weaknesses of Kronos Worldwide INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Kronos Worldwide INC compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 36% points.The greatest weakness of Kronos Worldwide INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 18% points.

The company's Economic Capital Ratio, given in the ranking table, is 139%, being 15% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001257640_2012_Kronos_Worldwide_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "5.33", "Liabilities": "0.507", "Stockholders Equity": "0.515", "ECR before LimitedLiability": "29.7", "Liabilities, Noncurrent": "-17.6", "Liabilities, Current": "11.1", "Selling, General and Administrative Expense": "3.14", "Expenses": "14.4", "Net Income": "36.1", "Other Expenses": "-14.6", "Cost of Revenues": "27.7", "Other Revenues": "21.2", "Revenues": "21.2", "Other Assets": "-0.706", "Assets, Noncurrent": "8.85", "Intangible Assets": "-3.71", "Property, Plant and Equipment, Net": "-2.95", "Comprehensive Net Income": "33.8", "Other Net Income": "-1.10", "Other Compr. Net Income": "-1.90", "Economic Capital Ratio": "14.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001257640_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "865,000", "Assets, Noncurrent": "473,400", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "328,000", "Liabilities, Noncurrent": "571,600", "Other Assets": "0", "Other Compr. Net Income": "-33,500", "Other Expenses": "1,432,700", "Other Liabilities": "0", "Other Net Income": "5,400", "Other Revenues": "1,943,300", "Property, Plant and Equipment, Net": "485,500", "Selling, General and Administrative Expense": "195,000" }, "output_variables": { "Liabilities": "899,600", "Assets": "1,823,900", "Expenses": "1,627,700", "Revenues": "1,943,300", "Stockholders Equity": "924,300", "Net Income": "321,000", "Comprehensive Net Income": "287,500", "BaseVar": "3,166,700", "ECR before LimitedLiability": "76%", "Economic Capital Ratio": "139%" } } }, "top_rated": false, "trend": null, "value": 1.385276420207254, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001257640.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001257640.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001257640.svg" }, { "company_id": "0001026655", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001026655.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001026655.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001026655.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001026655_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001026655_main_keyfigs.svg", "name": "CORE Molding Technologies INC", "rank": 41, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001026655.svg", "report_text": "The relative strengths and weaknesses of CORE Molding Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of CORE Molding Technologies INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 50% points.The greatest weakness of CORE Molding Technologies INC is the variable Other Expenses, reducing the Economic Capital Ratio by 45% points.

The company's Economic Capital Ratio, given in the ranking table, is 138%, being 14% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001026655_2012_CORE_Molding_Technologies_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-4.23", "Liabilities": "18.9", "Stockholders Equity": "-7.93", "ECR before LimitedLiability": "28.8", "Liabilities, Noncurrent": "13.0", "Liabilities, Current": "10.3", "Assets, Current": "-5.70", "Assets": "-9.69", "Assets, Noncurrent": "-3.93", "Intangible Assets": "-4.39", "Property, Plant and Equipment, Net": "4.40", "Selling, General and Administrative Expense": "3.86", "Expenses": "-10.1", "Revenues": "50.0", "Net Income": "34.9", "Other Expenses": "-44.6", "Cost of Revenues": "37.0", "Other Revenues": "50.0", "Comprehensive Net Income": "34.7", "Other Net Income": "-1.80", "Economic Capital Ratio": "14.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001026655_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "41,797", "Assets, Noncurrent": "15", "Cost of Revenues": "0", "Intangible Assets": "1,097", "Liabilities, Current": "24,814", "Liabilities, Noncurrent": "9,477", "Other Assets": "1,045", "Other Compr. Net Income": "0", "Other Expenses": "119,956", "Other Liabilities": "8,911", "Other Net Income": "0", "Other Revenues": "143,421", "Property, Plant and Equipment, Net": "49,344", "Selling, General and Administrative Expense": "12,939" }, "output_variables": { "Liabilities": "43,202", "Assets": "93,298", "Expenses": "132,895", "Revenues": "143,421", "Stockholders Equity": "50,096", "Net Income": "10,526", "Comprehensive Net Income": "10,526", "BaseVar": "206,408", "ECR before LimitedLiability": "75%", "Economic Capital Ratio": "138%" } } }, "top_rated": false, "trend": null, "value": 1.3764742115429853, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001026655.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001026655.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001026655.svg" }, { "company_id": "0001262823", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001262823.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001262823.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001262823.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001262823_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001262823_main_keyfigs.svg", "name": "Westlake CORP", "rank": 42, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001262823.svg", "report_text": "The relative strengths and weaknesses of Westlake CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Westlake CORP compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 30% points.The greatest weakness of Westlake CORP is the variable Other Expenses, reducing the Economic Capital Ratio by 32% points.

The company's Economic Capital Ratio, given in the ranking table, is 134%, being 11% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001262823_2012_Westlake_CORP.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-6.27", "Liabilities": "6.19", "Stockholders Equity": "1.53", "ECR before LimitedLiability": "25.5", "Liabilities, Noncurrent": "-8.80", "Liabilities, Current": "19.7", "Assets, Current": "2.56", "Assets": "-1.59", "Assets, Noncurrent": "-1.08", "Intangible Assets": "-4.25", "Property, Plant and Equipment, Net": "1.09", "Selling, General and Administrative Expense": "11.4", "Expenses": "4.57", "Revenues": "23.3", "Net Income": "27.0", "Other Expenses": "-32.3", "Cost of Revenues": "30.2", "Other Revenues": "23.3", "Comprehensive Net Income": "26.8", "Other Net Income": "-1.32", "Economic Capital Ratio": "10.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001262823_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "1,756,156", "Assets, Noncurrent": "182,316", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "364,595", "Liabilities, Noncurrent": "815,123", "Other Assets": "96,283", "Other Compr. Net Income": "0", "Other Expenses": "3,254,300", "Other Liabilities": "330,791", "Other Net Income": "5,628", "Other Revenues": "3,619,848", "Property, Plant and Equipment, Net": "1,232,066", "Selling, General and Administrative Expense": "112,210" }, "output_variables": { "Liabilities": "1,510,509", "Assets": "3,266,821", "Expenses": "3,366,510", "Revenues": "3,619,848", "Stockholders Equity": "1,756,312", "Net Income": "258,966", "Comprehensive Net Income": "258,966", "BaseVar": "5,884,658", "ECR before LimitedLiability": "70%", "Economic Capital Ratio": "134%" } } }, "top_rated": false, "trend": null, "value": 1.3436976412171118, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001262823.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001262823.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001262823.svg" }, { "company_id": "0001369774", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001369774.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001369774.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001369774_main_keyfigs.svg", "name": "Shiner International Inc", "rank": 43, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001369774.svg", "report_text": "The relative strengths and weaknesses of Shiner International Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Shiner International Inc compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Shiner International Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 33% points.

The company's Economic Capital Ratio, given in the ranking table, is 133%, being 9.2% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001369774_2012_Shiner_International_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-10.1", "Liabilities": "5.12", "Stockholders Equity": "6.03", "ECR before LimitedLiability": "23.9", "Liabilities, Noncurrent": "18.5", "Liabilities, Current": "-4.83", "Assets, Current": "-2.03", "Assets": "1.35", "Other Assets": "8.14", "Assets, Noncurrent": "-3.41", "Intangible Assets": "-1.32", "Selling, General and Administrative Expense": "14.5", "Expenses": "6.08", "Revenues": "14.1", "Net Income": "19.6", "Other Expenses": "-32.6", "Cost of Revenues": "28.9", "Other Revenues": "14.1", "Comprehensive Net Income": "21.6", "Other Compr. Net Income": "1.74", "Economic Capital Ratio": "9.17" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001369774_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "32,009", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "5,087", "Liabilities, Current": "24,347", "Liabilities, Noncurrent": "0", "Other Assets": "12,801", "Other Compr. Net Income": "1,406", "Other Expenses": "74,027", "Other Liabilities": "9,957", "Other Net Income": "373", "Other Revenues": "75,295", "Property, Plant and Equipment, Net": "27,836", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "34,304", "Assets": "77,733", "Expenses": "74,027", "Revenues": "75,295", "Stockholders Equity": "43,429", "Net Income": "1,640", "Comprehensive Net Income": "3,047", "BaseVar": "131,569", "ECR before LimitedLiability": "68%", "Economic Capital Ratio": "133%" } } }, "top_rated": false, "trend": null, "value": 1.3276801090872528, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001369774.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001369774.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001369774.svg" }, { "company_id": "0000790051", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000790051.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000790051.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000790051.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000790051_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000790051_main_keyfigs.svg", "name": "Carlisle Companies INC", "rank": 44, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000790051.svg", "report_text": "The relative strengths and weaknesses of Carlisle Companies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Carlisle Companies INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 52% points.The greatest weakness of Carlisle Companies INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 50% points.

The company's Economic Capital Ratio, given in the ranking table, is 125%, being 1.5% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000790051_2012_Carlisle_Companies_INC.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "3.25", "Liabilities": "-0.819", "Stockholders Equity": "-3.14", "ECR before LimitedLiability": "1.10", "Liabilities, Noncurrent": "-11.2", "Liabilities, Current": "6.57", "Assets, Current": "-1.12", "Assets": "-1.49", "Property, Plant and Equipment, Net": "-4.37", "Other Assets": "-0.325", "Intangible Assets": "10.3", "Assets, Noncurrent": "-3.92", "Other Revenues": "4.24", "Revenues": "4.24", "Net Income": "5.16", "Selling, General and Administrative Expense": "8.92", "Comprehensive Net Income": "5.36", "Other Expenses": "46.6", "Other Net Income": "1.05", "Cost of Revenues": "-46.1", "Economic Capital Ratio": "-1.33" }, "2011": { "Other Liabilities": "5.25", "Liabilities": "-1.94", "Stockholders Equity": "-2.39", "ECR before LimitedLiability": "16.3", "Liabilities, Noncurrent": "-18.3", "Liabilities, Current": "9.62", "Assets, Current": "-4.28", "Assets": "-0.630", "Assets, Noncurrent": "-3.59", "Intangible Assets": "23.2", "Property, Plant and Equipment, Net": "-7.80", "Selling, General and Administrative Expense": "1.21", "Expenses": "9.19", "Revenues": "16.7", "Net Income": "24.2", "Other Expenses": "52.3", "Cost of Revenues": "-49.6", "Other Revenues": "16.7", "Comprehensive Net Income": "23.8", "Other Net Income": "-2.20", "Economic Capital Ratio": "1.52" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000790051_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "1,016,900", "Assets, Noncurrent": "12,600", "Cost of Revenues": "1,999,000", "Intangible Assets": "965,000", "Liabilities, Current": "456,400", "Liabilities, Noncurrent": "732,400", "Other Assets": "1,600", "Other Compr. Net Income": "0", "Other Expenses": "64,400", "Other Liabilities": "0", "Other Net Income": "15,000", "Other Revenues": "2,527,700", "Property, Plant and Equipment, Net": "533,400", "Selling, General and Administrative Expense": "333,700" }, "output_variables": { "Liabilities": "1,188,800", "Assets": "2,529,500", "Expenses": "2,397,100", "Revenues": "2,527,700", "Stockholders Equity": "1,340,700", "Net Income": "145,600", "Comprehensive Net Income": "145,600", "BaseVar": "4,329,050", "ECR before LimitedLiability": "66%", "Economic Capital Ratio": "131%" } }, "2011": { "input_variables": { "Assets, Current": "1,214,100", "Assets, Noncurrent": "19,000", "Cost of Revenues": "2,547,400", "Intangible Assets": "1,324,400", "Liabilities, Current": "613,500", "Liabilities, Noncurrent": "1,024,300", "Other Assets": "20,100", "Other Compr. Net Income": "-6,900", "Other Expenses": "68,700", "Other Liabilities": "0", "Other Net Income": "-22,800", "Other Revenues": "3,224,500", "Property, Plant and Equipment, Net": "560,300", "Selling, General and Administrative Expense": "405,300" }, "output_variables": { "Liabilities": "1,637,800", "Assets": "3,137,900", "Expenses": "3,021,400", "Revenues": "3,224,500", "Stockholders Equity": "1,500,100", "Net Income": "180,300", "Comprehensive Net Income": "173,400", "BaseVar": "5,525,650", "ECR before LimitedLiability": "58%", "Economic Capital Ratio": "125%" } } }, "top_rated": false, "trend": -33.0, "value": 1.251227506767212, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000790051.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000790051.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000790051.svg" }, { "company_id": "0001321646", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001321646.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001321646.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001321646.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001321646_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001321646_main_keyfigs.svg", "name": "Kraton Corp", "rank": 45, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001321646.svg", "report_text": "The relative strengths and weaknesses of Kraton Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Kraton Corp compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 33% points.The greatest weakness of Kraton Corp is the variable Other Expenses, reducing the Economic Capital Ratio by 31% points.

The company's Economic Capital Ratio, given in the ranking table, is 124%, being 0.66% points above the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001321646_2012_Kraton_Corp.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "5.22", "Liabilities": "1.84", "Stockholders Equity": "-9.67", "ECR before LimitedLiability": "15.4", "Liabilities, Noncurrent": "-25.3", "Liabilities, Current": "18.6", "Assets, Current": "2.38", "Assets": "-6.60", "Assets, Noncurrent": "-3.32", "Intangible Assets": "-2.62", "Property, Plant and Equipment, Net": "-3.31", "Selling, General and Administrative Expense": "4.71", "Expenses": "1.83", "Revenues": "28.8", "Net Income": "28.7", "Other Expenses": "-30.9", "Cost of Revenues": "33.3", "Other Revenues": "28.8", "Comprehensive Net Income": "28.6", "Other Net Income": "-1.84", "Economic Capital Ratio": "0.657" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001321646_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "665,535", "Assets, Noncurrent": "24,608", "Cost of Revenues": "0", "Intangible Assets": "66,184", "Liabilities, Current": "161,090", "Liabilities, Noncurrent": "468,658", "Other Assets": "24,456", "Other Compr. Net Income": "0", "Other Expenses": "1,214,496", "Other Liabilities": "6,214", "Other Net Income": "-2,456", "Other Revenues": "1,437,479", "Property, Plant and Equipment, Net": "372,973", "Selling, General and Administrative Expense": "129,602" }, "output_variables": { "Liabilities": "635,962", "Assets": "1,153,756", "Expenses": "1,344,098", "Revenues": "1,437,479", "Stockholders Equity": "517,794", "Net Income": "90,925", "Comprehensive Net Income": "90,925", "BaseVar": "2,286,876", "ECR before LimitedLiability": "57%", "Economic Capital Ratio": "124%" } } }, "top_rated": false, "trend": null, "value": 1.2425669806814463, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001321646.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001321646.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001321646.svg" }, { "company_id": "0000002969", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000002969.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000002969.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000002969.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000002969_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000002969_main_keyfigs.svg", "name": "Air Products Chemicals Inc", "rank": 46, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000002969.svg", "report_text": "The relative strengths and weaknesses of Air Products Chemicals Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Air Products Chemicals Inc compared to the market average is the variable Assets, Noncurrent, increasing the Economic Capital Ratio by 50% points.The greatest weakness of Air Products Chemicals Inc is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 33% points.

The company's Economic Capital Ratio, given in the ranking table, is 122%, being 2.0% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000002969_2012_Air_Products_Chemicals_Inc.pdf", "shrinked_graph_json": { "2009": { "Liabilities, Current": "-1.06", "Liabilities": "-15.7", "Stockholders Equity": "-10.7", "ECR before LimitedLiability": "-16.6", "Liabilities, Noncurrent": "-21.6", "Other Liabilities": "6.12", "Other Assets": "-23.6", "Assets": "0.551", "Assets, Current": "-3.25", "Property, Plant and Equipment, Net": "7.41", "Intangible Assets": "-4.40", "Assets, Noncurrent": "41.2", "Cost of Revenues": "-17.5", "Expenses": "7.23", "Revenues": "-6.55", "Comprehensive Net Income": "-0.531", "Selling, General and Administrative Expense": "0.738", "Other Expenses": "26.5", "Other Revenues": "-6.55", "Other Compr. Net Income": "-1.02", "Economic Capital Ratio": "-14.9" }, "2010": { "Other Liabilities": "2.52", "Liabilities": "-22.1", "Stockholders Equity": "-4.26", "ECR before LimitedLiability": "-8.92", "Liabilities, Noncurrent": "-29.4", "Liabilities, Current": "3.51", "Assets, Current": "-6.47", "Assets": "8.41", "Property, Plant and Equipment, Net": "18.2", "Other Assets": "-22.8", "Intangible Assets": "-4.03", "Assets, Noncurrent": "49.7", "Other Expenses": "34.9", "Expenses": "19.9", "Revenues": "-12.8", "Net Income": "7.31", "Selling, General and Administrative Expense": "10.5", "Cost of Revenues": "-22.0", "Other Revenues": "-12.8", "Comprehensive Net Income": "7.48", "Economic Capital Ratio": "-11.4" }, "2011": { "Other Liabilities": "4.15", "Liabilities": "-19.4", "ECR before LimitedLiability": "12.8", "Liabilities, Noncurrent": "-33.4", "Liabilities, Current": "7.26", "Assets, Current": "-7.90", "Assets": "10.5", "Other Assets": "-22.0", "Assets, Noncurrent": "50.3", "Intangible Assets": "-0.308", "Property, Plant and Equipment, Net": "14.4", "Selling, General and Administrative Expense": "4.18", "Expenses": "27.1", "Net Income": "23.8", "Other Expenses": "47.8", "Cost of Revenues": "-25.6", "Other Revenues": "-3.66", "Revenues": "-3.66", "Comprehensive Net Income": "23.7", "Other Net Income": "0.808", "Economic Capital Ratio": "-2.00" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000002969_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "2,997,800", "Assets, Noncurrent": "10,031,300", "Cost of Revenues": "6,042,100", "Intangible Assets": "1,178,600", "Liabilities, Current": "2,503,600", "Liabilities, Noncurrent": "5,595,500", "Other Assets": "-8,038,200", "Other Compr. Net Income": "0", "Other Expenses": "638,300", "Other Liabilities": "0", "Other Net Income": "126,600", "Other Revenues": "8,256,200", "Property, Plant and Equipment, Net": "6,859,600", "Selling, General and Administrative Expense": "1,059,700" }, "output_variables": { "Liabilities": "8,099,100", "Assets": "13,029,100", "Expenses": "7,740,100", "Revenues": "8,256,200", "Stockholders Equity": "4,930,000", "Net Income": "642,700", "Comprehensive Net Income": "642,700", "BaseVar": "18,625,550", "ECR before LimitedLiability": "44%", "Economic Capital Ratio": "114%" } }, "2010": { "input_variables": { "Assets, Current": "3,033,800", "Assets, Noncurrent": "10,472,100", "Cost of Revenues": "6,503,000", "Intangible Assets": "1,200,300", "Liabilities, Current": "2,244,100", "Liabilities, Noncurrent": "5,564,200", "Other Assets": "-8,251,600", "Other Compr. Net Income": "0", "Other Expenses": "562,500", "Other Liabilities": "0", "Other Net Income": "165,600", "Other Revenues": "9,026,000", "Property, Plant and Equipment, Net": "7,051,300", "Selling, General and Administrative Expense": "1,071,600" }, "output_variables": { "Liabilities": "7,808,300", "Assets": "13,505,900", "Expenses": "8,137,100", "Revenues": "9,026,000", "Stockholders Equity": "5,697,600", "Net Income": "1,054,500", "Comprehensive Net Income": "1,054,500", "BaseVar": "19,321,450", "ECR before LimitedLiability": "53%", "Economic Capital Ratio": "121%" } }, "2011": { "input_variables": { "Assets, Current": "3,189,800", "Assets, Noncurrent": "11,100,900", "Cost of Revenues": "7,098,300", "Intangible Assets": "1,056,700", "Liabilities, Current": "2,342,000", "Liabilities, Noncurrent": "6,010,000", "Other Assets": "-8,279,400", "Other Compr. Net Income": "0", "Other Expenses": "539,300", "Other Liabilities": "0", "Other Net Income": "285,900", "Other Revenues": "9,673,700", "Property, Plant and Equipment, Net": "7,222,700", "Selling, General and Administrative Expense": "1,060,500" }, "output_variables": { "Liabilities": "8,352,000", "Assets": "14,290,700", "Expenses": "8,698,100", "Revenues": "9,673,700", "Stockholders Equity": "5,938,700", "Net Income": "1,261,500", "Comprehensive Net Income": "1,261,500", "BaseVar": "20,650,200", "ECR before LimitedLiability": "54%", "Economic Capital Ratio": "122%" } } }, "top_rated": false, "trend": -32.0, "value": 1.2159913885405838, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000002969.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000002969.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000002969.svg" }, { "company_id": "0000778164", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000778164.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000778164.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000778164.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000778164_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000778164_main_keyfigs.svg", "name": "Alto Ingredients Inc", "rank": 47, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000778164.svg", "report_text": "The relative strengths and weaknesses of Alto Ingredients Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Alto Ingredients Inc compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 86% points.The greatest weakness of Alto Ingredients Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 226% points.

The company's Economic Capital Ratio, given in the ranking table, is 122%, being 2.1% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000778164_2012_Alto_Ingredients_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "10.5", "Liabilities": "48.9", "Stockholders Equity": "-62.8", "ECR before LimitedLiability": "12.7", "Liabilities, Noncurrent": "4.53", "Liabilities, Current": "48.2", "Assets, Current": "-31.1", "Assets": "-41.1", "Other Assets": "-2.55", "Assets, Noncurrent": "-9.83", "Intangible Assets": "-11.4", "Property, Plant and Equipment, Net": "-11.1", "Selling, General and Administrative Expense": "35.7", "Expenses": "-107", "Revenues": "85.8", "Net Income": "47.7", "Other Expenses": "-226", "Cost of Revenues": "51.5", "Other Revenues": "85.8", "Comprehensive Net Income": "47.7", "Economic Capital Ratio": "-2.05" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000778164_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "66,748", "Assets, Noncurrent": "1,653", "Cost of Revenues": "0", "Intangible Assets": "4,458", "Liabilities, Current": "8,982", "Liabilities, Noncurrent": "96,915", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "897,343", "Other Liabilities": "7,315", "Other Net Income": "7,559", "Other Revenues": "901,188", "Property, Plant and Equipment, Net": "159,617", "Selling, General and Administrative Expense": "15,427" }, "output_variables": { "Liabilities": "113,212", "Assets": "232,476", "Expenses": "912,770", "Revenues": "901,188", "Stockholders Equity": "119,264", "Net Income": "-4,023", "Comprehensive Net Income": "-4,023", "BaseVar": "1,083,602", "ECR before LimitedLiability": "54%", "Economic Capital Ratio": "122%" } } }, "top_rated": false, "trend": null, "value": 1.215451087803413, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000778164.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000778164.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000778164.svg" }, { "company_id": "0000105770", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000105770.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000105770.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000105770.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000105770_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000105770_main_keyfigs.svg", "name": "WEST Pharmaceutical Services INC", "rank": 48, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000105770.svg", "report_text": "The relative strengths and weaknesses of WEST Pharmaceutical Services INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of WEST Pharmaceutical Services INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 48% points.The greatest weakness of WEST Pharmaceutical Services INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 34% points.

The company's Economic Capital Ratio, given in the ranking table, is 121%, being 2.7% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000105770_2012_WEST_Pharmaceutical_Services_INC.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "1.21", "Liabilities": "-10.0", "Stockholders Equity": "-3.66", "ECR before LimitedLiability": "-4.95", "Liabilities, Noncurrent": "-22.7", "Liabilities, Current": "9.81", "Assets, Current": "-2.93", "Assets": "2.27", "Property, Plant and Equipment, Net": "8.53", "Other Assets": "4.53", "Intangible Assets": "-2.87", "Assets, Noncurrent": "-3.35", "Other Expenses": "41.4", "Expenses": "7.52", "Revenues": "-3.72", "Net Income": "4.47", "Selling, General and Administrative Expense": "3.98", "Cost of Revenues": "-31.4", "Other Revenues": "-3.72", "Comprehensive Net Income": "4.66", "Economic Capital Ratio": "-7.38" }, "2011": { "Other Liabilities": "3.10", "Liabilities": "-7.98", "ECR before LimitedLiability": "12.1", "Liabilities, Noncurrent": "-22.0", "Liabilities, Current": "9.27", "Assets, Current": "-5.02", "Assets": "4.44", "Other Assets": "5.14", "Assets, Noncurrent": "-2.75", "Intangible Assets": "1.61", "Property, Plant and Equipment, Net": "6.64", "Selling, General and Administrative Expense": "-2.90", "Expenses": "17.1", "Net Income": "22.6", "Other Expenses": "47.8", "Cost of Revenues": "-34.3", "Other Revenues": "5.88", "Revenues": "5.88", "Comprehensive Net Income": "19.1", "Other Compr. Net Income": "-3.06", "Economic Capital Ratio": "-2.66" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000105770_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "436,600", "Assets, Noncurrent": "22,600", "Cost of Revenues": "786,600", "Intangible Assets": "167,600", "Liabilities, Current": "169,700", "Liabilities, Noncurrent": "478,900", "Other Assets": "112,700", "Other Compr. Net Income": "0", "Other Expenses": "46,200", "Other Liabilities": "20,000", "Other Net Income": "5,000", "Other Revenues": "1,104,700", "Property, Plant and Equipment, Net": "554,800", "Selling, General and Administrative Expense": "211,600" }, "output_variables": { "Liabilities": "668,600", "Assets": "1,294,300", "Expenses": "1,044,400", "Revenues": "1,104,700", "Stockholders Equity": "625,700", "Net Income": "65,300", "Comprehensive Net Income": "65,300", "BaseVar": "2,058,500", "ECR before LimitedLiability": "58%", "Economic Capital Ratio": "125%" } }, "2011": { "input_variables": { "Assets, Current": "472,000", "Assets, Noncurrent": "28,700", "Cost of Revenues": "853,000", "Intangible Assets": "163,500", "Liabilities, Current": "243,200", "Liabilities, Noncurrent": "479,400", "Other Assets": "141,300", "Other Compr. Net Income": "-40,200", "Other Expenses": "51,200", "Other Liabilities": "21,600", "Other Net Income": "7,600", "Other Revenues": "1,192,300", "Property, Plant and Equipment, Net": "593,600", "Selling, General and Administrative Expense": "220,200" }, "output_variables": { "Liabilities": "744,200", "Assets": "1,399,100", "Expenses": "1,124,400", "Revenues": "1,192,300", "Stockholders Equity": "654,900", "Net Income": "75,500", "Comprehensive Net Income": "35,300", "BaseVar": "2,253,900", "ECR before LimitedLiability": "53%", "Economic Capital Ratio": "121%" } } }, "top_rated": false, "trend": -35.0, "value": 1.2093827001833923, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000105770.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000105770.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000105770.svg" }, { "company_id": "0000884905", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000884905.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000884905.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000884905.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000884905_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000884905_main_keyfigs.svg", "name": "Linde INC", "rank": 49, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000884905.svg", "report_text": "The relative strengths and weaknesses of Linde INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Linde INC compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 30% points.The greatest weakness of Linde INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 34% points.

The company's Economic Capital Ratio, given in the ranking table, is 118%, being 5.4% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000884905_2012_Linde_INC.pdf", "shrinked_graph_json": { "2009": { "Liabilities, Current": "5.43", "Liabilities": "-15.1", "Stockholders Equity": "-8.36", "ECR before LimitedLiability": "-6.58", "Liabilities, Noncurrent": "-22.4", "Other Liabilities": "0.887", "Other Assets": "2.70", "Assets": "1.41", "Assets, Current": "-5.90", "Property, Plant and Equipment, Net": "13.7", "Assets, Noncurrent": "-5.13", "Cost of Revenues": "29.0", "Expenses": "11.8", "Net Income": "4.60", "Other Expenses": "-15.4", "Other Revenues": "-6.09", "Revenues": "-6.09", "Other Compr. Net Income": "3.26", "Comprehensive Net Income": "7.94", "Other Net Income": "-0.700", "Economic Capital Ratio": "-4.84" }, "2010": { "Other Liabilities": "-3.89", "Liabilities": "-24.4", "Stockholders Equity": "-5.61", "ECR before LimitedLiability": "-10.7", "Liabilities, Noncurrent": "-27.5", "Liabilities, Current": "6.24", "Assets, Current": "-9.52", "Assets": "8.85", "Property, Plant and Equipment, Net": "28.6", "Other Assets": "-0.336", "Intangible Assets": "-1.24", "Other Expenses": "-13.7", "Expenses": "21.4", "Revenues": "-12.9", "Net Income": "7.58", "Selling, General and Administrative Expense": "9.98", "Cost of Revenues": "26.4", "Other Revenues": "-12.9", "Comprehensive Net Income": "7.74", "Other Net Income": "0.613", "Economic Capital Ratio": "-13.2" }, "2011": { "Other Liabilities": "-0.588", "Liabilities": "-24.2", "Stockholders Equity": "-4.02", "ECR before LimitedLiability": "9.43", "Liabilities, Noncurrent": "-33.6", "Liabilities, Current": "8.07", "Assets, Current": "-10.9", "Assets": "10.4", "Other Assets": "-0.788", "Intangible Assets": "4.40", "Property, Plant and Equipment, Net": "24.8", "Selling, General and Administrative Expense": "3.50", "Expenses": "30.0", "Revenues": "-2.99", "Net Income": "25.5", "Other Expenses": "2.36", "Cost of Revenues": "23.3", "Other Revenues": "-2.99", "Comprehensive Net Income": "25.4", "Other Net Income": "-0.892", "Economic Capital Ratio": "-5.35" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000884905_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "2,223,000", "Assets, Noncurrent": "892,000", "Cost of Revenues": "0", "Intangible Assets": "2,212,000", "Liabilities, Current": "1,813,000", "Liabilities, Noncurrent": "6,134,000", "Other Assets": "0", "Other Compr. Net Income": "619,000", "Other Expenses": "6,486,000", "Other Liabilities": "722,000", "Other Net Income": "24,000", "Other Revenues": "8,921,000", "Property, Plant and Equipment, Net": "8,990,000", "Selling, General and Administrative Expense": "1,162,000" }, "output_variables": { "Liabilities": "8,669,000", "Assets": "14,317,000", "Expenses": "7,648,000", "Revenues": "8,921,000", "Stockholders Equity": "5,648,000", "Net Income": "1,297,000", "Comprehensive Net Income": "1,916,000", "BaseVar": "20,099,000", "ECR before LimitedLiability": "56%", "Economic Capital Ratio": "124%" } }, "2010": { "input_variables": { "Assets, Current": "2,378,000", "Assets, Noncurrent": "1,166,000", "Cost of Revenues": "0", "Intangible Assets": "2,198,000", "Liabilities, Current": "2,110,000", "Liabilities, Noncurrent": "6,108,000", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "7,650,000", "Other Liabilities": "911,000", "Other Net Income": "38,000", "Other Revenues": "10,121,000", "Property, Plant and Equipment, Net": "9,532,000", "Selling, General and Administrative Expense": "1,275,000" }, "output_variables": { "Liabilities": "9,129,000", "Assets": "15,274,000", "Expenses": "8,925,000", "Revenues": "10,121,000", "Stockholders Equity": "6,145,000", "Net Income": "1,234,000", "Comprehensive Net Income": "1,234,000", "BaseVar": "21,743,500", "ECR before LimitedLiability": "51%", "Economic Capital Ratio": "119%" } }, "2011": { "input_variables": { "Assets, Current": "2,607,000", "Assets, Noncurrent": "1,079,000", "Cost of Revenues": "0", "Intangible Assets": "2,539,000", "Liabilities, Current": "2,535,000", "Liabilities, Noncurrent": "7,066,000", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "8,248,000", "Other Liabilities": "738,000", "Other Net Income": "47,000", "Other Revenues": "11,252,000", "Property, Plant and Equipment, Net": "10,131,000", "Selling, General and Administrative Expense": "1,329,000" }, "output_variables": { "Liabilities": "10,339,000", "Assets": "16,356,000", "Expenses": "9,577,000", "Revenues": "11,252,000", "Stockholders Equity": "6,017,000", "Net Income": "1,722,000", "Comprehensive Net Income": "1,722,000", "BaseVar": "23,785,500", "ECR before LimitedLiability": "49%", "Economic Capital Ratio": "118%" } } }, "top_rated": false, "trend": -33.0, "value": 1.1824889304658486, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000884905.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000884905.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000884905.svg" }, { "company_id": "0000110621", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000110621.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000110621.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000110621.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000110621_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000110621_main_keyfigs.svg", "name": "RPM International INC DE", "rank": 50, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000110621.svg", "report_text": "The relative strengths and weaknesses of RPM International INC DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of RPM International INC DE compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 29% points.The greatest weakness of RPM International INC DE is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 26% points.

The company's Economic Capital Ratio, given in the ranking table, is 116%, being 7.3% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000110621_2012_RPM_International_INC_DE.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "3.28", "Liabilities": "-10.4", "Stockholders Equity": "-19.3", "ECR before LimitedLiability": "-14.5", "Liabilities, Noncurrent": "-20.6", "Liabilities, Current": "5.77", "Assets": "-7.95", "Property, Plant and Equipment, Net": "-10.8", "Other Assets": "-16.6", "Intangible Assets": "8.62", "Assets, Noncurrent": "21.7", "Other Expenses": "-21.4", "Expenses": "-1.82", "Revenues": "6.69", "Net Income": "5.29", "Selling, General and Administrative Expense": "-12.2", "Cost of Revenues": "36.8", "Other Revenues": "6.69", "Comprehensive Net Income": "5.51", "Other Net Income": "0.482", "Economic Capital Ratio": "-16.9" }, "2011": { "Other Liabilities": "4.91", "Liabilities": "-11.6", "Stockholders Equity": "-8.54", "ECR before LimitedLiability": "7.51", "Liabilities, Noncurrent": "-25.8", "Liabilities, Current": "7.40", "Selling, General and Administrative Expense": "-15.6", "Expenses": "13.6", "Net Income": "23.9", "Other Expenses": "2.44", "Cost of Revenues": "29.1", "Other Revenues": "11.0", "Revenues": "11.0", "Assets, Current": "3.86", "Other Assets": "-0.987", "Assets, Noncurrent": "-2.52", "Intangible Assets": "16.2", "Property, Plant and Equipment, Net": "-11.4", "Comprehensive Net Income": "23.7", "Other Net Income": "-1.37", "Economic Capital Ratio": "-7.27" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000110621_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "1,450,161", "Assets, Noncurrent": "1,171,336", "Cost of Revenues": "0", "Intangible Assets": "1,071,403", "Liabilities, Current": "631,494", "Liabilities, Noncurrent": "1,211,289", "Other Assets": "-1,071,403", "Other Compr. Net Income": "0", "Other Expenses": "2,123,941", "Other Liabilities": "0", "Other Net Income": "-370", "Other Revenues": "3,412,716", "Property, Plant and Equipment, Net": "382,527", "Selling, General and Administrative Expense": "1,107,278" }, "output_variables": { "Liabilities": "1,842,783", "Assets": "3,004,024", "Expenses": "3,231,219", "Revenues": "3,412,716", "Stockholders Equity": "1,161,241", "Net Income": "181,127", "Comprehensive Net Income": "181,127", "BaseVar": "5,745,556", "ECR before LimitedLiability": "46%", "Economic Capital Ratio": "116%" } }, "2011": { "input_variables": { "Assets, Current": "1,867,970", "Assets, Noncurrent": "112,676", "Cost of Revenues": "0", "Intangible Assets": "1,144,356", "Liabilities, Current": "735,289", "Liabilities, Noncurrent": "1,392,372", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "2,138,286", "Other Liabilities": "0", "Other Net Income": "2,397", "Other Revenues": "3,397,523", "Property, Plant and Equipment, Net": "390,027", "Selling, General and Administrative Expense": "1,058,466" }, "output_variables": { "Liabilities": "2,127,661", "Assets": "3,515,029", "Expenses": "3,196,752", "Revenues": "3,397,523", "Stockholders Equity": "1,387,368", "Net Income": "203,168", "Comprehensive Net Income": "203,168", "BaseVar": "6,119,681", "ECR before LimitedLiability": "47%", "Economic Capital Ratio": "116%" } } }, "top_rated": false, "trend": -32.0, "value": 1.1632778724690918, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000110621.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000110621.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000110621.svg" }, { "company_id": "0000051253", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000051253.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000051253.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000051253_main_keyfigs.svg", "name": "International Flavors Fragrances INC", "rank": 51, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000051253.svg", "report_text": "The relative strengths and weaknesses of International Flavors Fragrances INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of International Flavors Fragrances INC compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 29% points.The greatest weakness of International Flavors Fragrances INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 31% points.

The company's Economic Capital Ratio, given in the ranking table, is 114%, being 9.7% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000051253_2012_International_Flavors_Fragrances_INC.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "2.84", "Liabilities": "-21.1", "Stockholders Equity": "-16.3", "ECR before LimitedLiability": "-15.3", "Liabilities, Noncurrent": "-25.1", "Liabilities, Current": "0.573", "Assets, Current": "2.41", "Assets": "-1.16", "Property, Plant and Equipment, Net": "-6.20", "Other Assets": "2.11", "Intangible Assets": "3.03", "Assets, Noncurrent": "-1.69", "Other Expenses": "-15.4", "Expenses": "11.7", "Revenues": "-3.43", "Net Income": "8.53", "Selling, General and Administrative Expense": "-1.65", "Cost of Revenues": "31.6", "Other Revenues": "-3.43", "Comprehensive Net Income": "8.56", "Economic Capital Ratio": "-17.8" }, "2011": { "Other Liabilities": "4.79", "Liabilities": "-14.4", "Stockholders Equity": "-9.84", "ECR before LimitedLiability": "5.12", "Liabilities, Noncurrent": "-30.6", "Liabilities, Current": "8.90", "Selling, General and Administrative Expense": "-8.44", "Expenses": "19.1", "Net Income": "27.4", "Cost of Revenues": "28.8", "Other Revenues": "9.04", "Revenues": "9.04", "Assets, Current": "-1.16", "Other Assets": "2.09", "Assets, Noncurrent": "-0.923", "Intangible Assets": "9.62", "Property, Plant and Equipment, Net": "-7.22", "Comprehensive Net Income": "23.4", "Other Net Income": "-1.43", "Other Compr. Net Income": "-3.50", "Economic Capital Ratio": "-9.65" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000051253_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "1,325,195", "Assets, Noncurrent": "171,926", "Cost of Revenues": "0", "Intangible Assets": "714,416", "Liabilities, Current": "660,951", "Liabilities, Noncurrent": "1,208,349", "Other Assets": "122,800", "Other Compr. Net Income": "-4,377", "Other Expenses": "1,693,141", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "2,622,862", "Property, Plant and Equipment, Net": "538,118", "Selling, General and Administrative Expense": "666,164" }, "output_variables": { "Liabilities": "1,869,300", "Assets": "2,872,455", "Expenses": "2,359,305", "Revenues": "2,622,862", "Stockholders Equity": "1,003,155", "Net Income": "263,557", "Comprehensive Net Income": "259,180", "BaseVar": "4,864,150", "ECR before LimitedLiability": "45%", "Economic Capital Ratio": "115%" } }, "2011": { "input_variables": { "Assets, Current": "1,317,220", "Assets, Noncurrent": "179,833", "Cost of Revenues": "0", "Intangible Assets": "708,345", "Liabilities, Current": "564,566", "Liabilities, Noncurrent": "1,293,608", "Other Assets": "152,118", "Other Compr. Net Income": "-99,958", "Other Expenses": "1,857,397", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "2,788,018", "Property, Plant and Equipment, Net": "608,065", "Selling, General and Administrative Expense": "663,755" }, "output_variables": { "Liabilities": "1,858,174", "Assets": "2,965,581", "Expenses": "2,521,152", "Revenues": "2,788,018", "Stockholders Equity": "1,107,407", "Net Income": "266,866", "Comprehensive Net Income": "166,908", "BaseVar": "5,116,442", "ECR before LimitedLiability": "44%", "Economic Capital Ratio": "114%" } } }, "top_rated": false, "trend": -32.0, "value": 1.1394650791050327, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000051253.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000051253.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000051253.svg" }, { "company_id": "0001094139", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001094139.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001094139.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001094139.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001094139_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001094139_main_keyfigs.svg", "name": "Ourpets CO", "rank": 52, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001094139.svg", "report_text": "The relative strengths and weaknesses of Ourpets CO are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Ourpets CO compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 40% points.The greatest weakness of Ourpets CO is the variable Other Expenses, reducing the Economic Capital Ratio by 35% points.

The company's Economic Capital Ratio, given in the ranking table, is 114%, being 9.8% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001094139_2012_Ourpets_CO.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "6.76", "Liabilities": "10.4", "Stockholders Equity": "-21.3", "ECR before LimitedLiability": "5.02", "Liabilities, Noncurrent": "-6.02", "Liabilities, Current": "9.44", "Assets, Current": "7.22", "Assets": "-17.5", "Other Assets": "-3.04", "Assets, Noncurrent": "-2.24", "Intangible Assets": "-5.84", "Property, Plant and Equipment, Net": "-14.2", "Selling, General and Administrative Expense": "-15.5", "Expenses": "-16.3", "Revenues": "40.1", "Net Income": "26.1", "Other Expenses": "-35.5", "Cost of Revenues": "39.9", "Other Revenues": "40.1", "Comprehensive Net Income": "25.9", "Economic Capital Ratio": "-9.75" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001094139_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "9,232", "Assets, Noncurrent": "836", "Cost of Revenues": "0", "Intangible Assets": "347", "Liabilities, Current": "3,620", "Liabilities, Noncurrent": "3,563", "Other Assets": "-347", "Other Compr. Net Income": "0", "Other Expenses": "15,300", "Other Liabilities": "0", "Other Net Income": "23", "Other Revenues": "19,667", "Property, Plant and Equipment, Net": "2,265", "Selling, General and Administrative Expense": "4,270" }, "output_variables": { "Liabilities": "7,183", "Assets": "12,333", "Expenses": "19,569", "Revenues": "19,667", "Stockholders Equity": "5,150", "Net Income": "121", "Comprehensive Net Income": "121", "BaseVar": "29,388", "ECR before LimitedLiability": "44%", "Economic Capital Ratio": "114%" } } }, "top_rated": false, "trend": null, "value": 1.1384549229831167, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001094139.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001094139.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001094139.svg" }, { "company_id": "0000035214", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000035214.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000035214.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000035214.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000035214_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000035214_main_keyfigs.svg", "name": "Ferro CORP", "rank": 53, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000035214.svg", "report_text": "The relative strengths and weaknesses of Ferro CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Ferro CORP compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 46% points.The greatest weakness of Ferro CORP is the variable Cost of Revenues, reducing the Economic Capital Ratio by 76% points.

The company's Economic Capital Ratio, given in the ranking table, is 114%, being 9.9% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000035214_2012_Ferro_CORP.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "6.43", "Liabilities": "6.10", "Stockholders Equity": "-20.0", "ECR before LimitedLiability": "4.92", "Liabilities, Noncurrent": "-16.4", "Liabilities, Current": "14.5", "Assets, Current": "-9.40", "Assets": "-15.2", "Other Assets": "7.97", "Assets, Noncurrent": "-5.69", "Property, Plant and Equipment, Net": "-9.83", "Selling, General and Administrative Expense": "-2.22", "Expenses": "-10.6", "Revenues": "39.8", "Net Income": "26.3", "Other Expenses": "45.7", "Cost of Revenues": "-75.6", "Other Revenues": "39.8", "Comprehensive Net Income": "26.1", "Other Net Income": "-2.42", "Economic Capital Ratio": "-9.86" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000035214_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "630,899", "Assets, Noncurrent": "0", "Cost of Revenues": "1,742,605", "Intangible Assets": "226,657", "Liabilities, Current": "324,634", "Liabilities, Noncurrent": "533,523", "Other Assets": "203,759", "Other Compr. Net Income": "0", "Other Expenses": "79,008", "Other Liabilities": "0", "Other Net Income": "-7,010", "Other Revenues": "2,155,792", "Property, Plant and Equipment, Net": "379,336", "Selling, General and Administrative Expense": "294,802" }, "output_variables": { "Liabilities": "858,157", "Assets": "1,440,651", "Expenses": "2,116,415", "Revenues": "2,155,792", "Stockholders Equity": "582,494", "Net Income": "32,367", "Comprehensive Net Income": "32,367", "BaseVar": "3,289,012", "ECR before LimitedLiability": "44%", "Economic Capital Ratio": "114%" } } }, "top_rated": false, "trend": null, "value": 1.1374448485647128, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000035214.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000035214.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000035214.svg" }, { "company_id": "0000007431", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000007431.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000007431.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000007431.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000007431_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000007431_main_keyfigs.svg", "name": "Armstrong World Industries INC", "rank": 54, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000007431.svg", "report_text": "The relative strengths and weaknesses of Armstrong World Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Armstrong World Industries INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 41% points.The greatest weakness of Armstrong World Industries INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 42% points.

The company's Economic Capital Ratio, given in the ranking table, is 112%, being 11% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000007431_2012_Armstrong_World_Industries_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "4.91", "Liabilities": "-12.6", "Stockholders Equity": "-10.6", "ECR before LimitedLiability": "3.64", "Liabilities, Noncurrent": "-37.7", "Liabilities, Current": "15.5", "Assets, Current": "-4.12", "Assets": "-0.936", "Other Assets": "18.7", "Assets, Noncurrent": "-2.82", "Intangible Assets": "-5.53", "Property, Plant and Equipment, Net": "-2.69", "Selling, General and Administrative Expense": "-1.84", "Expenses": "12.4", "Revenues": "8.65", "Net Income": "22.1", "Other Expenses": "40.6", "Cost of Revenues": "-42.0", "Other Revenues": "8.65", "Comprehensive Net Income": "21.9", "Economic Capital Ratio": "-11.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000007431_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "1,209,300", "Assets, Noncurrent": "90,500", "Cost of Revenues": "2,187,900", "Intangible Assets": "0", "Liabilities, Current": "386,100", "Liabilities, Noncurrent": "1,478,400", "Other Assets": "792,000", "Other Compr. Net Income": "0", "Other Expenses": "139,600", "Other Liabilities": "0", "Other Net Income": "54,900", "Other Revenues": "2,863,300", "Property, Plant and Equipment, Net": "902,900", "Selling, General and Administrative Expense": "478,300" }, "output_variables": { "Liabilities": "1,864,500", "Assets": "2,994,700", "Expenses": "2,805,800", "Revenues": "2,863,300", "Stockholders Equity": "1,130,200", "Net Income": "112,400", "Comprehensive Net Income": "112,400", "BaseVar": "5,291,600", "ECR before LimitedLiability": "42%", "Economic Capital Ratio": "112%" } } }, "top_rated": false, "trend": null, "value": 1.124593049434202, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000007431.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000007431.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000007431.svg" }, { "company_id": "0000059255", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000059255.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000059255.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000059255.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000059255_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000059255_main_keyfigs.svg", "name": "Valhi INC DE", "rank": 55, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000059255.svg", "report_text": "The relative strengths and weaknesses of Valhi INC DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Valhi INC DE compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 30% points.The greatest weakness of Valhi INC DE is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 41% points.

The company's Economic Capital Ratio, given in the ranking table, is 112%, being 12% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000059255_2012_Valhi_INC_DE.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "4.24", "Liabilities": "-22.7", "Stockholders Equity": "-7.68", "ECR before LimitedLiability": "3.17", "Liabilities, Noncurrent": "-41.2", "Liabilities, Current": "10.3", "Assets, Current": "-4.76", "Assets": "7.24", "Other Assets": "-8.47", "Assets, Noncurrent": "28.2", "Intangible Assets": "3.56", "Property, Plant and Equipment, Net": "-2.87", "Selling, General and Administrative Expense": "2.62", "Expenses": "29.7", "Net Income": "27.0", "Cost of Revenues": "25.5", "Other Net Income": "-1.28", "Comprehensive Net Income": "21.9", "Other Compr. Net Income": "-4.38", "Other Revenues": "-1.11", "Economic Capital Ratio": "-11.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000059255_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "944,200", "Assets, Noncurrent": "1,170,000", "Cost of Revenues": "0", "Intangible Assets": "402,200", "Liabilities, Current": "415,600", "Liabilities, Noncurrent": "1,429,400", "Other Assets": "-402,200", "Other Compr. Net Income": "-122,000", "Other Expenses": "1,567,400", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "2,141,000", "Property, Plant and Equipment, Net": "723,800", "Selling, General and Administrative Expense": "278,600" }, "output_variables": { "Liabilities": "1,845,000", "Assets": "2,838,000", "Expenses": "1,846,000", "Revenues": "2,141,000", "Stockholders Equity": "993,000", "Net Income": "295,000", "Comprehensive Net Income": "173,000", "BaseVar": "4,396,000", "ECR before LimitedLiability": "42%", "Economic Capital Ratio": "112%" } } }, "top_rated": false, "trend": null, "value": 1.1199033183506326, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000059255.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000059255.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000059255.svg" }, { "company_id": "0000915389", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000915389.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000915389.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000915389.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000915389_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000915389_main_keyfigs.svg", "name": "Eastman Chemical CO", "rank": 56, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000915389.svg", "report_text": "The relative strengths and weaknesses of Eastman Chemical CO are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Eastman Chemical CO compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 32% points.The greatest weakness of Eastman Chemical CO is the variable Other Liabilities, reducing the Economic Capital Ratio by 22% points.

The company's Economic Capital Ratio, given in the ranking table, is 111%, being 13% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000915389_2012_Eastman_Chemical_CO.pdf", "shrinked_graph_json": { "2009": { "Liabilities, Current": "7.60", "Liabilities": "-13.5", "Stockholders Equity": "-27.8", "ECR before LimitedLiability": "-30.6", "Other Liabilities": "-20.1", "Other Assets": "4.63", "Assets": "-13.3", "Assets, Current": "-2.71", "Property, Plant and Equipment, Net": "3.72", "Intangible Assets": "-9.35", "Assets, Noncurrent": "-9.33", "Cost of Revenues": "26.3", "Expenses": "-5.22", "Revenues": "5.08", "Net Income": "-3.09", "Other Expenses": "-38.3", "Other Revenues": "5.08", "Comprehensive Net Income": "-5.25", "Other Net Income": "-2.82", "Other Compr. Net Income": "-2.20", "Economic Capital Ratio": "-28.8" }, "2010": { "Other Liabilities": "-24.3", "Liabilities": "-25.3", "Stockholders Equity": "-24.8", "ECR before LimitedLiability": "-25.5", "Liabilities, Noncurrent": "-8.11", "Liabilities, Current": "6.92", "Assets, Current": "-6.39", "Assets": "-5.38", "Property, Plant and Equipment, Net": "16.3", "Intangible Assets": "-8.63", "Assets, Noncurrent": "-2.62", "Other Expenses": "-28.8", "Expenses": "13.9", "Revenues": "-3.55", "Net Income": "6.61", "Selling, General and Administrative Expense": "13.7", "Cost of Revenues": "30.7", "Other Revenues": "-3.55", "Comprehensive Net Income": "6.01", "Other Net Income": "-3.28", "Economic Capital Ratio": "-28.0" }, "2011": { "Other Liabilities": "-22.3", "Liabilities": "-14.1", "Assets": "-6.98", "Stockholders Equity": "-19.9", "ECR before LimitedLiability": "1.80", "Liabilities, Noncurrent": "-6.39", "Liabilities, Current": "13.0", "Assets, Current": "-8.35", "Intangible Assets": "-2.47", "Property, Plant and Equipment, Net": "7.69", "Selling, General and Administrative Expense": "5.57", "Expenses": "12.8", "Revenues": "19.8", "Net Income": "31.8", "Other Expenses": "-21.5", "Cost of Revenues": "32.2", "Other Revenues": "19.8", "Comprehensive Net Income": "29.6", "Other Net Income": "-1.87", "Other Compr. Net Income": "-1.82", "Economic Capital Ratio": "-13.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000915389_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "1,735,000", "Assets, Noncurrent": "355,000", "Cost of Revenues": "0", "Intangible Assets": "315,000", "Liabilities, Current": "800,000", "Liabilities, Noncurrent": "1,723,000", "Other Assets": "0", "Other Compr. Net Income": "-50,000", "Other Expenses": "4,284,000", "Other Liabilities": "1,479,000", "Other Net Income": "-91,000", "Other Revenues": "5,047,000", "Property, Plant and Equipment, Net": "3,110,000", "Selling, General and Administrative Expense": "536,000" }, "output_variables": { "Liabilities": "4,002,000", "Assets": "5,515,000", "Expenses": "4,820,000", "Revenues": "5,047,000", "Stockholders Equity": "1,513,000", "Net Income": "136,000", "Comprehensive Net Income": "86,000", "BaseVar": "9,762,500", "ECR before LimitedLiability": "28%", "Economic Capital Ratio": "100%" } }, "2010": { "input_variables": { "Assets, Current": "2,047,000", "Assets, Noncurrent": "322,000", "Cost of Revenues": "0", "Intangible Assets": "375,000", "Liabilities, Current": "1,070,000", "Liabilities, Noncurrent": "1,728,000", "Other Assets": "23,000", "Other Compr. Net Income": "-47,000", "Other Expenses": "4,595,000", "Other Liabilities": "1,561,000", "Other Net Income": "-226,000", "Other Revenues": "5,842,000", "Property, Plant and Equipment, Net": "3,219,000", "Selling, General and Administrative Expense": "583,000" }, "output_variables": { "Liabilities": "4,359,000", "Assets": "5,986,000", "Expenses": "5,178,000", "Revenues": "5,842,000", "Stockholders Equity": "1,627,000", "Net Income": "438,000", "Comprehensive Net Income": "391,000", "BaseVar": "10,819,000", "ECR before LimitedLiability": "33%", "Economic Capital Ratio": "105%" } }, "2011": { "input_variables": { "Assets, Current": "2,302,000", "Assets, Noncurrent": "369,000", "Cost of Revenues": "0", "Intangible Assets": "406,000", "Liabilities, Current": "1,114,000", "Liabilities, Noncurrent": "1,579,000", "Other Assets": "0", "Other Compr. Net Income": "-106,000", "Other Expenses": "5,837,000", "Other Liabilities": "1,621,000", "Other Net Income": "-18,000", "Other Revenues": "7,178,000", "Property, Plant and Equipment, Net": "3,107,000", "Selling, General and Administrative Expense": "627,000" }, "output_variables": { "Liabilities": "4,314,000", "Assets": "6,184,000", "Expenses": "6,464,000", "Revenues": "7,178,000", "Stockholders Equity": "1,870,000", "Net Income": "696,000", "Comprehensive Net Income": "590,000", "BaseVar": "12,132,000", "ECR before LimitedLiability": "40%", "Economic Capital Ratio": "111%" } } }, "top_rated": false, "trend": -36.0, "value": 1.1062364580227013, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000915389.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000915389.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000915389.svg" }, { "company_id": "0001091862", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001091862.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001091862.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001091862_main_keyfigs.svg", "name": "Lanxess Solutions US Inc", "rank": 57, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001091862.svg", "report_text": "The relative strengths and weaknesses of Lanxess Solutions US Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Lanxess Solutions US Inc compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 32% points.The greatest weakness of Lanxess Solutions US Inc is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 36% points.

The company's Economic Capital Ratio, given in the ranking table, is 109%, being 14% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001091862_2012_Lanxess_Solutions_US_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "5.17", "Liabilities": "-10.2", "Stockholders Equity": "-14.0", "Economic Capital Ratio": "-14.3", "Liabilities, Noncurrent": "-36.3", "Liabilities, Current": "16.3", "Assets, Current": "-2.59", "Assets": "-4.72", "Other Assets": "-1.17", "Intangible Assets": "6.51", "Property, Plant and Equipment, Net": "-6.20", "Selling, General and Administrative Expense": "3.29", "Expenses": "9.88", "Net Income": "24.0", "Other Expenses": "-22.0", "Cost of Revenues": "32.2", "Other Revenues": "14.1", "Revenues": "14.1", "Comprehensive Net Income": "21.0", "Other Compr. Net Income": "-2.65", "Other Net Income": "-0.617" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001091862_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "1,321,000", "Assets, Noncurrent": "216,000", "Cost of Revenues": "0", "Intangible Assets": "566,000", "Liabilities, Current": "390,000", "Liabilities, Noncurrent": "1,419,000", "Other Assets": "0", "Other Compr. Net Income": "-70,000", "Other Expenses": "2,593,000", "Other Liabilities": "0", "Other Net Income": "27,000", "Other Revenues": "3,025,000", "Property, Plant and Equipment, Net": "752,000", "Selling, General and Administrative Expense": "339,000" }, "output_variables": { "Liabilities": "1,809,000", "Assets": "2,855,000", "Expenses": "2,932,000", "Revenues": "3,025,000", "Stockholders Equity": "1,046,000", "Net Income": "120,000", "Comprehensive Net Income": "50,000", "BaseVar": "5,359,000", "ECR before LimitedLiability": "38%", "Economic Capital Ratio": "109%" } } }, "top_rated": false, "trend": null, "value": 1.0926470524720489, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001091862.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001091862.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001091862.svg" }, { "company_id": "0001309402", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001309402.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001309402.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001309402.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001309402_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001309402_main_keyfigs.svg", "name": "Green Plains Inc", "rank": 58, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001309402.svg", "report_text": "The relative strengths and weaknesses of Green Plains Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Green Plains Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 56% points.The greatest weakness of Green Plains Inc is the variable Cost of Revenues, reducing the Economic Capital Ratio by 166% points.

The company's Economic Capital Ratio, given in the ranking table, is 109%, being 15% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001309402_2012_Green_Plains_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "5.09", "Liabilities": "28.3", "Stockholders Equity": "-44.3", "Economic Capital Ratio": "-14.7", "Liabilities, Noncurrent": "-2.71", "Liabilities, Current": "26.3", "Assets, Current": "-22.4", "Assets": "-33.8", "Other Assets": "-2.03", "Assets, Noncurrent": "-7.38", "Intangible Assets": "-8.73", "Property, Plant and Equipment, Net": "-6.10", "Selling, General and Administrative Expense": "23.2", "Expenses": "-43.2", "Revenues": "44.1", "Net Income": "35.1", "Other Expenses": "55.7", "Cost of Revenues": "-166", "Other Revenues": "44.1", "Comprehensive Net Income": "35.1", "Other Net Income": "-5.39" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001309402_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "576,420", "Assets, Noncurrent": "26,742", "Cost of Revenues": "3,381,480", "Intangible Assets": "40,877", "Liabilities, Current": "360,965", "Liabilities, Noncurrent": "498,536", "Other Assets": "0", "Other Compr. Net Income": "-2,533", "Other Expenses": "23,686", "Other Liabilities": "55,970", "Other Net Income": "-37,114", "Other Revenues": "3,553,712", "Property, Plant and Equipment, Net": "776,789", "Selling, General and Administrative Expense": "73,219" }, "output_variables": { "Liabilities": "915,471", "Assets": "1,420,828", "Expenses": "3,478,385", "Revenues": "3,553,712", "Stockholders Equity": "505,357", "Net Income": "38,213", "Comprehensive Net Income": "35,680", "BaseVar": "4,704,022", "ECR before LimitedLiability": "38%", "Economic Capital Ratio": "109%" } } }, "top_rated": false, "trend": null, "value": 1.089448227554895, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001309402.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001309402.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001309402.svg" }, { "company_id": "0000805264", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000805264.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000805264.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000805264_main_keyfigs.svg", "name": "Axiall CORP DE", "rank": 59, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000805264.svg", "report_text": "The relative strengths and weaknesses of Axiall CORP DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Axiall CORP DE compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 43% points.The greatest weakness of Axiall CORP DE is the variable Cost of Revenues, reducing the Economic Capital Ratio by 112% points.

The company's Economic Capital Ratio, given in the ranking table, is 103%, being 21% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000805264_2012_Axiall_CORP_DE.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-11.9", "Liabilities": "9.51", "Stockholders Equity": "-38.1", "ECR before LimitedLiability": "-5.85", "Liabilities, Noncurrent": "-6.76", "Liabilities, Current": "25.4", "Assets, Current": "-18.4", "Assets": "-27.8", "Other Assets": "-1.67", "Assets, Noncurrent": "-4.92", "Property, Plant and Equipment, Net": "-9.55", "Selling, General and Administrative Expense": "12.9", "Expenses": "-24.0", "Revenues": "31.9", "Net Income": "29.1", "Other Expenses": "42.6", "Cost of Revenues": "-112", "Other Revenues": "31.9", "Comprehensive Net Income": "29.1", "Other Net Income": "-2.67", "Economic Capital Ratio": "-20.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000805264_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "663,617", "Assets, Noncurrent": "75,601", "Cost of Revenues": "2,919,625", "Intangible Assets": "260,323", "Liabilities, Current": "278,888", "Liabilities, Noncurrent": "561,584", "Other Assets": "3,770", "Other Compr. Net Income": "-17,941", "Other Expenses": "71,867", "Other Liabilities": "315,075", "Other Net Income": "-5,414", "Other Revenues": "3,222,884", "Property, Plant and Equipment, Net": "640,900", "Selling, General and Administrative Expense": "168,221" }, "output_variables": { "Liabilities": "1,155,547", "Assets": "1,644,211", "Expenses": "3,159,713", "Revenues": "3,222,884", "Stockholders Equity": "488,664", "Net Income": "57,757", "Comprehensive Net Income": "39,816", "BaseVar": "4,602,855", "ECR before LimitedLiability": "31%", "Economic Capital Ratio": "103%" } } }, "top_rated": false, "trend": null, "value": 1.0297198956230869, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000805264.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000805264.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000805264.svg" }, { "company_id": "0000102741", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000102741.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000102741.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000102741.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000102741_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000102741_main_keyfigs.svg", "name": "Valspar CORP", "rank": 60, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000102741.svg", "report_text": "The relative strengths and weaknesses of Valspar CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Valspar CORP compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 31% points.The greatest weakness of Valspar CORP is the variable Cost of Revenues, reducing the Economic Capital Ratio by 45% points.

The company's Economic Capital Ratio, given in the ranking table, is 101%, being 22% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000102741_2012_Valspar_CORP.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "-4.36", "Liabilities": "-16.7", "Stockholders Equity": "-8.66", "ECR before LimitedLiability": "-11.0", "Liabilities, Noncurrent": "-11.2", "Liabilities, Current": "-0.726", "Assets, Current": "-3.45", "Assets": "2.25", "Property, Plant and Equipment, Net": "-7.10", "Intangible Assets": "25.0", "Assets, Noncurrent": "-4.25", "Other Expenses": "40.6", "Expenses": "10.9", "Revenues": "-5.86", "Net Income": "5.16", "Selling, General and Administrative Expense": "2.33", "Cost of Revenues": "-26.5", "Other Revenues": "-5.86", "Comprehensive Net Income": "5.34", "Other Net Income": "0.450", "Economic Capital Ratio": "-13.5" }, "2011": { "Liabilities": "-9.12", "Stockholders Equity": "-18.2", "ECR before LimitedLiability": "-7.57", "Liabilities, Noncurrent": "-3.95", "Liabilities, Current": "-4.22", "Assets, Current": "-9.61", "Assets": "-8.64", "Other Assets": "-1.32", "Assets, Noncurrent": "-5.53", "Intangible Assets": "27.4", "Property, Plant and Equipment, Net": "-13.8", "Selling, General and Administrative Expense": "-9.12", "Expenses": "1.17", "Revenues": "16.9", "Net Income": "16.3", "Other Expenses": "30.7", "Cost of Revenues": "-44.7", "Other Revenues": "16.9", "Comprehensive Net Income": "16.1", "Other Net Income": "-1.77", "Economic Capital Ratio": "-22.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000102741_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "1,284,922", "Assets, Noncurrent": "17,398", "Cost of Revenues": "2,155,009", "Intangible Assets": "1,993,208", "Liabilities, Current": "884,851", "Liabilities, Noncurrent": "1,096,195", "Other Assets": "4,778", "Other Compr. Net Income": "0", "Other Expenses": "155,408", "Other Liabilities": "256,525", "Other Net Income": "1,387", "Other Revenues": "3,226,687", "Property, Plant and Equipment, Net": "567,630", "Selling, General and Administrative Expense": "695,601" }, "output_variables": { "Liabilities": "2,237,571", "Assets": "3,867,936", "Expenses": "3,006,018", "Revenues": "3,226,687", "Stockholders Equity": "1,630,365", "Net Income": "222,056", "Comprehensive Net Income": "222,056", "BaseVar": "6,169,800", "ECR before LimitedLiability": "51%", "Economic Capital Ratio": "119%" } }, "2011": { "input_variables": { "Assets, Current": "1,325,137", "Assets, Noncurrent": "13,560", "Cost of Revenues": "2,721,146", "Intangible Assets": "1,611,292", "Liabilities, Current": "1,259,933", "Liabilities, Noncurrent": "812,748", "Other Assets": "1,909", "Other Compr. Net Income": "0", "Other Expenses": "506,672", "Other Liabilities": "214,920", "Other Net Income": "-1,577", "Other Revenues": "3,952,954", "Property, Plant and Equipment, Net": "548,253", "Selling, General and Administrative Expense": "862,160" }, "output_variables": { "Liabilities": "2,287,601", "Assets": "3,500,151", "Expenses": "4,089,978", "Revenues": "3,952,954", "Stockholders Equity": "1,212,550", "Net Income": "-138,601", "Comprehensive Net Income": "-138,601", "BaseVar": "6,916,130", "ECR before LimitedLiability": "29%", "Economic Capital Ratio": "101%" } } }, "top_rated": false, "trend": -43.0, "value": 1.012515008304141, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000102741.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000102741.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000102741.svg" }, { "company_id": "0001418862", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001418862.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001418862.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001418862_main_keyfigs.svg", "name": "Kior Inc", "rank": 61, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001418862.svg", "report_text": "The relative strengths and weaknesses of Kior Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Kior Inc compared to the market average is the variable Assets, increasing the Economic Capital Ratio by 36% points.The greatest weakness of Kior Inc is the variable Other Net Income, reducing the Economic Capital Ratio by 53% points.

The company's Economic Capital Ratio, given in the ranking table, is 101%, being 23% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001418862_2012_Kior_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "3.02", "Liabilities": "-1.38", "Stockholders Equity": "29.9", "ECR before LimitedLiability": "-7.91", "Liabilities, Noncurrent": "-10.1", "Liabilities, Current": "5.23", "Assets, Current": "25.0", "Assets": "35.7", "Assets, Noncurrent": "-3.21", "Intangible Assets": "-3.51", "Property, Plant and Equipment, Net": "29.2", "Selling, General and Administrative Expense": "9.68", "Expenses": "32.5", "Revenues": "-50.9", "Net Income": "-43.5", "Other Expenses": "27.9", "Cost of Revenues": "19.0", "Other Revenues": "-50.9", "Comprehensive Net Income": "-43.6", "Other Net Income": "-53.1", "Economic Capital Ratio": "-22.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001418862_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "132,637", "Assets, Noncurrent": "471", "Cost of Revenues": "0", "Intangible Assets": "2,233", "Liabilities, Current": "29,221", "Liabilities, Noncurrent": "47,304", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "47", "Other Liabilities": "0", "Other Net Income": "-130,332", "Other Revenues": "0", "Property, Plant and Equipment, Net": "169,923", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "76,525", "Assets": "305,264", "Expenses": "47", "Revenues": "0", "Stockholders Equity": "228,739", "Net Income": "-130,379", "Comprehensive Net Income": "-130,379", "BaseVar": "256,084", "ECR before LimitedLiability": "29%", "Economic Capital Ratio": "101%" } } }, "top_rated": false, "trend": null, "value": 1.009082039018788, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001418862.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001418862.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001418862.svg" }, { "company_id": "0000079879", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000079879.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000079879.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000079879.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000079879_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000079879_main_keyfigs.svg", "name": "PPG Industries INC", "rank": 62, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000079879.svg", "report_text": "The relative strengths and weaknesses of PPG Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of PPG Industries INC compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 26% points.The greatest weakness of PPG Industries INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 24% points.

The company's Economic Capital Ratio, given in the ranking table, is 100%, being 24% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000079879_2012_PPG_Industries_INC.pdf", "shrinked_graph_json": { "2009": { "Liabilities, Current": "-3.05", "Liabilities": "-14.9", "Stockholders Equity": "-26.2", "ECR before LimitedLiability": "-27.0", "Liabilities, Noncurrent": "-7.68", "Other Liabilities": "-3.77", "Other Assets": "6.90", "Assets": "-11.3", "Assets, Current": "5.08", "Property, Plant and Equipment, Net": "-16.4", "Intangible Assets": "6.43", "Assets, Noncurrent": "-9.04", "Cost of Revenues": "29.6", "Expenses": "-3.78", "Revenues": "2.63", "Net Income": "-2.39", "Selling, General and Administrative Expense": "-9.71", "Other Expenses": "-26.3", "Other Revenues": "2.63", "Comprehensive Net Income": "-1.67", "Economic Capital Ratio": "-25.3" }, "2010": { "Other Liabilities": "-8.26", "Liabilities": "-28.2", "Stockholders Equity": "-25.2", "ECR before LimitedLiability": "-29.5", "Liabilities, Noncurrent": "-19.1", "Assets, Current": "2.31", "Assets": "-3.98", "Property, Plant and Equipment, Net": "-8.38", "Other Assets": "2.01", "Intangible Assets": "4.22", "Assets, Noncurrent": "-3.06", "Other Expenses": "-19.9", "Expenses": "12.8", "Revenues": "-7.50", "Net Income": "5.21", "Selling, General and Administrative Expense": "2.54", "Cost of Revenues": "26.9", "Other Revenues": "-7.50", "Comprehensive Net Income": "3.61", "Other Compr. Net Income": "-1.56", "Economic Capital Ratio": "-31.9" }, "2011": { "Other Liabilities": "-7.30", "Liabilities": "-21.9", "Stockholders Equity": "-23.6", "ECR before LimitedLiability": "-8.91", "Liabilities, Noncurrent": "-19.2", "Liabilities, Current": "4.69", "Assets, Current": "-3.05", "Assets": "-5.98", "Assets, Noncurrent": "-1.92", "Intangible Assets": "12.1", "Property, Plant and Equipment, Net": "-11.0", "Selling, General and Administrative Expense": "-7.12", "Expenses": "18.1", "Revenues": "10.9", "Net Income": "26.0", "Other Expenses": "-4.79", "Cost of Revenues": "26.1", "Other Revenues": "10.9", "Comprehensive Net Income": "24.3", "Other Compr. Net Income": "-3.64", "Economic Capital Ratio": "-23.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000079879_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "5,981,000", "Assets, Noncurrent": "806,000", "Cost of Revenues": "0", "Intangible Assets": "4,200,000", "Liabilities, Current": "3,577,000", "Liabilities, Noncurrent": "5,165,000", "Other Assets": "499,000", "Other Compr. Net Income": "277,000", "Other Expenses": "9,042,000", "Other Liabilities": "1,576,000", "Other Net Income": "-13,000", "Other Revenues": "12,417,000", "Property, Plant and Equipment, Net": "2,754,000", "Selling, General and Administrative Expense": "2,936,000" }, "output_variables": { "Liabilities": "10,318,000", "Assets": "14,240,000", "Expenses": "11,978,000", "Revenues": "12,417,000", "Stockholders Equity": "3,922,000", "Net Income": "426,000", "Comprehensive Net Income": "703,000", "BaseVar": "24,621,500", "ECR before LimitedLiability": "32%", "Economic Capital Ratio": "103%" } }, "2010": { "input_variables": { "Assets, Current": "7,058,000", "Assets, Noncurrent": "694,000", "Cost of Revenues": "0", "Intangible Assets": "3,987,000", "Liabilities, Current": "3,625,000", "Liabilities, Noncurrent": "5,830,000", "Other Assets": "550,000", "Other Compr. Net Income": "-261,000", "Other Expenses": "9,766,000", "Other Liabilities": "1,687,000", "Other Net Income": "-12,000", "Other Revenues": "13,637,000", "Property, Plant and Equipment, Net": "2,686,000", "Selling, General and Administrative Expense": "2,979,000" }, "output_variables": { "Liabilities": "11,142,000", "Assets": "14,975,000", "Expenses": "12,745,000", "Revenues": "13,637,000", "Stockholders Equity": "3,833,000", "Net Income": "880,000", "Comprehensive Net Income": "619,000", "BaseVar": "26,386,000", "ECR before LimitedLiability": "29%", "Economic Capital Ratio": "101%" } }, "2011": { "input_variables": { "Assets, Current": "6,694,000", "Assets, Noncurrent": "795,000", "Cost of Revenues": "0", "Intangible Assets": "3,785,000", "Liabilities, Current": "3,702,000", "Liabilities, Noncurrent": "5,414,000", "Other Assets": "387,000", "Other Compr. Net Income": "-506,000", "Other Expenses": "10,646,000", "Other Liabilities": "1,820,000", "Other Net Income": "30,000", "Other Revenues": "15,062,000", "Property, Plant and Equipment, Net": "2,721,000", "Selling, General and Administrative Expense": "3,234,000" }, "output_variables": { "Liabilities": "10,936,000", "Assets": "14,382,000", "Expenses": "13,880,000", "Revenues": "15,062,000", "Stockholders Equity": "3,446,000", "Net Income": "1,212,000", "Comprehensive Net Income": "706,000", "BaseVar": "27,398,000", "ECR before LimitedLiability": "28%", "Economic Capital Ratio": "100%" } } }, "top_rated": false, "trend": -40.0, "value": 0.99910101554029, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000079879.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000079879.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000079879.svg" }, { "company_id": "0001325740", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001325740.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001325740.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001325740.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001325740_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001325740_main_keyfigs.svg", "name": "Advanced Bioenergy LLC", "rank": 63, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001325740.svg", "report_text": "The relative strengths and weaknesses of Advanced Bioenergy LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Advanced Bioenergy LLC compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Advanced Bioenergy LLC is the variable Liabilities, reducing the Economic Capital Ratio by 54% points.

The company's Economic Capital Ratio, given in the ranking table, is 100%, being 24% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001325740_2012_Advanced_Bioenergy_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "0.556", "Liabilities": "-54.1", "Stockholders Equity": "2.50", "ECR before LimitedLiability": "-8.95", "Liabilities, Noncurrent": "-53.1", "Liabilities, Current": "-1.20", "Assets, Current": "2.65", "Assets": "27.5", "Assets, Noncurrent": "-2.08", "Intangible Assets": "-3.23", "Property, Plant and Equipment, Net": "28.4", "Selling, General and Administrative Expense": "7.38", "Expenses": "28.1", "Revenues": "-39.8", "Net Income": "9.57", "Other Expenses": "26.1", "Cost of Revenues": "14.4", "Other Revenues": "-39.8", "Comprehensive Net Income": "9.50", "Other Net Income": "1.25", "Economic Capital Ratio": "-23.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001325740_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "63,470", "Assets, Noncurrent": "1,883", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "35,751", "Liabilities, Noncurrent": "126,571", "Other Assets": "2,002", "Other Compr. Net Income": "0", "Other Expenses": "3,617", "Other Liabilities": "4,208", "Other Net Income": "4,491", "Other Revenues": "935", "Property, Plant and Equipment, Net": "164,821", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "166,530", "Assets": "232,176", "Expenses": "3,617", "Revenues": "935", "Stockholders Equity": "65,646", "Net Income": "1,809", "Comprehensive Net Income": "1,809", "BaseVar": "203,874", "ECR before LimitedLiability": "28%", "Economic Capital Ratio": "100%" } } }, "top_rated": false, "trend": null, "value": 0.9986917053263882, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001325740.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001325740.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001325740.svg" }, { "company_id": "0000077597", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000077597.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000077597.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000077597_main_keyfigs.svg", "name": "Spartech CORP", "rank": 64, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000077597.svg", "report_text": "The relative strengths and weaknesses of Spartech CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Spartech CORP compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Spartech CORP is the variable Other Expenses, reducing the Economic Capital Ratio by 76% points.

The company's Economic Capital Ratio, given in the ranking table, is 98%, being 25% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000077597_2012_Spartech_CORP.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "13.0", "Stockholders Equity": "-39.5", "ECR before LimitedLiability": "-10.6", "Liabilities, Noncurrent": "2.94", "Liabilities, Current": "10.1", "Assets, Current": "-15.9", "Assets": "-31.1", "Other Assets": "-2.01", "Assets, Noncurrent": "-7.93", "Intangible Assets": "-3.38", "Property, Plant and Equipment, Net": "-11.7", "Selling, General and Administrative Expense": "10.3", "Expenses": "-32.4", "Revenues": "28.3", "Net Income": "24.3", "Other Expenses": "-76.3", "Cost of Revenues": "25.8", "Other Revenues": "28.3", "Comprehensive Net Income": "24.3", "Other Net Income": "-2.04", "Economic Capital Ratio": "-25.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000077597_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "277,606", "Assets, Noncurrent": "3,684", "Cost of Revenues": "0", "Intangible Assets": "60,338", "Liabilities, Current": "196,758", "Liabilities, Noncurrent": "138,336", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,051,353", "Other Liabilities": "41,676", "Other Net Income": "2,316", "Other Revenues": "1,102,290", "Property, Plant and Equipment, Net": "208,074", "Selling, General and Administrative Expense": "74,320" }, "output_variables": { "Liabilities": "376,770", "Assets": "549,702", "Expenses": "1,125,673", "Revenues": "1,102,290", "Stockholders Equity": "172,932", "Net Income": "-21,067", "Comprehensive Net Income": "-21,067", "BaseVar": "1,578,376", "ECR before LimitedLiability": "26%", "Economic Capital Ratio": "98%" } } }, "top_rated": false, "trend": null, "value": 0.981917215403996, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000077597.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000077597.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000077597.svg" }, { "company_id": "0001012100", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001012100.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001012100.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001012100.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001012100_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001012100_main_keyfigs.svg", "name": "Sealed AIR CORP DE", "rank": 65, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001012100.svg", "report_text": "The relative strengths and weaknesses of Sealed AIR CORP DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Sealed AIR CORP DE compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 25% points.The greatest weakness of Sealed AIR CORP DE is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 39% points.

The company's Economic Capital Ratio, given in the ranking table, is 98%, being 26% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001012100_2012_Sealed_AIR_CORP_DE.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "2.67", "Liabilities": "-14.4", "Stockholders Equity": "-6.63", "ECR before LimitedLiability": "-9.49", "Liabilities, Noncurrent": "-11.7", "Liabilities, Current": "-5.26", "Assets, Current": "-0.897", "Assets": "2.57", "Property, Plant and Equipment, Net": "-5.60", "Other Assets": "1.51", "Intangible Assets": "11.3", "Assets, Noncurrent": "-1.70", "Other Expenses": "39.8", "Expenses": "10.4", "Revenues": "-5.63", "Net Income": "4.15", "Selling, General and Administrative Expense": "7.26", "Cost of Revenues": "-30.6", "Other Revenues": "-5.63", "Comprehensive Net Income": "4.38", "Economic Capital Ratio": "-11.9" }, "2011": { "Other Liabilities": "-0.908", "Liabilities": "-38.5", "Stockholders Equity": "-10.8", "ECR before LimitedLiability": "-11.2", "Liabilities, Noncurrent": "-38.8", "Liabilities, Current": "1.12", "Assets, Current": "-5.38", "Assets": "18.5", "Assets, Noncurrent": "-1.39", "Intangible Assets": "25.2", "Property, Plant and Equipment, Net": "-9.57", "Selling, General and Administrative Expense": "1.93", "Expenses": "24.1", "Revenues": "-17.6", "Net Income": "15.0", "Other Expenses": "25.2", "Cost of Revenues": "-13.8", "Other Revenues": "-17.6", "Comprehensive Net Income": "14.6", "Other Net Income": "-1.27", "Economic Capital Ratio": "-26.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001012100_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "2,040,000", "Assets, Noncurrent": "285,600", "Cost of Revenues": "3,237,300", "Intangible Assets": "1,945,900", "Liabilities, Current": "1,447,700", "Liabilities, Noncurrent": "1,542,100", "Other Assets": "179,600", "Other Compr. Net Income": "2,400", "Other Expenses": "250,800", "Other Liabilities": "8,000", "Other Net Income": "-35,900", "Other Revenues": "4,490,100", "Property, Plant and Equipment, Net": "948,300", "Selling, General and Administrative Expense": "710,200" }, "output_variables": { "Liabilities": "2,997,800", "Assets": "5,399,400", "Expenses": "4,198,300", "Revenues": "4,490,100", "Stockholders Equity": "2,401,600", "Net Income": "255,900", "Comprehensive Net Income": "258,300", "BaseVar": "8,561,950", "ECR before LimitedLiability": "52%", "Economic Capital Ratio": "121%" } }, "2011": { "input_variables": { "Assets, Current": "3,262,600", "Assets, Noncurrent": "459,000", "Cost of Revenues": "3,999,700", "Intangible Assets": "6,323,700", "Liabilities, Current": "2,383,500", "Liabilities, Noncurrent": "5,628,800", "Other Assets": "129,300", "Other Compr. Net Income": "-34,800", "Other Expenses": "443,000", "Other Liabilities": "532,000", "Other Net Income": "-14,200", "Other Revenues": "5,640,900", "Property, Plant and Equipment, Net": "1,322,100", "Selling, General and Administrative Expense": "1,034,900" }, "output_variables": { "Liabilities": "8,544,300", "Assets": "11,496,700", "Expenses": "5,477,600", "Revenues": "5,640,900", "Stockholders Equity": "2,952,400", "Net Income": "149,100", "Comprehensive Net Income": "114,300", "BaseVar": "15,604,250", "ECR before LimitedLiability": "25%", "Economic Capital Ratio": "98%" } } }, "top_rated": false, "trend": -50.0, "value": 0.9758066754489019, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001012100.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001012100.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001012100.svg" }, { "company_id": "0000030554", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000030554.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000030554.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000030554.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000030554_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000030554_main_keyfigs.svg", "name": "EIDP Inc", "rank": 66, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000030554.svg", "report_text": "The relative strengths and weaknesses of EIDP Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of EIDP Inc compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 23% points.The greatest weakness of EIDP Inc is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 42% points.

The company's Economic Capital Ratio, given in the ranking table, is 97%, being 26% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000030554_2012_EIDP_Inc.pdf", "shrinked_graph_json": { "2010": { "Other Liabilities": "2.31", "Liabilities": "-33.1", "Stockholders Equity": "-23.2", "ECR before LimitedLiability": "-27.5", "Liabilities, Noncurrent": "-35.8", "Assets, Current": "4.16", "Assets": "0.304", "Property, Plant and Equipment, Net": "-1.03", "Other Assets": "-0.457", "Intangible Assets": "-3.84", "Assets, Noncurrent": "1.89", "Other Expenses": "-17.6", "Expenses": "18.5", "Revenues": "-13.8", "Net Income": "6.88", "Selling, General and Administrative Expense": "7.91", "Cost of Revenues": "28.8", "Other Revenues": "-13.8", "Comprehensive Net Income": "7.06", "Other Net Income": "3.46", "Economic Capital Ratio": "-29.9" }, "2011": { "Other Liabilities": "2.26", "Liabilities": "-34.5", "Stockholders Equity": "-22.2", "ECR before LimitedLiability": "-11.5", "Liabilities, Noncurrent": "-42.0", "Liabilities, Current": "3.53", "Assets, Current": "-4.91", "Assets": "2.86", "Other Assets": "4.80", "Assets, Noncurrent": "-1.99", "Intangible Assets": "9.83", "Property, Plant and Equipment, Net": "-3.36", "Selling, General and Administrative Expense": "0.730", "Expenses": "23.4", "Revenues": "-4.09", "Net Income": "23.4", "Other Expenses": "0.631", "Cost of Revenues": "23.4", "Other Revenues": "-4.09", "Comprehensive Net Income": "23.4", "Economic Capital Ratio": "-26.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000030554_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "19,059,000", "Assets, Noncurrent": "4,691,000", "Cost of Revenues": "0", "Intangible Assets": "5,321,000", "Liabilities, Current": "9,389,000", "Liabilities, Noncurrent": "21,163,000", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "24,361,000", "Other Liabilities": "115,000", "Other Net Income": "1,228,000", "Other Revenues": "31,505,000", "Property, Plant and Equipment, Net": "11,339,000", "Selling, General and Administrative Expense": "5,320,000" }, "output_variables": { "Liabilities": "30,667,000", "Assets": "40,410,000", "Expenses": "29,681,000", "Revenues": "31,505,000", "Stockholders Equity": "9,743,000", "Net Income": "3,052,000", "Comprehensive Net Income": "3,052,000", "BaseVar": "66,745,500", "ECR before LimitedLiability": "31%", "Economic Capital Ratio": "103%" } }, "2011": { "input_variables": { "Assets, Current": "18,058,000", "Assets, Noncurrent": "2,129,000", "Cost of Revenues": "0", "Intangible Assets": "10,826,000", "Liabilities, Current": "11,185,000", "Liabilities, Noncurrent": "27,244,000", "Other Assets": "4,067,000", "Other Compr. Net Income": "0", "Other Expenses": "29,083,000", "Other Liabilities": "1,001,000", "Other Net Income": "758,000", "Other Revenues": "37,961,000", "Property, Plant and Equipment, Net": "13,412,000", "Selling, General and Administrative Expense": "6,126,000" }, "output_variables": { "Liabilities": "39,430,000", "Assets": "48,492,000", "Expenses": "35,209,000", "Revenues": "37,961,000", "Stockholders Equity": "9,062,000", "Net Income": "3,510,000", "Comprehensive Net Income": "3,510,000", "BaseVar": "80,925,000", "ECR before LimitedLiability": "25%", "Economic Capital Ratio": "97%" } } }, "top_rated": false, "trend": -45.0, "value": 0.9729008165233968, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000030554.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000030554.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000030554.svg" }, { "company_id": "0001049210", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001049210.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001049210.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001049210_main_keyfigs.svg", "name": "Verenium CORP", "rank": 67, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001049210.svg", "report_text": "The relative strengths and weaknesses of Verenium CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Verenium CORP compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 21% points.The greatest weakness of Verenium CORP is the variable Liabilities, Current, reducing the Economic Capital Ratio by 55% points.

The company's Economic Capital Ratio, given in the ranking table, is 95%, being 29% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001049210_2012_Verenium_CORP.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "4.78", "Liabilities": "-27.3", "Stockholders Equity": "-31.0", "ECR before LimitedLiability": "-14.1", "Liabilities, Noncurrent": "15.5", "Liabilities, Current": "-55.2", "Assets, Current": "20.9", "Assets": "-9.12", "Assets, Noncurrent": "-5.26", "Intangible Assets": "-7.02", "Property, Plant and Equipment, Net": "-15.7", "Selling, General and Administrative Expense": "-27.8", "Expenses": "16.2", "Revenues": "-4.67", "Net Income": "20.9", "Other Expenses": "16.1", "Cost of Revenues": "21.1", "Other Revenues": "-4.67", "Comprehensive Net Income": "20.9", "Other Net Income": "15.9", "Economic Capital Ratio": "-28.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001049210_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "53,849", "Assets, Noncurrent": "482", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "54,486", "Liabilities, Noncurrent": "889", "Other Assets": "3,200", "Other Compr. Net Income": "0", "Other Expenses": "37,056", "Other Liabilities": "17", "Other Net Income": "11,267", "Other Revenues": "61,267", "Property, Plant and Equipment, Net": "7,806", "Selling, General and Administrative Expense": "30,351" }, "output_variables": { "Liabilities": "55,392", "Assets": "65,337", "Expenses": "67,407", "Revenues": "61,267", "Stockholders Equity": "9,945", "Net Income": "5,127", "Comprehensive Net Income": "5,127", "BaseVar": "130,335", "ECR before LimitedLiability": "22%", "Economic Capital Ratio": "95%" } } }, "top_rated": false, "trend": null, "value": 0.947270625830514, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001049210.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001049210.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001049210.svg" }, { "company_id": "0001424844", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001424844.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001424844.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001424844.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001424844_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001424844_main_keyfigs.svg", "name": "Southwest Iowa Renewable Energy LLC", "rank": 68, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001424844.svg", "report_text": "The relative strengths and weaknesses of Southwest Iowa Renewable Energy LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Southwest Iowa Renewable Energy LLC compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 20% points.The greatest weakness of Southwest Iowa Renewable Energy LLC is the variable Other Expenses, reducing the Economic Capital Ratio by 58% points.

The company's Economic Capital Ratio, given in the ranking table, is 93%, being 31% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001424844_2012_Southwest_Iowa_Renewable_Energy_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "8.39", "Liabilities": "-5.80", "Stockholders Equity": "-36.6", "ECR before LimitedLiability": "-16.0", "Liabilities, Noncurrent": "-38.6", "Liabilities, Current": "18.4", "Assets, Current": "-24.8", "Assets": "-23.5", "Assets, Noncurrent": "-6.99", "Intangible Assets": "-9.11", "Property, Plant and Equipment, Net": "19.1", "Selling, General and Administrative Expense": "18.9", "Expenses": "-7.28", "Revenues": "19.8", "Net Income": "19.0", "Other Expenses": "-57.7", "Cost of Revenues": "20.0", "Other Revenues": "19.8", "Comprehensive Net Income": "18.9", "Other Net Income": "-6.83", "Economic Capital Ratio": "-30.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001424844_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "44,908", "Assets, Noncurrent": "1,539", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "39,985", "Liabilities, Noncurrent": "127,240", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "325,956", "Other Liabilities": "-5,239", "Other Net Income": "-9,840", "Other Revenues": "333,089", "Property, Plant and Equipment, Net": "164,263", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "161,986", "Assets": "210,710", "Expenses": "325,956", "Revenues": "333,089", "Stockholders Equity": "48,724", "Net Income": "-2,707", "Comprehensive Net Income": "-2,707", "BaseVar": "520,790", "ECR before LimitedLiability": "20%", "Economic Capital Ratio": "93%" } } }, "top_rated": false, "trend": null, "value": 0.9280160192460346, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001424844.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001424844.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001424844.svg" }, { "company_id": "0000350832", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000350832.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000350832.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000350832_main_keyfigs.svg", "name": "American Pacific CORP", "rank": 69, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000350832.svg", "report_text": "The relative strengths and weaknesses of American Pacific CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of American Pacific CORP compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 14% points.The greatest weakness of American Pacific CORP is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 41% points.

The company's Economic Capital Ratio, given in the ranking table, is 87%, being 37% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000350832_2012_American_Pacific_CORP.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "-33.0", "Stockholders Equity": "-24.4", "ECR before LimitedLiability": "-21.8", "Liabilities, Noncurrent": "-41.0", "Liabilities, Current": "6.63", "Assets, Current": "1.25", "Assets": "1.21", "Other Assets": "3.02", "Assets, Noncurrent": "-2.87", "Intangible Assets": "-5.92", "Property, Plant and Equipment, Net": "6.65", "Selling, General and Administrative Expense": "13.2", "Expenses": "13.3", "Revenues": "-5.65", "Net Income": "13.2", "Other Expenses": "-19.5", "Cost of Revenues": "13.7", "Other Revenues": "-5.65", "Comprehensive Net Income": "13.2", "Other Net Income": "-1.39", "Economic Capital Ratio": "-36.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000350832_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "128,047", "Assets, Noncurrent": "10,068", "Cost of Revenues": "0", "Intangible Assets": "3,515", "Liabilities, Current": "54,223", "Liabilities, Noncurrent": "150,546", "Other Assets": "14,788", "Other Compr. Net Income": "0", "Other Expenses": "219,994", "Other Liabilities": "14,174", "Other Net Income": "174", "Other Revenues": "212,584", "Property, Plant and Equipment, Net": "112,232", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "218,943", "Assets": "268,650", "Expenses": "219,994", "Revenues": "212,584", "Stockholders Equity": "49,707", "Net Income": "-7,236", "Comprehensive Net Income": "-7,236", "BaseVar": "460,172", "ECR before LimitedLiability": "14%", "Economic Capital Ratio": "87%" } } }, "top_rated": false, "trend": null, "value": 0.8706152568214488, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000350832.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000350832.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000350832.svg" }, { "company_id": "0000785787", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000785787.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000785787.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000785787.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000785787_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000785787_main_keyfigs.svg", "name": "AEP Industries INC", "rank": 70, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000785787.svg", "report_text": "The relative strengths and weaknesses of AEP Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of AEP Industries INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 21% points.The greatest weakness of AEP Industries INC is the variable Other Expenses, reducing the Economic Capital Ratio by 91% points.

The company's Economic Capital Ratio, given in the ranking table, is 87%, being 37% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000785787_2012_AEP_Industries_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-52.8", "Liabilities": "5.46", "Stockholders Equity": "-57.7", "ECR before LimitedLiability": "-21.8", "Liabilities, Noncurrent": "13.4", "Liabilities, Current": "13.3", "Assets, Current": "-20.1", "Assets": "-40.5", "Other Assets": "-1.18", "Assets, Noncurrent": "-8.86", "Intangible Assets": "-11.4", "Property, Plant and Equipment, Net": "-15.2", "Selling, General and Administrative Expense": "13.6", "Expenses": "-34.1", "Revenues": "21.2", "Net Income": "14.2", "Other Expenses": "-91.3", "Cost of Revenues": "16.5", "Other Revenues": "21.2", "Comprehensive Net Income": "14.2", "Economic Capital Ratio": "-36.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000785787_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "228,866", "Assets, Noncurrent": "6,428", "Cost of Revenues": "0", "Intangible Assets": "3,924", "Liabilities, Current": "111,646", "Liabilities, Noncurrent": "7,319", "Other Assets": "6,871", "Other Compr. Net Income": "0", "Other Expenses": "970,806", "Other Liabilities": "246,718", "Other Net Income": "8,402", "Other Revenues": "974,792", "Property, Plant and Equipment, Net": "169,580", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "365,683", "Assets": "415,669", "Expenses": "970,806", "Revenues": "974,792", "Stockholders Equity": "49,986", "Net Income": "12,388", "Comprehensive Net Income": "12,388", "BaseVar": "1,367,676", "ECR before LimitedLiability": "14%", "Economic Capital Ratio": "87%" } } }, "top_rated": false, "trend": null, "value": 0.8705007020593314, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000785787.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000785787.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000785787.svg" }, { "company_id": "0001326396", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001326396.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001326396.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001326396_main_keyfigs.svg", "name": "Keyuan Petrochemicals Inc", "rank": 71, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001326396.svg", "report_text": "The relative strengths and weaknesses of Keyuan Petrochemicals Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Keyuan Petrochemicals Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 21% points.The greatest weakness of Keyuan Petrochemicals Inc is the variable Cost of Revenues, reducing the Economic Capital Ratio by 70% points.

The company's Economic Capital Ratio, given in the ranking table, is 86%, being 37% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001326396_2012_Keyuan_Petrochemicals_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "5.05", "Liabilities": "-22.7", "Stockholders Equity": "-34.0", "ECR before LimitedLiability": "-22.5", "Liabilities, Noncurrent": "12.5", "Liabilities, Current": "-53.4", "Assets, Current": "3.53", "Assets": "-14.1", "Assets, Noncurrent": "-6.70", "Intangible Assets": "-8.10", "Property, Plant and Equipment, Net": "-3.99", "Selling, General and Administrative Expense": "12.5", "Expenses": "7.97", "Revenues": "12.4", "Net Income": "12.6", "Other Expenses": "21.3", "Cost of Revenues": "-70.0", "Other Revenues": "12.4", "Comprehensive Net Income": "12.5", "Other Net Income": "-3.16", "Economic Capital Ratio": "-37.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001326396_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "324,035", "Assets, Noncurrent": "0", "Cost of Revenues": "604,670", "Intangible Assets": "979", "Liabilities, Current": "444,147", "Liabilities, Noncurrent": "0", "Other Assets": "13,962", "Other Compr. Net Income": "0", "Other Expenses": "21,951", "Other Liabilities": "0", "Other Net Income": "-7,205", "Other Revenues": "626,685", "Property, Plant and Equipment, Net": "190,868", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "444,147", "Assets": "529,844", "Expenses": "626,621", "Revenues": "626,685", "Stockholders Equity": "85,697", "Net Income": "-7,141", "Comprehensive Net Income": "-7,141", "BaseVar": "1,117,251", "ECR before LimitedLiability": "13%", "Economic Capital Ratio": "86%" } } }, "top_rated": false, "trend": null, "value": 0.863448568368989, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001326396.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001326396.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001326396.svg" }, { "company_id": "0001090061", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001090061.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001090061.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001090061.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001090061_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001090061_main_keyfigs.svg", "name": "Omnova Solutions INC", "rank": 72, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001090061.svg", "report_text": "The relative strengths and weaknesses of Omnova Solutions INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Omnova Solutions INC compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 13% points.The greatest weakness of Omnova Solutions INC is the variable Other Liabilities, reducing the Economic Capital Ratio by 52% points.

The company's Economic Capital Ratio, given in the ranking table, is 86%, being 38% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001090061_2012_Omnova_Solutions_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-51.9", "Liabilities": "-18.4", "Stockholders Equity": "-39.4", "ECR before LimitedLiability": "-23.3", "Liabilities, Noncurrent": "8.95", "Liabilities, Current": "11.6", "Assets, Current": "-12.6", "Assets": "-20.6", "Other Assets": "5.87", "Assets, Noncurrent": "-6.68", "Intangible Assets": "6.07", "Property, Plant and Equipment, Net": "-13.4", "Other Revenues": "12.0", "Revenues": "12.0", "Net Income": "11.9", "Cost of Revenues": "13.1", "Comprehensive Net Income": "11.9", "Selling, General and Administrative Expense": "6.25", "Other Net Income": "-4.21", "Other Expenses": "-37.2", "Economic Capital Ratio": "-38.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001090061_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "377,800", "Assets, Noncurrent": "8,300", "Cost of Revenues": "0", "Intangible Assets": "175,500", "Liabilities, Current": "156,500", "Liabilities, Noncurrent": "106,500", "Other Assets": "82,700", "Other Compr. Net Income": "0", "Other Expenses": "1,075,800", "Other Liabilities": "480,400", "Other Net Income": "-19,500", "Other Revenues": "1,201,100", "Property, Plant and Equipment, Net": "220,800", "Selling, General and Administrative Expense": "108,600" }, "output_variables": { "Liabilities": "743,400", "Assets": "865,100", "Expenses": "1,184,400", "Revenues": "1,201,100", "Stockholders Equity": "121,700", "Net Income": "-2,800", "Comprehensive Net Income": "-2,800", "BaseVar": "2,006,750", "ECR before LimitedLiability": "12%", "Economic Capital Ratio": "86%" } } }, "top_rated": false, "trend": null, "value": 0.8551292819622147, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001090061.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001090061.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001090061.svg" }, { "company_id": "0001120970", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001120970.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001120970.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001120970.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001120970_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001120970_main_keyfigs.svg", "name": "Comstock Inc", "rank": 73, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001120970.svg", "report_text": "The relative strengths and weaknesses of Comstock Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Comstock Inc compared to the market average is the variable Assets, increasing the Economic Capital Ratio by 15% points.The greatest weakness of Comstock Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 60% points.

The company's Economic Capital Ratio, given in the ranking table, is 84%, being 40% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001120970_2012_Comstock_Inc.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "-9.65", "Stockholders Equity": "11.1", "ECR before LimitedLiability": "-25.3", "Liabilities, Noncurrent": "-6.80", "Liabilities, Current": "-6.28", "Assets, Current": "9.68", "Assets": "14.6", "Other Assets": "10.5", "Assets, Noncurrent": "-4.17", "Intangible Assets": "-5.87", "Property, Plant and Equipment, Net": "9.74", "Selling, General and Administrative Expense": "9.65", "Expenses": "6.53", "Revenues": "-60.3", "Net Income": "-41.0", "Other Expenses": "-26.3", "Cost of Revenues": "10.0", "Other Revenues": "-60.3", "Comprehensive Net Income": "-41.1", "Other Net Income": "9.83", "Economic Capital Ratio": "-40.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001120970_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "11,009", "Assets, Noncurrent": "165", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "6,045", "Liabilities, Noncurrent": "4,331", "Other Assets": "6,417", "Other Compr. Net Income": "0", "Other Expenses": "15,952", "Other Liabilities": "0", "Other Net Income": "3,872", "Other Revenues": "473", "Property, Plant and Equipment, Net": "9,384", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "10,376", "Assets": "26,974", "Expenses": "15,952", "Revenues": "473", "Stockholders Equity": "16,598", "Net Income": "-11,606", "Comprehensive Net Income": "-11,606", "BaseVar": "28,824", "ECR before LimitedLiability": "9.8%", "Economic Capital Ratio": "84%" } } }, "top_rated": false, "trend": null, "value": 0.835418296313388, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001120970.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001120970.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001120970.svg" }, { "company_id": "0001121702", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001121702.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001121702.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001121702.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001121702_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001121702_main_keyfigs.svg", "name": "Yield10 Bioscience INC", "rank": 74, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001121702.svg", "report_text": "The relative strengths and weaknesses of Yield10 Bioscience INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Yield10 Bioscience INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Yield10 Bioscience INC is the variable Other Revenues, reducing the Economic Capital Ratio by 47% points.

The company's Economic Capital Ratio, given in the ranking table, is 74%, being 50% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001121702_2012_Yield10_Bioscience_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-40.6", "Liabilities": "-16.1", "Stockholders Equity": "1.72", "Liabilities, Noncurrent": "0.604", "Liabilities, Current": "0.454", "Assets, Current": "34.6", "Assets": "11.2", "Other Assets": "0.0905", "Assets, Noncurrent": "-0.177", "Intangible Assets": "-0.207", "Property, Plant and Equipment, Net": "-6.76", "Selling, General and Administrative Expense": "-3.73", "Expenses": "1.25", "Revenues": "-47.1", "Net Income": "-35.2", "Other Expenses": "0.646", "Cost of Revenues": "1.83", "Other Revenues": "-47.1", "ECR before LimitedLiability": "-35.2", "Comprehensive Net Income": "-35.3", "Economic Capital Ratio": "-49.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001121702_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "78,439", "Assets, Noncurrent": "72", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "7,165", "Liabilities, Noncurrent": "119", "Other Assets": "2,125", "Other Compr. Net Income": "0", "Other Expenses": "24,445", "Other Liabilities": "36,165", "Other Net Income": "0", "Other Revenues": "1,425", "Property, Plant and Equipment, Net": "2,276", "Selling, General and Administrative Expense": "15,841" }, "output_variables": { "Liabilities": "43,449", "Assets": "82,912", "Expenses": "40,286", "Revenues": "1,425", "Stockholders Equity": "39,463", "Net Income": "-38,861", "Comprehensive Net Income": "-38,861", "BaseVar": "84,036", "ECR before LimitedLiability": "-11%", "Economic Capital Ratio": "74%" } } }, "top_rated": false, "trend": null, "value": 0.7365274410823278, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001121702.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001121702.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001121702.svg" }, { "company_id": "0001307969", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001307969.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001307969.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001307969.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001307969_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001307969_main_keyfigs.svg", "name": "024 Pharma Inc", "rank": 75, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001307969.svg", "report_text": "The relative strengths and weaknesses of 024 Pharma Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of 024 Pharma Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 11% points.The greatest weakness of 024 Pharma Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 68% points.

The company's Economic Capital Ratio, given in the ranking table, is 74%, being 50% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001307969_2012_024_Pharma_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "0.176", "Liabilities": "-43.4", "Stockholders Equity": "-24.3", "Liabilities, Noncurrent": "0.769", "Liabilities, Current": "-68.0", "Assets, Current": "10.7", "Assets": "0.727", "Assets, Noncurrent": "-0.222", "Intangible Assets": "-0.158", "Property, Plant and Equipment, Net": "-10.4", "Selling, General and Administrative Expense": "-26.4", "Expenses": "3.91", "Revenues": "-39.2", "Net Income": "0.244", "Other Expenses": "8.52", "Cost of Revenues": "1.66", "Other Revenues": "-39.2", "ECR before LimitedLiability": "-35.2", "Comprehensive Net Income": "0.236", "Other Net Income": "2.69", "Economic Capital Ratio": "-50.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001307969_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "1,187", "Assets, Noncurrent": "0", "Cost of Revenues": "64", "Intangible Assets": "53", "Liabilities, Current": "1,273", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "20", "Other Liabilities": "0", "Other Net Income": "341", "Other Revenues": "266", "Property, Plant and Equipment, Net": "10", "Selling, General and Administrative Expense": "656" }, "output_variables": { "Liabilities": "1,273", "Assets": "1,250", "Expenses": "739", "Revenues": "266", "Stockholders Equity": "-23", "Net Income": "-131", "Comprehensive Net Income": "-131", "BaseVar": "1,935", "ECR before LimitedLiability": "-12%", "Economic Capital Ratio": "74%" } } }, "top_rated": false, "trend": null, "value": 0.7360399670677369, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001307969.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001307969.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001307969.svg" }, { "company_id": "0001324759", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001324759.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001324759.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001324759_main_keyfigs.svg", "name": "HONG YUAN Holding Group", "rank": 76, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001324759.svg", "report_text": "The relative strengths and weaknesses of HONG YUAN Holding Group are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of HONG YUAN Holding Group compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 4.0% points.The greatest weakness of HONG YUAN Holding Group is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 22% points.

The company's Economic Capital Ratio, given in the ranking table, is 73%, being 51% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001324759_2012_HONG_YUAN_Holding_Group.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "0.319", "Liabilities": "-7.34", "Stockholders Equity": "-0.815", "Liabilities, Noncurrent": "-22.2", "Liabilities, Current": "0.620", "Assets, Current": "3.81", "Assets": "0.755", "ECR before LimitedLiability": "-35.7", "Assets, Noncurrent": "-0.220", "Intangible Assets": "-0.551", "Property, Plant and Equipment, Net": "-0.205", "Selling, General and Administrative Expense": "-12.0", "Expenses": "0.739", "Revenues": "-8.96", "Net Income": "-8.10", "Other Expenses": "1.02", "Cost of Revenues": "4.03", "Other Revenues": "-8.96", "Comprehensive Net Income": "-8.19", "Other Net Income": "-0.458", "Economic Capital Ratio": "-50.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001324759_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "24,056", "Assets, Noncurrent": "1,594", "Cost of Revenues": "0", "Intangible Assets": "183", "Liabilities, Current": "6,501", "Liabilities, Noncurrent": "20,052", "Other Assets": "-183", "Other Compr. Net Income": "14", "Other Expenses": "18,223", "Other Liabilities": "0", "Other Net Income": "-1,590", "Other Revenues": "20,256", "Property, Plant and Equipment, Net": "10,601", "Selling, General and Administrative Expense": "14,445" }, "output_variables": { "Liabilities": "26,553", "Assets": "36,251", "Expenses": "32,668", "Revenues": "20,256", "Stockholders Equity": "9,698", "Net Income": "-14,002", "Comprehensive Net Income": "-13,988", "BaseVar": "58,666", "ECR before LimitedLiability": "-20%", "Economic Capital Ratio": "73%" } } }, "top_rated": false, "trend": null, "value": 0.7309208291593811, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001324759.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001324759.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001324759.svg" }, { "company_id": "0001405041", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001405041.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001405041.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001405041.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001405041_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001405041_main_keyfigs.svg", "name": "Momentive Performance Materials Inc", "rank": 77, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001405041.svg", "report_text": "The relative strengths and weaknesses of Momentive Performance Materials Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Momentive Performance Materials Inc compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 3.9% points.The greatest weakness of Momentive Performance Materials Inc is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 45% points.

The company's Economic Capital Ratio, given in the ranking table, is 73%, being 51% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001405041_2012_Momentive_Performance_Materials_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-0.291", "Liabilities": "-37.0", "Stockholders Equity": "-35.2", "Liabilities, Noncurrent": "-44.7", "Liabilities, Current": "0.780", "Assets, Current": "-0.884", "Assets": "-0.691", "ECR before LimitedLiability": "-35.8", "Assets, Noncurrent": "-0.372", "Intangible Assets": "2.23", "Property, Plant and Equipment, Net": "-0.293", "Selling, General and Administrative Expense": "0.0846", "Expenses": "3.80", "Revenues": "-0.786", "Net Income": "1.46", "Other Expenses": "-0.108", "Cost of Revenues": "3.87", "Other Revenues": "-0.786", "Comprehensive Net Income": "1.44", "Other Net Income": "-0.125", "Economic Capital Ratio": "-50.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001405041_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "993,000", "Assets, Noncurrent": "89,000", "Cost of Revenues": "0", "Intangible Assets": "974,000", "Liabilities, Current": "611,000", "Liabilities, Noncurrent": "2,946,000", "Other Assets": "25,000", "Other Compr. Net Income": "0", "Other Expenses": "2,311,000", "Other Liabilities": "344,000", "Other Net Income": "0", "Other Revenues": "2,637,000", "Property, Plant and Equipment, Net": "1,084,000", "Selling, General and Administrative Expense": "467,000" }, "output_variables": { "Liabilities": "3,901,000", "Assets": "3,165,000", "Expenses": "2,778,000", "Revenues": "2,637,000", "Stockholders Equity": "-736,000", "Net Income": "-141,000", "Comprehensive Net Income": "-141,000", "BaseVar": "6,240,500", "ECR before LimitedLiability": "-21%", "Economic Capital Ratio": "73%" } } }, "top_rated": false, "trend": null, "value": 0.729772802566931, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001405041.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001405041.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001405041.svg" }, { "company_id": "0001365916", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001365916.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001365916.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001365916.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001365916_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001365916_main_keyfigs.svg", "name": "Amyris INC", "rank": 78, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001365916.svg", "report_text": "The relative strengths and weaknesses of Amyris INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Amyris INC compared to the market average is the variable Cost of Revenues, increasing the Economic Capital Ratio by 5.0% points.The greatest weakness of Amyris INC is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 34% points.

The company's Economic Capital Ratio, given in the ranking table, is 73%, being 51% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001365916_2012_Amyris_INC.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "-0.571", "Stockholders Equity": "0.880", "ECR before LimitedLiability": "-36.1", "Liabilities, Current": "-0.403", "Assets, Current": "0.443", "Assets": "2.59", "Other Assets": "-0.179", "Assets, Noncurrent": "1.05", "Intangible Assets": "-0.562", "Property, Plant and Equipment, Net": "1.82", "Selling, General and Administrative Expense": "-30.3", "Expenses": "-1.11", "Revenues": "-14.7", "Net Income": "-31.0", "Other Expenses": "0.900", "Cost of Revenues": "4.96", "Other Revenues": "-14.7", "Comprehensive Net Income": "-34.1", "Other Net Income": "-0.153", "Other Compr. Net Income": "-0.334", "Economic Capital Ratio": "-50.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001365916_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "139,471", "Assets, Noncurrent": "43,001", "Cost of Revenues": "0", "Intangible Assets": "9,538", "Liabilities, Current": "92,266", "Liabilities, Noncurrent": "50,360", "Other Assets": "0", "Other Compr. Net Income": "-8,155", "Other Expenses": "156,167", "Other Liabilities": "16,673", "Other Net Income": "213", "Other Revenues": "146,991", "Property, Plant and Equipment, Net": "128,101", "Selling, General and Administrative Expense": "170,548" }, "output_variables": { "Liabilities": "159,299", "Assets": "320,111", "Expenses": "326,715", "Revenues": "146,991", "Stockholders Equity": "160,812", "Net Income": "-179,511", "Comprehensive Net Income": "-187,666", "BaseVar": "480,742", "ECR before LimitedLiability": "-24%", "Economic Capital Ratio": "73%" } } }, "top_rated": false, "trend": null, "value": 0.7268395190937481, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001365916.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001365916.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001365916.svg" }, { "company_id": "0001392380", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001392380.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001392380.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001392380.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001392380_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001392380_main_keyfigs.svg", "name": "Gevo Inc", "rank": 79, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001392380.svg", "report_text": "The relative strengths and weaknesses of Gevo Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Gevo Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 21% points.The greatest weakness of Gevo Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 62% points.

The company's Economic Capital Ratio, given in the ranking table, is 65%, being 58% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001392380_2012_Gevo_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-2.64", "Liabilities": "3.39", "Stockholders Equity": "6.32", "ECR before LimitedLiability": "-43.5", "Liabilities, Noncurrent": "2.98", "Liabilities, Current": "2.83", "Assets, Current": "20.9", "Assets": "-0.609", "Assets, Noncurrent": "-2.81", "Intangible Assets": "-3.53", "Property, Plant and Equipment, Net": "-4.45", "Selling, General and Administrative Expense": "-61.1", "Expenses": "-15.3", "Revenues": "-7.14", "Net Income": "-61.5", "Other Expenses": "3.03", "Cost of Revenues": "12.3", "Other Revenues": "-7.14", "Comprehensive Net Income": "-61.6", "Other Net Income": "-3.29", "Economic Capital Ratio": "-58.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001392380_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "102,734", "Assets, Noncurrent": "502", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "16,117", "Liabilities, Noncurrent": "24", "Other Assets": "1,017", "Other Compr. Net Income": "0", "Other Expenses": "75,282", "Other Liabilities": "24,752", "Other Net Income": "-10,710", "Other Revenues": "82,188", "Property, Plant and Equipment, Net": "28,777", "Selling, General and Administrative Expense": "127,544" }, "output_variables": { "Liabilities": "40,893", "Assets": "133,030", "Expenses": "202,826", "Revenues": "82,188", "Stockholders Equity": "92,137", "Net Income": "-131,348", "Comprehensive Net Income": "-131,348", "BaseVar": "234,824", "ECR before LimitedLiability": "-65%", "Economic Capital Ratio": "65%" } } }, "top_rated": false, "trend": null, "value": 0.6529370076736901, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001392380.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001392380.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001392380.svg" }, { "company_id": "0001090967", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001090967.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001090967.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001090967_main_keyfigs.svg", "name": "Global Energy INC", "rank": 80, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001090967.svg", "report_text": "The relative strengths and weaknesses of Global Energy INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Global Energy INC compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 20% points.The greatest weakness of Global Energy INC is the variable Liabilities, Current, reducing the Economic Capital Ratio by 41% points.

The company's Economic Capital Ratio, given in the ranking table, is 62%, being 62% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001090967_2012_Global_Energy_INC.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "-17.5", "Stockholders Equity": "-13.4", "ECR before LimitedLiability": "-47.3", "Liabilities, Noncurrent": "1.25", "Liabilities, Current": "-41.2", "Assets, Current": "11.2", "Assets": "0.673", "Other Assets": "-0.297", "Assets, Noncurrent": "-1.63", "Intangible Assets": "-2.00", "Property, Plant and Equipment, Net": "-3.54", "Selling, General and Administrative Expense": "2.65", "Expenses": "20.4", "Revenues": "-11.2", "Net Income": "-3.90", "Other Expenses": "11.5", "Cost of Revenues": "5.22", "Other Revenues": "-11.2", "Comprehensive Net Income": "-3.92", "Other Net Income": "-5.55", "Economic Capital Ratio": "-62.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001090967_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "4,152", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "9,840", "Liabilities, Noncurrent": "0", "Other Assets": "18", "Other Compr. Net Income": "0", "Other Expenses": "341", "Other Liabilities": "69", "Other Net Income": "-1,538", "Other Revenues": "0", "Property, Plant and Equipment, Net": "784", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "9,909", "Assets": "4,954", "Expenses": "341", "Revenues": "0", "Stockholders Equity": "-4,955", "Net Income": "-1,879", "Comprehensive Net Income": "-1,879", "BaseVar": "8,371", "ECR before LimitedLiability": "-79%", "Economic Capital Ratio": "62%" } } }, "top_rated": false, "trend": null, "value": 0.6153777029114628, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001090967.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001090967.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001090967.svg" }, { "company_id": "0000738214", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000738214.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000738214.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000738214.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000738214_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000738214_main_keyfigs.svg", "name": "Aemetis INC", "rank": 81, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000738214.svg", "report_text": "The relative strengths and weaknesses of Aemetis INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Aemetis INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 43% points.The greatest weakness of Aemetis INC is the variable Cost of Revenues, reducing the Economic Capital Ratio by 156% points.

The company's Economic Capital Ratio, given in the ranking table, is 56%, being 68% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000738214_2012_Aemetis_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "1.29", "Liabilities": "1.27", "Stockholders Equity": "-74.1", "ECR before LimitedLiability": "-53.0", "Liabilities, Noncurrent": "-0.367", "Liabilities, Current": "0.325", "Assets, Current": "-18.1", "Assets": "-51.6", "Assets, Noncurrent": "-7.62", "Intangible Assets": "-7.10", "Property, Plant and Equipment, Net": "-14.7", "Selling, General and Administrative Expense": "5.21", "Expenses": "-39.8", "Revenues": "38.5", "Comprehensive Net Income": "-1.53", "Other Expenses": "42.6", "Cost of Revenues": "-156", "Other Revenues": "38.5", "Other Compr. Net Income": "-1.25", "Other Net Income": "-1.56", "Economic Capital Ratio": "-67.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000738214_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "7,129", "Assets, Noncurrent": "0", "Cost of Revenues": "137,216", "Intangible Assets": "2,768", "Liabilities, Current": "29,428", "Liabilities, Noncurrent": "19,993", "Other Assets": "1,790", "Other Compr. Net Income": "-1,372", "Other Expenses": "13,466", "Other Liabilities": "0", "Other Net Income": "-325", "Other Revenues": "141,858", "Property, Plant and Equipment, Net": "15,531", "Selling, General and Administrative Expense": "9,147" }, "output_variables": { "Liabilities": "49,421", "Assets": "27,218", "Expenses": "159,829", "Revenues": "141,858", "Stockholders Equity": "-22,203", "Net Income": "-18,296", "Comprehensive Net Income": "-19,669", "BaseVar": "190,012", "ECR before LimitedLiability": "-98%", "Economic Capital Ratio": "56%" } } }, "top_rated": false, "trend": null, "value": 0.5578562745824952, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000738214.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000738214.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000738214.svg" }, { "company_id": "0000753048", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0000753048.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0000753048.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000753048_main_keyfigs.svg", "name": "Axion International Holdings INC", "rank": 82, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0000753048.svg", "report_text": "The relative strengths and weaknesses of Axion International Holdings INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Axion International Holdings INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 15% points.The greatest weakness of Axion International Holdings INC is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 56% points.

The company's Economic Capital Ratio, given in the ranking table, is 42%, being 82% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0000753048_2012_Axion_International_Holdings_INC.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "0.502", "Stockholders Equity": "-5.36", "ECR before LimitedLiability": "-67.1", "Liabilities, Noncurrent": "0.571", "Liabilities, Current": "-0.391", "Assets, Current": "15.4", "Assets": "-14.7", "Other Assets": "-2.26", "Assets, Noncurrent": "-5.33", "Intangible Assets": "-6.88", "Property, Plant and Equipment, Net": "-13.9", "Selling, General and Administrative Expense": "3.52", "Expenses": "-24.8", "Revenues": "-16.6", "Net Income": "-55.3", "Other Expenses": "-15.1", "Cost of Revenues": "-15.2", "Other Revenues": "-16.6", "Comprehensive Net Income": "-55.5", "Other Net Income": "-11.7", "Economic Capital Ratio": "-81.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0000753048_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "4,416", "Assets, Noncurrent": "79", "Cost of Revenues": "3,772", "Intangible Assets": "68", "Liabilities, Current": "2,376", "Liabilities, Noncurrent": "488", "Other Assets": "-68", "Other Compr. Net Income": "0", "Other Expenses": "6,293", "Other Liabilities": "0", "Other Net Income": "-1,348", "Other Revenues": "3,885", "Property, Plant and Equipment, Net": "1,047", "Selling, General and Administrative Expense": "533" }, "output_variables": { "Liabilities": "2,864", "Assets": "5,542", "Expenses": "10,599", "Revenues": "3,885", "Stockholders Equity": "2,678", "Net Income": "-8,062", "Comprehensive Net Income": "-8,062", "BaseVar": "12,119", "ECR before LimitedLiability": "-140%", "Economic Capital Ratio": "42%" } } }, "top_rated": false, "trend": null, "value": 0.41684998018081976, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0000753048.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0000753048.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0000753048.svg" }, { "company_id": "0001445235", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001445235.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001445235.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001445235_main_keyfigs.svg", "name": "Hybrid Coating Technologies Inc", "rank": 83, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001445235.svg", "report_text": "The relative strengths and weaknesses of Hybrid Coating Technologies Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Hybrid Coating Technologies Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 12% points.The greatest weakness of Hybrid Coating Technologies Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 42% points.

The company's Economic Capital Ratio, given in the ranking table, is 17%, being 107% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001445235_2012_Hybrid_Coating_Technologies_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "4.08", "Liabilities": "12.4", "Stockholders Equity": "-42.4", "ECR before LimitedLiability": "-92.3", "Liabilities, Noncurrent": "-1.07", "Liabilities, Current": "8.05", "Assets, Current": "-18.9", "Assets": "-24.6", "Other Assets": "-0.691", "Assets, Noncurrent": "-3.14", "Intangible Assets": "10.0", "Property, Plant and Equipment, Net": "-14.4", "Selling, General and Administrative Expense": "2.70", "Expenses": "-7.14", "Revenues": "-23.1", "Net Income": "-33.5", "Other Expenses": "-18.6", "Cost of Revenues": "4.86", "Other Revenues": "-23.1", "Comprehensive Net Income": "-33.5", "Economic Capital Ratio": "-107" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001445235_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "38", "Assets, Noncurrent": "0", "Cost of Revenues": "4.0", "Intangible Assets": "846", "Liabilities, Current": "2,536", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "2,931", "Other Liabilities": "1,220", "Other Net Income": "0", "Other Revenues": "4.9", "Property, Plant and Equipment, Net": "0", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "3,756", "Assets": "883", "Expenses": "2,935", "Revenues": "4.9", "Stockholders Equity": "-2,873", "Net Income": "-2,930", "Comprehensive Net Income": "-2,930", "BaseVar": "3,790", "ECR before LimitedLiability": "-227%", "Economic Capital Ratio": "17%" } } }, "top_rated": false, "trend": null, "value": 0.16551624540454782, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001445235.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001445235.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001445235.svg" }, { "company_id": "0001403676", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001403676.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001403676.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001403676_main_keyfigs.svg", "name": "Geltech Solutions Inc", "rank": 84, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001403676.svg", "report_text": "The relative strengths and weaknesses of Geltech Solutions Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Geltech Solutions Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 13% points.The greatest weakness of Geltech Solutions Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 63% points.

The company's Economic Capital Ratio, given in the ranking table, is 16%, being 108% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001403676_2012_Geltech_Solutions_Inc.pdf", "shrinked_graph_json": { "2010": { "Liabilities": "6.19", "Stockholders Equity": "-31.5", "ECR before LimitedLiability": "-112", "Liabilities, Noncurrent": "-1.51", "Liabilities, Current": "9.90", "Assets, Current": "-4.27", "Assets": "-25.5", "Property, Plant and Equipment, Net": "-17.2", "Other Assets": "10.3", "Intangible Assets": "-11.6", "Assets, Noncurrent": "-5.19", "Other Expenses": "8.54", "Expenses": "-16.7", "Revenues": "-28.1", "Net Income": "-51.8", "Selling, General and Administrative Expense": "-43.7", "Cost of Revenues": "7.36", "Other Revenues": "-28.1", "Comprehensive Net Income": "-51.7", "Other Net Income": "-6.22", "Economic Capital Ratio": "-114" }, "2011": { "Other Liabilities": "5.07", "Liabilities": "1.11", "Stockholders Equity": "-6.68", "ECR before LimitedLiability": "-92.7", "Liabilities, Noncurrent": "-1.54", "Liabilities, Current": "-1.29", "Assets, Current": "13.4", "Assets": "-8.58", "Assets, Noncurrent": "-4.55", "Intangible Assets": "-5.71", "Property, Plant and Equipment, Net": "-16.8", "Selling, General and Administrative Expense": "3.03", "Expenses": "-26.6", "Revenues": "-32.2", "Net Income": "-63.0", "Other Expenses": "-43.6", "Cost of Revenues": "6.58", "Other Revenues": "-32.2", "Comprehensive Net Income": "-63.2", "Other Net Income": "-8.51", "Economic Capital Ratio": "-108" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001403676_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "892", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "2,580", "Liabilities, Noncurrent": "0", "Other Assets": "553", "Other Compr. Net Income": "0", "Other Expenses": "186", "Other Liabilities": "0", "Other Net Income": "-505", "Other Revenues": "566", "Property, Plant and Equipment, Net": "20", "Selling, General and Administrative Expense": "3,412" }, "output_variables": { "Liabilities": "2,580", "Assets": "1,465", "Expenses": "3,598", "Revenues": "566", "Stockholders Equity": "-1,114", "Net Income": "-3,537", "Comprehensive Net Income": "-3,537", "BaseVar": "4,357", "ECR before LimitedLiability": "-220%", "Economic Capital Ratio": "18%" } }, "2011": { "input_variables": { "Assets, Current": "2,527", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "450", "Liabilities, Noncurrent": "0", "Other Assets": "16", "Other Compr. Net Income": "0", "Other Expenses": "5,393", "Other Liabilities": "1,497", "Other Net Income": "-764", "Other Revenues": "222", "Property, Plant and Equipment, Net": "210", "Selling, General and Administrative Expense": "92" }, "output_variables": { "Liabilities": "1,947", "Assets": "2,752", "Expenses": "5,485", "Revenues": "222", "Stockholders Equity": "805", "Net Income": "-6,027", "Comprehensive Net Income": "-6,027", "BaseVar": "5,585", "ECR before LimitedLiability": "-229%", "Economic Capital Ratio": "16%" } } }, "top_rated": false, "trend": -60.0, "value": 0.16089448290725802, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001403676.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001403676.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001403676.svg" }, { "company_id": "0001428765", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001428765.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001428765.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001428765.jpg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001428765_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001428765_main_keyfigs.svg", "name": "Green Envirotech Holdings CORP", "rank": 85, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001428765.svg", "report_text": "The relative strengths and weaknesses of Green Envirotech Holdings CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Green Envirotech Holdings CORP compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 11% points.The greatest weakness of Green Envirotech Holdings CORP is the variable Stockholders Equity, reducing the Economic Capital Ratio by 39% points.

The company's Economic Capital Ratio, given in the ranking table, is 11%, being 113% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001428765_2012_Green_Envirotech_Holdings_CORP.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "9.69", "Stockholders Equity": "-39.5", "ECR before LimitedLiability": "-97.8", "Liabilities, Noncurrent": "-1.28", "Liabilities, Current": "10.8", "Assets, Current": "-14.9", "Assets": "-25.8", "Other Assets": "-0.612", "Assets, Noncurrent": "2.22", "Intangible Assets": "-3.56", "Property, Plant and Equipment, Net": "-8.24", "Selling, General and Administrative Expense": "2.16", "Expenses": "0.996", "Revenues": "-21.6", "Net Income": "-38.8", "Other Expenses": "-6.61", "Cost of Revenues": "3.66", "Other Revenues": "-21.6", "Comprehensive Net Income": "-38.8", "Other Net Income": "-12.5", "Economic Capital Ratio": "-113" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001428765_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "187", "Assets, Noncurrent": "262", "Cost of Revenues": "28", "Intangible Assets": "0", "Liabilities, Current": "2,882", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,757", "Other Liabilities": "0", "Other Net Income": "-1,000", "Other Revenues": "1.9", "Property, Plant and Equipment, Net": "239", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "2,882", "Assets": "688", "Expenses": "1,785", "Revenues": "1.9", "Stockholders Equity": "-2,194", "Net Income": "-2,783", "Comprehensive Net Income": "-2,783", "BaseVar": "3,179", "ECR before LimitedLiability": "-255%", "Economic Capital Ratio": "11%" } } }, "top_rated": false, "trend": null, "value": 0.11036899372059544, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001428765.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001428765.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001428765.svg" }, { "company_id": "0001271046", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001271046.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001271046.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001271046_main_keyfigs.svg", "name": "Energy Holdings International INC", "rank": 86, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001271046.svg", "report_text": "The relative strengths and weaknesses of Energy Holdings International INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Energy Holdings International INC compared to the market average is the variable Liabilities, Noncurrent, increasing the Economic Capital Ratio by 3.7% points.The greatest weakness of Energy Holdings International INC is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 66% points.

The company's Economic Capital Ratio, given in the ranking table, is 5.5%, being 118% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001271046_2012_Energy_Holdings_International_INC.pdf", "shrinked_graph_json": { "2010": { "Liabilities": "18.9", "Stockholders Equity": "-104", "ECR before LimitedLiability": "-45.1", "Liabilities, Noncurrent": "14.7", "Liabilities, Current": "12.1", "Assets, Current": "-34.8", "Assets": "-72.8", "Property, Plant and Equipment, Net": "-46.5", "Other Assets": "-14.9", "Intangible Assets": "-39.8", "Assets, Noncurrent": "-10.9", "Other Expenses": "-423", "Expenses": "-201", "Revenues": "51.2", "Net Income": "-48.1", "Selling, General and Administrative Expense": "25.2", "Cost of Revenues": "36.7", "Other Revenues": "51.2", "Comprehensive Net Income": "-47.5", "Other Net Income": "12.3", "Economic Capital Ratio": "-47.6" }, "2011": { "Other Liabilities": "-5.64", "Liabilities": "1.55", "Stockholders Equity": "-10.3", "ECR before LimitedLiability": "-103", "Liabilities, Noncurrent": "3.71", "Liabilities, Current": "3.63", "Assets, Current": "3.11", "Assets": "-19.9", "Other Assets": "-1.80", "Intangible Assets": "-3.90", "Property, Plant and Equipment, Net": "-15.6", "Selling, General and Administrative Expense": "1.82", "Expenses": "-30.3", "Revenues": "-20.3", "Net Income": "-66.4", "Other Expenses": "-51.7", "Cost of Revenues": "3.02", "Other Revenues": "-20.3", "Comprehensive Net Income": "-66.5", "Other Net Income": "-2.17", "Economic Capital Ratio": "-118" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001271046_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "377", "Assets, Noncurrent": "75", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "192", "Liabilities, Noncurrent": "0", "Other Assets": "-67", "Other Compr. Net Income": "0", "Other Expenses": "2,215", "Other Liabilities": "0", "Other Net Income": "105", "Other Revenues": "1,936", "Property, Plant and Equipment, Net": "67", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "192", "Assets": "452", "Expenses": "2,215", "Revenues": "1,936", "Stockholders Equity": "260", "Net Income": "-174", "Comprehensive Net Income": "-174", "BaseVar": "2,450", "ECR before LimitedLiability": "11%", "Economic Capital Ratio": "85%" } }, "2011": { "input_variables": { "Assets, Current": "551", "Assets, Noncurrent": "37", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "618", "Liabilities, Noncurrent": "523", "Other Assets": "-29", "Other Compr. Net Income": "0", "Other Expenses": "1,835", "Other Liabilities": "-523", "Other Net Income": "-105", "Other Revenues": "167", "Property, Plant and Equipment, Net": "29", "Selling, General and Administrative Expense": "0" }, "output_variables": { "Liabilities": "618", "Assets": "588", "Expenses": "1,835", "Revenues": "167", "Stockholders Equity": "-30", "Net Income": "-1,773", "Comprehensive Net Income": "-1,773", "BaseVar": "1,656", "ECR before LimitedLiability": "-298%", "Economic Capital Ratio": "5.5%" } } }, "top_rated": false, "trend": -63.0, "value": 0.0554983238881348, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001271046.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001271046.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001271046.svg" }, { "company_id": "0001413119", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001413119.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001413119.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001413119.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001413119_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001413119_main_keyfigs.svg", "name": "Kraig Biocraft Laboratories Inc", "rank": 87, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001413119.svg", "report_text": "The relative strengths and weaknesses of Kraig Biocraft Laboratories Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Kraig Biocraft Laboratories Inc compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 5.4% points.The greatest weakness of Kraig Biocraft Laboratories Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 41% points.

The company's Economic Capital Ratio, given in the ranking table, is 5.4%, being 118% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001413119_2012_Kraig_Biocraft_Laboratories_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-0.216", "Liabilities": "5.26", "Stockholders Equity": "-34.5", "ECR before LimitedLiability": "-103", "Liabilities, Noncurrent": "-1.24", "Liabilities, Current": "5.37", "Assets, Current": "-6.18", "Assets": "-27.0", "Other Assets": "-0.431", "Assets, Noncurrent": "-2.06", "Intangible Assets": "-2.63", "Property, Plant and Equipment, Net": "-10.3", "Selling, General and Administrative Expense": "-2.33", "Expenses": "-11.5", "Revenues": "-16.9", "Net Income": "-40.8", "Other Expenses": "-13.5", "Cost of Revenues": "2.28", "Other Revenues": "-16.9", "Comprehensive Net Income": "-40.9", "Economic Capital Ratio": "-118" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001413119_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "201", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "1,117", "Liabilities, Noncurrent": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,047", "Other Liabilities": "13", "Other Net Income": "2.1", "Other Revenues": "0", "Property, Plant and Equipment, Net": "22", "Selling, General and Administrative Expense": "251" }, "output_variables": { "Liabilities": "1,130", "Assets": "224", "Expenses": "1,297", "Revenues": "0", "Stockholders Equity": "-906", "Net Income": "-1,295", "Comprehensive Net Income": "-1,295", "BaseVar": "1,327", "ECR before LimitedLiability": "-300%", "Economic Capital Ratio": "5.4%" } } }, "top_rated": false, "trend": null, "value": 0.053781368575079605, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001413119.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001413119.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001413119.svg" }, { "company_id": "0001039466", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001039466.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001039466.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001039466.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001039466_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001039466_main_keyfigs.svg", "name": "Novaccess Global Inc", "rank": 88, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001039466.svg", "report_text": "The relative strengths and weaknesses of Novaccess Global Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Novaccess Global Inc compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 3.2% points.The greatest weakness of Novaccess Global Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 47% points.

The company's Economic Capital Ratio, given in the ranking table, is 3.3%, being 120% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001039466_2012_Novaccess_Global_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "-0.357", "Liabilities": "3.03", "Stockholders Equity": "-26.4", "ECR before LimitedLiability": "-106", "Liabilities, Noncurrent": "-1.31", "Liabilities, Current": "3.24", "Assets, Current": "-13.3", "Assets": "-31.1", "Other Assets": "1.86", "Assets, Noncurrent": "-1.98", "Intangible Assets": "-2.56", "Property, Plant and Equipment, Net": "-9.63", "Selling, General and Administrative Expense": "-3.43", "Expenses": "-17.9", "Revenues": "-11.0", "Net Income": "-47.0", "Other Expenses": "-17.6", "Cost of Revenues": "1.77", "Other Revenues": "-11.0", "Comprehensive Net Income": "-47.0", "Economic Capital Ratio": "-120" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001039466_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "76", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "0", "Liabilities, Current": "730", "Liabilities, Noncurrent": "0", "Other Assets": "85", "Other Compr. Net Income": "0", "Other Expenses": "985", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "165", "Property, Plant and Equipment, Net": "43", "Selling, General and Administrative Expense": "282" }, "output_variables": { "Liabilities": "730", "Assets": "204", "Expenses": "1,267", "Revenues": "165", "Stockholders Equity": "-526", "Net Income": "-1,103", "Comprehensive Net Income": "-1,103", "BaseVar": "1,183", "ECR before LimitedLiability": "-327%", "Economic Capital Ratio": "3.3%" } } }, "top_rated": false, "trend": null, "value": 0.03253958475967398, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001039466.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001039466.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001039466.svg" }, { "company_id": "0001371128", "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution_0001371128.svg", "graph_url": "https://www.realrate-archive.com/us_chemicals/2011/graphs/IME_0001371128.svg", "logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001371128.png", "logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001371128_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001371128_main_keyfigs.svg", "name": "Newhydrogen Inc", "rank": 89, "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_0001371128.svg", "report_text": "The relative strengths and weaknesses of Newhydrogen Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Newhydrogen Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 0.00058% points.The greatest weakness of Newhydrogen Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 153% points.

The company's Economic Capital Ratio, given in the ranking table, is 0.00058%, being 124% points below the market average of 124%.", "report_url": "https://www.realrate-archive.com/us_chemicals/2011/report/0001371128_2012_Newhydrogen_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "0", "Liabilities": "-0.201", "ECR before LimitedLiability": "-109", "Liabilities, Noncurrent": "-0.0129", "Liabilities, Current": "-0.0307", "Assets, Current": "-0.459", "Assets": "-1.04", "Other Assets": "0", "Assets, Noncurrent": "0", "Intangible Assets": "0", "Property, Plant and Equipment, Net": "-0.202", "Selling, General and Administrative Expense": "0", "Expenses": "-38.5", "Net Income": "-153", "Other Expenses": "-65.8", "Cost of Revenues": "0", "Other Revenues": "-0.812", "Revenues": "-0.812", "Stockholders Equity": "0", "Comprehensive Net Income": "-153", "Economic Capital Ratio": "-124" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2011/plot_over_time/0001371128_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "83", "Assets, Noncurrent": "0", "Cost of Revenues": "0", "Intangible Assets": "141", "Liabilities, Current": "18", "Liabilities, Noncurrent": "0", "Other Assets": "0.77", "Other Compr. Net Income": "0", "Other Expenses": "1,105", "Other Liabilities": "0", "Other Net Income": "-0.67", "Other Revenues": "0", "Property, Plant and Equipment, Net": "53", "Selling, General and Administrative Expense": "41" }, "output_variables": { "Liabilities": "18", "Assets": "277", "Expenses": "1,146", "Revenues": "0", "Stockholders Equity": "260", "Net Income": "-1,147", "Comprehensive Net Income": "-1,147", "BaseVar": "721", "ECR before LimitedLiability": "-635%", "Economic Capital Ratio": "0.00058%" } } }, "top_rated": false, "trend": null, "value": 5.829745571467556e-06, "company_index": "https://www.realrate-archive.com/us_chemicals/2011/industry_indexes/0001371128.svg", "analysing_equity": "https://www.realrate-archive.com/us_chemicals/2011/analytics/equity/0001371128.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2011/analytics/profit_loss/0001371128.svg" } ], "feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2011/feature_distribution/feature_distribution.svg", "final_var_label": "Economic Capital Ratio", "industry_box": [ [ "Revenues", "223 B" ], [ "Assets", "259 B" ], [ "Expenses", "217 B" ], [ "Stockholders Equity", "129 B" ] ], "industry_id": "us_chemicals", "industry_label": "Plastic & Chemicals", "num_companies": 89, "num_top_companies": 22, "ecr_records": { "2009": { "0001306830": { "rank": 1, "ecr": "168" }, "0000029915": { "rank": 2, "ecr": "163" }, "0000884905": { "rank": 3, "ecr": "124" }, "0000002969": { "rank": 4, "ecr": "114" }, "0000079879": { "rank": 5, "ecr": "103" }, "0000915389": { "rank": 6, "ecr": "100" } }, "2010": { "0000915913": { "rank": 1, "ecr": "187" }, "0001282637": { "rank": 2, "ecr": "180" }, "0000310142": { "rank": 3, "ecr": "180" }, "0000896622": { "rank": 4, "ecr": "169" }, "0001306830": { "rank": 5, "ecr": "168" }, "0001008654": { "rank": 6, "ecr": "166" }, "0000029915": { "rank": 7, "ecr": "164" }, "0000814453": { "rank": 8, "ecr": "157" }, "0000891014": { "rank": 9, "ecr": "153" }, "0000812701": { "rank": 10, "ecr": "151" }, "0000790051": { "rank": 11, "ecr": "131" }, "0000717605": { "rank": 12, "ecr": "131" }, "0000105770": { "rank": 13, "ecr": "125" }, "0000002969": { "rank": 14, "ecr": "121" }, "0001012100": { "rank": 15, "ecr": "121" }, "0000884905": { "rank": 16, "ecr": "119" }, "0000102741": { "rank": 17, "ecr": "119" }, "0000110621": { "rank": 18, "ecr": "116" }, "0000051253": { "rank": 19, "ecr": "115" }, "0000915389": { "rank": 20, "ecr": "105" }, "0000030554": { "rank": 21, "ecr": "103" }, "0000079879": { "rank": 22, "ecr": "101" }, "0001271046": { "rank": 23, "ecr": "85" }, "0001403676": { "rank": 24, "ecr": "18" } }, "2011": { "0001206942": { "rank": 1, "ecr": "210" }, "0001366744": { "rank": 2, "ecr": "204" }, "0001352081": { "rank": 3, "ecr": "193" }, "0001371451": { "rank": 4, "ecr": "192" }, "0001101302": { "rank": 5, "ecr": "192" }, "0000915913": { "rank": 6, "ecr": "190" }, "0001156174": { "rank": 7, "ecr": "188" }, "0000082166": { "rank": 8, "ecr": "187" }, "0001282637": { "rank": 9, "ecr": "186" }, "0001425715": { "rank": 10, "ecr": "183" }, "0001410056": { "rank": 11, "ecr": "183" }, "0001286964": { "rank": 12, "ecr": "182" }, "0000310142": { "rank": 13, "ecr": "181" }, "0000084748": { "rank": 14, "ecr": "180" }, "0000060714": { "rank": 15, "ecr": "180" }, "0001181749": { "rank": 16, "ecr": "179" }, "0001426780": { "rank": 17, "ecr": "178" }, "0000100790": { "rank": 18, "ecr": "175" }, "0001306830": { "rank": 19, "ecr": "174" }, "0001041577": { "rank": 20, "ecr": "174" }, "0001350420": { "rank": 21, "ecr": "173" }, "0001122976": { "rank": 22, "ecr": "168" }, "0000896622": { "rank": 23, "ecr": "164" }, "0001473597": { "rank": 24, "ecr": "163" }, "0001337298": { "rank": 25, "ecr": "163" }, "0000029915": { "rank": 26, "ecr": "163" }, "0000069488": { "rank": 27, "ecr": "158" }, "0000072162": { "rank": 28, "ecr": "153" }, "0000842295": { "rank": 29, "ecr": "153" }, "0000922247": { "rank": 30, "ecr": "152" }, "0000038264": { "rank": 31, "ecr": "152" }, "0000744187": { "rank": 32, "ecr": "151" }, "0000812701": { "rank": 33, "ecr": "150" }, "0001384135": { "rank": 34, "ecr": "149" }, "0000891014": { "rank": 35, "ecr": "147" }, "0001463258": { "rank": 36, "ecr": "147" }, "0001200375": { "rank": 37, "ecr": "145" }, "0001311230": { "rank": 38, "ecr": "145" }, "0000717605": { "rank": 39, "ecr": "142" }, "0001257640": { "rank": 40, "ecr": "139" }, "0001026655": { "rank": 41, "ecr": "138" }, "0001262823": { "rank": 42, "ecr": "134" }, "0001369774": { "rank": 43, "ecr": "133" }, "0000790051": { "rank": 44, "ecr": "125" }, "0001321646": { "rank": 45, "ecr": "124" }, "0000002969": { "rank": 46, "ecr": "122" }, "0000778164": { "rank": 47, "ecr": "122" }, "0000105770": { "rank": 48, "ecr": "121" }, "0000884905": { "rank": 49, "ecr": "118" }, "0000110621": { "rank": 50, "ecr": "116" }, "0000051253": { "rank": 51, "ecr": "114" }, "0001094139": { "rank": 52, "ecr": "114" }, "0000035214": { "rank": 53, "ecr": "114" }, "0000007431": { "rank": 54, "ecr": "112" }, "0000059255": { "rank": 55, "ecr": "112" }, "0000915389": { "rank": 56, "ecr": "111" }, "0001091862": { "rank": 57, "ecr": "109" }, "0001309402": { "rank": 58, "ecr": "109" }, "0000805264": { "rank": 59, "ecr": "103" }, "0000102741": { "rank": 60, "ecr": "101" }, "0001418862": { "rank": 61, "ecr": "101" }, "0000079879": { "rank": 62, "ecr": "100" }, "0001325740": { "rank": 63, "ecr": "100" }, "0000077597": { "rank": 64, "ecr": "98" }, "0001012100": { "rank": 65, "ecr": "98" }, "0000030554": { "rank": 66, "ecr": "97" }, "0001049210": { "rank": 67, "ecr": "95" }, "0001424844": { "rank": 68, "ecr": "93" }, "0000350832": { "rank": 69, "ecr": "87" }, "0000785787": { "rank": 70, "ecr": "87" }, "0001326396": { "rank": 71, "ecr": "86" }, "0001090061": { "rank": 72, "ecr": "86" }, "0001120970": { "rank": 73, "ecr": "84" }, "0001121702": { "rank": 74, "ecr": "74" }, "0001307969": { "rank": 75, "ecr": "74" }, "0001324759": { "rank": 76, "ecr": "73" }, "0001405041": { "rank": 77, "ecr": "73" }, "0001365916": { "rank": 78, "ecr": "73" }, "0001392380": { "rank": 79, "ecr": "65" }, "0001090967": { "rank": 80, "ecr": "62" }, "0000738214": { "rank": 81, "ecr": "56" }, "0000753048": { "rank": 82, "ecr": "42" }, "0001445235": { "rank": 83, "ecr": "17" }, "0001403676": { "rank": 84, "ecr": "16" }, "0001428765": { "rank": 85, "ecr": "11" }, "0001271046": { "rank": 86, "ecr": "5.5" }, "0001413119": { "rank": 87, "ecr": "5.4" }, "0001039466": { "rank": 88, "ecr": "3.3" }, "0001371128": { "rank": 89, "ecr": "0.00058" } } }, "rating_box": [ [ "Top rated", "22 of 89" ], [ "Best, worst rating", "210 %, < 0.001 %" ], [ "New companies", "67" ] ], "regression_plot": "https://www.realrate-archive.com/us_chemicals/2011/backtesting_correlation/regression_2011.svg", "scentences": [ "Albemarle CORP climbed -5 positions from 1 to 6 due to its excellent Stockholders Equity.", "Energy Holdings International INC lost 63 positions from 23 to 86 due to its bad Comprehensive Net Income.", "Golden Grain Energy entered the 2012 ranking at rank 1, making it the best newcomer." ], "url_segment": "2012-us-chemicals", "year": 2012, "feature_importance": "https://www.realrate-archive.com/us_chemicals/2011/feature_importance/feature_importance.svg", "obs_ecr": { "0000002969": { "2011": { "obs_EconomicCapitalRatio": 1.0976433139205226 }, "2012": { "obs_EconomicCapitalRatio": 0.9360041817768175 }, "2013": { "obs_EconomicCapitalRatio": 1.2491579146929779 }, "2014": { "obs_EconomicCapitalRatio": 1.7222596883155998 }, "2015": { "obs_EconomicCapitalRatio": 1.614411596429667 }, "2016": { "obs_EconomicCapitalRatio": 1.7537613281943967 }, "2017": { "obs_EconomicCapitalRatio": 2.171227339544988 }, "2018": { "obs_EconomicCapitalRatio": 2.0874340822226483 }, "2019": { "obs_EconomicCapitalRatio": 3.3496020317351674 }, "2020": { "obs_EconomicCapitalRatio": 2.7403711674472224 }, "2021": { "obs_EconomicCapitalRatio": 3.0039816709793827 }, "2022": { "obs_EconomicCapitalRatio": 3.1205873175604264 }, "2023": { "obs_EconomicCapitalRatio": 2.349325262988046 }, "2024": { "obs_EconomicCapitalRatio": 2.082949884472786 }, "2025": { "obs_EconomicCapitalRatio": 1.6693682249382806 } }, "0001306830": { "2011": { "obs_EconomicCapitalRatio": 1.0795597199260327 }, "2012": { "obs_EconomicCapitalRatio": 1.0744864508371528 }, "2013": { "obs_EconomicCapitalRatio": 1.3036505709409618 }, "2014": { "obs_EconomicCapitalRatio": 1.4697469921508195 }, "2015": { "obs_EconomicCapitalRatio": 1.6010258802276929 }, "2016": { "obs_EconomicCapitalRatio": 2.057300801619153 }, "2017": { "obs_EconomicCapitalRatio": 2.239159736487357 }, "2018": { "obs_EconomicCapitalRatio": 1.8384708779103238 }, "2019": { "obs_EconomicCapitalRatio": 2.3659780082061137 }, "2020": { "obs_EconomicCapitalRatio": 2.157741512673283 }, "2021": { "obs_EconomicCapitalRatio": 2.279367529348738 }, "2022": { "obs_EconomicCapitalRatio": 0.6944971645678013 }, "2023": { "obs_EconomicCapitalRatio": 1.0739815375961428 }, "2024": { "obs_EconomicCapitalRatio": 0.5579499137385675 }, "2025": { "obs_EconomicCapitalRatio": 0.3664347948729315 } }, "0000915389": { "2011": { "obs_EconomicCapitalRatio": 0.6709218129987479 }, "2012": { "obs_EconomicCapitalRatio": 0.6834932352170303 }, "2013": { "obs_EconomicCapitalRatio": 0.8195622048968719 }, "2014": { "obs_EconomicCapitalRatio": 0.5554081691455909 }, "2015": { "obs_EconomicCapitalRatio": 0.5252123383130736 }, "2016": { "obs_EconomicCapitalRatio": 0.621956571767049 }, "2017": { "obs_EconomicCapitalRatio": 0.7513459147065986 }, "2018": { "obs_EconomicCapitalRatio": 0.5844692773095668 }, "2019": { "obs_EconomicCapitalRatio": 0.6584777372063563 }, "2020": { "obs_EconomicCapitalRatio": 0.8733381760757748 }, "2021": { "obs_EconomicCapitalRatio": 1.031958712937266 }, "2022": { "obs_EconomicCapitalRatio": 0.7069622897019276 }, "2023": { "obs_EconomicCapitalRatio": 0.8077733875946396 }, "2024": { "obs_EconomicCapitalRatio": 0.809239617135343 }, "2025": { "obs_EconomicCapitalRatio": 0.605949714833355 } }, "0000079879": { "2011": { "obs_EconomicCapitalRatio": 0.7780557806919013 }, "2013": { "obs_EconomicCapitalRatio": 1.6064372334261137 }, "2014": { "obs_EconomicCapitalRatio": 1.7237761886140508 }, "2015": { "obs_EconomicCapitalRatio": 1.5136259329059834 }, "2016": { "obs_EconomicCapitalRatio": 1.5831715636878736 }, "2017": { "obs_EconomicCapitalRatio": 1.833809153344714 }, "2018": { "obs_EconomicCapitalRatio": 1.474343674528762 }, "2019": { "obs_EconomicCapitalRatio": 1.8422184602158846 }, "2020": { "obs_EconomicCapitalRatio": 1.8322627153315263 }, "2021": { "obs_EconomicCapitalRatio": 2.0006301399744304 }, "2022": { "obs_EconomicCapitalRatio": 1.5757084148865124 }, "2023": { "obs_EconomicCapitalRatio": 1.8797816372672098 }, "2024": { "obs_EconomicCapitalRatio": 1.6837665860129216 }, "2025": { "obs_EconomicCapitalRatio": 1.270629832342974 } }, "0000891014": { "2011": { "obs_EconomicCapitalRatio": 1.2196115824660183 }, "2013": { "obs_EconomicCapitalRatio": 2.520199436562207 }, "2014": { "obs_EconomicCapitalRatio": 0.8420966963083756 }, "2015": { "obs_EconomicCapitalRatio": 0.6143094634486403 }, "2016": { "obs_EconomicCapitalRatio": 1.1387471322001552 }, "2017": { "obs_EconomicCapitalRatio": 1.0067147927749704 }, "2018": { "obs_EconomicCapitalRatio": 0.713790728447913 }, "2019": { "obs_EconomicCapitalRatio": 0.8148959561065288 }, "2020": { "obs_EconomicCapitalRatio": 0.8259022739519024 }, "2021": { "obs_EconomicCapitalRatio": 0.9152018595823116 }, "2022": { "obs_EconomicCapitalRatio": 0.7347855440009189 }, "2023": { "obs_EconomicCapitalRatio": 0.8828261150921283 }, "2025": { "obs_EconomicCapitalRatio": 0.7425037708810072 } }, "0000030554": { "2011": { "obs_EconomicCapitalRatio": 1.1192517322544968 }, "2012": { "obs_EconomicCapitalRatio": 1.1644727688917607 }, "2013": { "obs_EconomicCapitalRatio": 1.027381948932993 }, "2014": { "obs_EconomicCapitalRatio": 1.2739813525244739 }, "2019": { "obs_EconomicCapitalRatio": 2.552382093764655e-07 } }, "0000717605": { "2011": { "obs_EconomicCapitalRatio": 2.281347992582869 }, "2012": { "obs_EconomicCapitalRatio": 2.2192405747567965 }, "2013": { "obs_EconomicCapitalRatio": 3.209541640316984 }, "2014": { "obs_EconomicCapitalRatio": 2.4933060760420447 }, "2015": { "obs_EconomicCapitalRatio": 2.5496131888159073 }, "2016": { "obs_EconomicCapitalRatio": 2.496343317905908 }, "2017": { "obs_EconomicCapitalRatio": 2.5883077593417965 }, "2018": { "obs_EconomicCapitalRatio": 2.146719610664719 }, "2019": { "obs_EconomicCapitalRatio": 2.48439144215883 }, "2020": { "obs_EconomicCapitalRatio": 1.7943395236961057 }, "2021": { "obs_EconomicCapitalRatio": 2.0045481673369747 }, "2022": { "obs_EconomicCapitalRatio": 2.2887256198873067 } }, "0000915913": { "2011": { "obs_EconomicCapitalRatio": 2.0184129066034515 }, "2012": { "obs_EconomicCapitalRatio": 2.373913132013944 }, "2013": { "obs_EconomicCapitalRatio": 2.1436593371926302 }, "2015": { "obs_EconomicCapitalRatio": 0.9724727715974824 }, "2016": { "obs_EconomicCapitalRatio": 1.8999779820103766 }, "2017": { "obs_EconomicCapitalRatio": 2.8487015464464203 }, "2018": { "obs_EconomicCapitalRatio": 1.6884521774474757 }, "2019": { "obs_EconomicCapitalRatio": 1.25209266376253 }, "2020": { "obs_EconomicCapitalRatio": 2.3998706851196427 }, "2021": { "obs_EconomicCapitalRatio": 3.990187329969337 }, "2022": { "obs_EconomicCapitalRatio": 2.781862601586399 }, "2023": { "obs_EconomicCapitalRatio": 1.531133521605186 }, "2024": { "obs_EconomicCapitalRatio": 1.1011056823531262 }, "2025": { "obs_EconomicCapitalRatio": 1.873363806000487 } }, "0000110621": { "2011": { "obs_EconomicCapitalRatio": 0.8159663229707331 }, "2012": { "obs_EconomicCapitalRatio": 1.0066182219866078 }, "2013": { "obs_EconomicCapitalRatio": 1.2216735778718413 }, "2015": { "obs_EconomicCapitalRatio": 1.1638598491154066 }, "2016": { "obs_EconomicCapitalRatio": 1.4613265756957852 }, "2017": { "obs_EconomicCapitalRatio": 1.3537489806535472 }, "2018": { "obs_EconomicCapitalRatio": 1.5170070287157547 }, "2019": { "obs_EconomicCapitalRatio": 1.829926329902574 }, "2020": { "obs_EconomicCapitalRatio": 2.107611524772258 }, "2021": { "obs_EconomicCapitalRatio": 2.1859728332722064 }, "2022": { "obs_EconomicCapitalRatio": 2.085361518544056 } }, "0000051253": { "2011": { "obs_EconomicCapitalRatio": 1.2608278857531472 }, "2012": { "obs_EconomicCapitalRatio": 1.5363533135328669 }, "2013": { "obs_EconomicCapitalRatio": 2.021741772063451 }, "2014": { "obs_EconomicCapitalRatio": 2.3279305904331866 }, "2015": { "obs_EconomicCapitalRatio": 2.5597560327190485 }, "2016": { "obs_EconomicCapitalRatio": 2.326927655454232 }, "2017": { "obs_EconomicCapitalRatio": 2.597342315071224 }, "2018": { "obs_EconomicCapitalRatio": 1.1756510004685328 }, "2019": { "obs_EconomicCapitalRatio": 1.1049896983456262 }, "2020": { "obs_EconomicCapitalRatio": 0.998970229835377 }, "2023": { "obs_EconomicCapitalRatio": 0.8217695801085897 }, "2024": { "obs_EconomicCapitalRatio": 0.9717487368226513 } }, "0000310142": { "2011": { "obs_EconomicCapitalRatio": 1.522182749884351 }, "2012": { "obs_EconomicCapitalRatio": 1.380788739979202 }, "2013": { "obs_EconomicCapitalRatio": 1.8011106108510149 }, "2014": { "obs_EconomicCapitalRatio": 2.377168760470051 }, "2015": { "obs_EconomicCapitalRatio": 2.396036404800919 }, "2016": { "obs_EconomicCapitalRatio": 3.053576044118711 }, "2017": { "obs_EconomicCapitalRatio": 2.751030025767579 }, "2018": { "obs_EconomicCapitalRatio": 1.9611832938641327 }, "2019": { "obs_EconomicCapitalRatio": 2.4788120703710677 }, "2020": { "obs_EconomicCapitalRatio": 2.845625772836302 }, "2021": { "obs_EconomicCapitalRatio": 3.79854741418168 }, "2022": { "obs_EconomicCapitalRatio": 2.5230849182210866 }, "2023": { "obs_EconomicCapitalRatio": 2.364913118243379 } }, "0001282637": { "2011": { "obs_EconomicCapitalRatio": 2.945613299177136 }, "2012": { "obs_EconomicCapitalRatio": 3.7842976687580396 }, "2014": { "obs_EconomicCapitalRatio": 3.9853441761546184 }, "2015": { "obs_EconomicCapitalRatio": 3.4180730158113795 }, "2016": { "obs_EconomicCapitalRatio": 3.5874127897345804 }, "2017": { "obs_EconomicCapitalRatio": 2.8054521566265405 }, "2018": { "obs_EconomicCapitalRatio": 2.6330556176793882 }, "2019": { "obs_EconomicCapitalRatio": 3.078758201505581 }, "2020": { "obs_EconomicCapitalRatio": 2.507320755560595 }, "2021": { "obs_EconomicCapitalRatio": 1.535501106844712 }, "2022": { "obs_EconomicCapitalRatio": 1.412219500459358 }, "2023": { "obs_EconomicCapitalRatio": 2.8822000219737256 }, "2024": { "obs_EconomicCapitalRatio": 2.0696616176006044 }, "2025": { "obs_EconomicCapitalRatio": 2.5524203409778674 } }, "0000105770": { "2011": { "obs_EconomicCapitalRatio": 1.080723686133535 }, "2012": { "obs_EconomicCapitalRatio": 1.440159978777089 }, "2013": { "obs_EconomicCapitalRatio": 2.6496866280130673 }, "2014": { "obs_EconomicCapitalRatio": 3.059297770910497 }, "2015": { "obs_EconomicCapitalRatio": 3.5870309029396745 }, "2016": { "obs_EconomicCapitalRatio": 5.178962101238499 }, "2017": { "obs_EconomicCapitalRatio": 5.862622367745658 }, "2018": { "obs_EconomicCapitalRatio": 5.491642513593138 }, "2019": { "obs_EconomicCapitalRatio": 7.0518141617419206 }, "2020": { "obs_EconomicCapitalRatio": 10.901516162358838 }, "2021": { "obs_EconomicCapitalRatio": 15.768601871582161 }, "2022": { "obs_EconomicCapitalRatio": 7.57316787604098 }, "2023": { "obs_EconomicCapitalRatio": 10.927242645615857 }, "2024": { "obs_EconomicCapitalRatio": 10.345191482060887 }, "2025": { "obs_EconomicCapitalRatio": 7.364852694707018 } }, "0000790051": { "2011": { "obs_EconomicCapitalRatio": 0.9523473743187331 }, "2012": { "obs_EconomicCapitalRatio": 1.2193531456019637 }, "2013": { "obs_EconomicCapitalRatio": 1.732226348910334 }, "2014": { "obs_EconomicCapitalRatio": 1.9079869226387787 }, "2015": { "obs_EconomicCapitalRatio": 1.828545613276869 }, "2016": { "obs_EconomicCapitalRatio": 2.358918001627138 }, "2017": { "obs_EconomicCapitalRatio": 1.5745695391359638 }, "2018": { "obs_EconomicCapitalRatio": 1.3226849068140094 }, "2019": { "obs_EconomicCapitalRatio": 2.042954206220577 }, "2020": { "obs_EconomicCapitalRatio": 1.7131727756966508 }, "2021": { "obs_EconomicCapitalRatio": 2.044524036269128 }, "2022": { "obs_EconomicCapitalRatio": 2.074178187080066 }, "2023": { "obs_EconomicCapitalRatio": 2.863749524996848 }, "2024": { "obs_EconomicCapitalRatio": 3.676042519977833 }, "2025": { "obs_EconomicCapitalRatio": 3.9241709221128183 } }, "0000814453": { "2017": { "obs_EconomicCapitalRatio": 0.3945245827290697 }, "2018": { "obs_EconomicCapitalRatio": 0.41354941300898324 }, "2019": { "obs_EconomicCapitalRatio": 0.4622826850929423 }, "2020": { "obs_EconomicCapitalRatio": 0.554973166701373 }, "2021": { "obs_EconomicCapitalRatio": 0.6222570787388074 }, "2022": { "obs_EconomicCapitalRatio": 0.4021645428351386 }, "2023": { "obs_EconomicCapitalRatio": 0.30508941801619077 }, "2024": { "obs_EconomicCapitalRatio": 0.40608427926573776 }, "2025": { "obs_EconomicCapitalRatio": 0.16284952532863772 } }, "0000896622": { "2011": { "obs_EconomicCapitalRatio": 2.0868313337444193 }, "2012": { "obs_EconomicCapitalRatio": 1.8807246688006947 }, "2013": { "obs_EconomicCapitalRatio": 2.4029125499934576 }, "2014": { "obs_EconomicCapitalRatio": 2.443567442826526 }, "2015": { "obs_EconomicCapitalRatio": 2.7764854165641975 }, "2016": { "obs_EconomicCapitalRatio": 2.5878406030054495 }, "2017": { "obs_EconomicCapitalRatio": 2.630067440589336 }, "2018": { "obs_EconomicCapitalRatio": 2.6343679023770394 }, "2019": { "obs_EconomicCapitalRatio": 3.1855125134954276 }, "2020": { "obs_EconomicCapitalRatio": 3.4171371120052183 }, "2021": { "obs_EconomicCapitalRatio": 2.8601027138624455 }, "2022": { "obs_EconomicCapitalRatio": 2.6705535243713014 }, "2023": { "obs_EconomicCapitalRatio": 2.812157464710154 }, "2024": { "obs_EconomicCapitalRatio": 3.755227885156863 }, "2025": { "obs_EconomicCapitalRatio": 2.489893782678988 } }, "0000059255": { "2011": { "obs_EconomicCapitalRatio": 2.073078761972932 }, "2012": { "obs_EconomicCapitalRatio": 1.209564157736749 }, "2013": { "obs_EconomicCapitalRatio": 1.5558400613187209 }, "2014": { "obs_EconomicCapitalRatio": 0.6078662556382622 }, "2015": { "obs_EconomicCapitalRatio": 0.15988577187297812 }, "2016": { "obs_EconomicCapitalRatio": 0.4372572540647698 }, "2017": { "obs_EconomicCapitalRatio": 0.6964223823669758 }, "2018": { "obs_EconomicCapitalRatio": 0.24827569951171105 }, "2019": { "obs_EconomicCapitalRatio": 0.23945336124774594 }, "2020": { "obs_EconomicCapitalRatio": 0.17709459114491516 }, "2021": { "obs_EconomicCapitalRatio": 0.29765217938535704 }, "2022": { "obs_EconomicCapitalRatio": 0.26938293231858007 } }, "0000060714": { "2011": { "obs_EconomicCapitalRatio": 2.039779842842567 }, "2012": { "obs_EconomicCapitalRatio": 2.2131807538336474 }, "2013": { "obs_EconomicCapitalRatio": 1.3904103475977485 }, "2014": { "obs_EconomicCapitalRatio": 1.100090273020253 }, "2015": { "obs_EconomicCapitalRatio": 0.2147896339331022 }, "2016": { "obs_EconomicCapitalRatio": 0.33578161880960755 }, "2017": { "obs_EconomicCapitalRatio": 0.38654346320293775 }, "2018": { "obs_EconomicCapitalRatio": 0.25178648371325596 }, "2019": { "obs_EconomicCapitalRatio": 0.21421590942666746 }, "2020": { "obs_EconomicCapitalRatio": 0.14095311916560824 }, "2021": { "obs_EconomicCapitalRatio": 1.5005382738592263 }, "2022": { "obs_EconomicCapitalRatio": 1.4179856468214125 } }, "0000072162": { "2011": { "obs_EconomicCapitalRatio": 0.7403156161368563 }, "2012": { "obs_EconomicCapitalRatio": 0.7287485479888595 }, "2013": { "obs_EconomicCapitalRatio": 0.6551218358570887 }, "2014": { "obs_EconomicCapitalRatio": 0.7476462291176851 }, "2015": { "obs_EconomicCapitalRatio": 0.34930765593564356 }, "2016": { "obs_EconomicCapitalRatio": 0.9169389503100207 }, "2017": { "obs_EconomicCapitalRatio": 1.1630608354568477 }, "2018": { "obs_EconomicCapitalRatio": 0.26261518088949715 }, "2019": { "obs_EconomicCapitalRatio": 0.33335368425682055 }, "2020": { "obs_EconomicCapitalRatio": 0.4120970293301054 }, "2021": { "obs_EconomicCapitalRatio": 0.6130774295503331 }, "2022": { "obs_EconomicCapitalRatio": 0.5925481499725161 }, "2023": { "obs_EconomicCapitalRatio": 0.5743145631525474 } }, "0001257640": { "2011": { "obs_EconomicCapitalRatio": 0.7473627284404054 }, "2012": { "obs_EconomicCapitalRatio": 0.6784490985651526 }, "2013": { "obs_EconomicCapitalRatio": 0.8805912426344558 }, "2014": { "obs_EconomicCapitalRatio": 0.6555238315485933 }, "2015": { "obs_EconomicCapitalRatio": 0.37668667016523305 }, "2016": { "obs_EconomicCapitalRatio": 0.9018899129986416 }, "2017": { "obs_EconomicCapitalRatio": 1.3553910892526544 }, "2018": { "obs_EconomicCapitalRatio": 0.5905285629816391 }, "2019": { "obs_EconomicCapitalRatio": 0.720346960805854 }, "2020": { "obs_EconomicCapitalRatio": 0.8043646522558651 }, "2021": { "obs_EconomicCapitalRatio": 0.8621361629256152 }, "2022": { "obs_EconomicCapitalRatio": 0.6234165514756979 }, "2023": { "obs_EconomicCapitalRatio": 0.728712524845626 } }, "0001413119": { "2011": { "obs_EconomicCapitalRatio": 63.50488062100584 }, "2012": { "obs_EconomicCapitalRatio": 37.2323359069094 }, "2014": { "obs_EconomicCapitalRatio": 23.400508092768746 }, "2015": { "obs_EconomicCapitalRatio": 16.723269343495897 }, "2016": { "obs_EconomicCapitalRatio": 24.683469858060686 }, "2019": { "obs_EconomicCapitalRatio": 46.5760886831237 }, "2020": { "obs_EconomicCapitalRatio": 24.33647360037783 }, "2021": { "obs_EconomicCapitalRatio": 13.608733158014035 }, "2022": { "obs_EconomicCapitalRatio": 4.85642253886002 }, "2023": { "obs_EconomicCapitalRatio": 6.791365640787896 }, "2024": { "obs_EconomicCapitalRatio": 18.60837869981268 }, "2025": { "obs_EconomicCapitalRatio": 13.17104618696241 } }, "0000084748": { "2011": { "obs_EconomicCapitalRatio": 1.6297295665504372 }, "2012": { "obs_EconomicCapitalRatio": 1.8904466957321773 }, "2013": { "obs_EconomicCapitalRatio": 2.425311183376347 }, "2014": { "obs_EconomicCapitalRatio": 3.046291777606733 }, "2015": { "obs_EconomicCapitalRatio": 1.8365238040624734 }, "2016": { "obs_EconomicCapitalRatio": 2.379857635941588 }, "2017": { "obs_EconomicCapitalRatio": 4.753068625237965 }, "2018": { "obs_EconomicCapitalRatio": 2.59132319937647 }, "2019": { "obs_EconomicCapitalRatio": 3.452130088367989 }, "2020": { "obs_EconomicCapitalRatio": 4.1357883963222495 }, "2021": { "obs_EconomicCapitalRatio": 5.8018013174325835 }, "2022": { "obs_EconomicCapitalRatio": 2.4047635348526097 }, "2023": { "obs_EconomicCapitalRatio": 3.063132968303847 }, "2024": { "obs_EconomicCapitalRatio": 2.3743773454577464 }, "2025": { "obs_EconomicCapitalRatio": 2.1636878503383694 } }, "0001122976": { "2011": { "obs_EconomicCapitalRatio": 0.6272134290483431 }, "2012": { "obs_EconomicCapitalRatio": 0.7545344653567579 }, "2013": { "obs_EconomicCapitalRatio": 1.0662668309104917 }, "2014": { "obs_EconomicCapitalRatio": 1.1662324035706073 }, "2015": { "obs_EconomicCapitalRatio": 0.9742841724695139 }, "2016": { "obs_EconomicCapitalRatio": 0.9514273808087566 }, "2017": { "obs_EconomicCapitalRatio": 1.2011187447303786 }, "2018": { "obs_EconomicCapitalRatio": 0.7550477309898862 }, "2019": { "obs_EconomicCapitalRatio": 0.8798567137767184 }, "2020": { "obs_EconomicCapitalRatio": 0.8056744819399897 }, "2021": { "obs_EconomicCapitalRatio": 1.101977209972516 }, "2022": { "obs_EconomicCapitalRatio": 0.5699142791320071 }, "2023": { "obs_EconomicCapitalRatio": 0.729904863778972 }, "2024": { "obs_EconomicCapitalRatio": 0.7827805402958028 }, "2025": { "obs_EconomicCapitalRatio": 0.5881259150778726 } }, "0001324759": { "2011": { "obs_EconomicCapitalRatio": 0.47779999203872364 }, "2012": { "obs_EconomicCapitalRatio": 0.047559045119414334 } }, "0000738214": { "2012": { "obs_EconomicCapitalRatio": 1.0239116004500597 }, "2013": { "obs_EconomicCapitalRatio": 0.6238452133492072 }, "2014": { "obs_EconomicCapitalRatio": 2.130359197315785 }, "2015": { "obs_EconomicCapitalRatio": 0.4274014796768218 }, "2016": { "obs_EconomicCapitalRatio": 0.3047847609156527 }, "2017": { "obs_EconomicCapitalRatio": 0.09043221222247719 }, "2018": { "obs_EconomicCapitalRatio": 0.07622127473757176 }, "2019": { "obs_EconomicCapitalRatio": 0.10855332519939714 }, "2020": { "obs_EconomicCapitalRatio": 0.26127311485613125 }, "2022": { "obs_EconomicCapitalRatio": 0.4536326588554047 }, "2023": { "obs_EconomicCapitalRatio": 0.6065208266688298 }, "2024": { "obs_EconomicCapitalRatio": 0.3432021715219472 }, "2025": { "obs_EconomicCapitalRatio": 0.2197483404246265 } }, "0000744187": { "2011": { "obs_EconomicCapitalRatio": 0.7615255644911764 }, "2012": { "obs_EconomicCapitalRatio": 0.520796967073116 }, "2013": { "obs_EconomicCapitalRatio": 1.379480373664334 }, "2014": { "obs_EconomicCapitalRatio": 1.84300106749189 }, "2015": { "obs_EconomicCapitalRatio": 1.4191783872826655 }, "2022": { "obs_EconomicCapitalRatio": 1.6974681588556615 }, "2023": { "obs_EconomicCapitalRatio": 2.5633258097042937 }, "2024": { "obs_EconomicCapitalRatio": 1.9548599073579234 }, "2025": { "obs_EconomicCapitalRatio": 2.8110715440300837 } }, "0000778164": { "2011": { "obs_EconomicCapitalRatio": 0.40795113728905225 }, "2012": { "obs_EconomicCapitalRatio": 0.2728570798946157 }, "2013": { "obs_EconomicCapitalRatio": 0.36362282639273047 }, "2014": { "obs_EconomicCapitalRatio": 1.3918790530834066 }, "2015": { "obs_EconomicCapitalRatio": 0.3655962213896531 }, "2016": { "obs_EconomicCapitalRatio": 0.7762319237434837 }, "2017": { "obs_EconomicCapitalRatio": 0.37859807101733556 }, "2018": { "obs_EconomicCapitalRatio": 0.083610793643223 }, "2019": { "obs_EconomicCapitalRatio": 0.06983055159676796 }, "2020": { "obs_EconomicCapitalRatio": 1.231532502989717 }, "2021": { "obs_EconomicCapitalRatio": 1.1234128589452403 }, "2022": { "obs_EconomicCapitalRatio": 0.6534061213973273 }, "2023": { "obs_EconomicCapitalRatio": 0.6807491182966778 } }, "0001120970": { "2011": { "obs_EconomicCapitalRatio": 2.8391047315428075 }, "2012": { "obs_EconomicCapitalRatio": 2.5685277934327084 }, "2013": { "obs_EconomicCapitalRatio": 3.351650078773552 }, "2014": { "obs_EconomicCapitalRatio": 1.7062441861998598 }, "2015": { "obs_EconomicCapitalRatio": 1.8413967718530309 }, "2016": { "obs_EconomicCapitalRatio": 1.8009656495006061 }, "2017": { "obs_EconomicCapitalRatio": 3.0311041975400186 }, "2018": { "obs_EconomicCapitalRatio": 0.39989217753849887 }, "2019": { "obs_EconomicCapitalRatio": 1.7797252585639252 }, "2020": { "obs_EconomicCapitalRatio": 1.308887645808208 }, "2021": { "obs_EconomicCapitalRatio": 1.1198050566573303 }, "2022": { "obs_EconomicCapitalRatio": 0.3352557132069845 }, "2024": { "obs_EconomicCapitalRatio": 1.37967500703654 }, "2025": { "obs_EconomicCapitalRatio": 1.742427165853982 } }, "0001200375": { "2011": { "obs_EconomicCapitalRatio": 2.342334864170049 }, "2012": { "obs_EconomicCapitalRatio": 1.4278133680149394 }, "2013": { "obs_EconomicCapitalRatio": 1.4036789453415757 }, "2015": { "obs_EconomicCapitalRatio": 5.461171189376292 }, "2016": { "obs_EconomicCapitalRatio": 7.462700171233544 }, "2017": { "obs_EconomicCapitalRatio": 9.499492838832932 }, "2018": { "obs_EconomicCapitalRatio": 17.558137963859057 }, "2020": { "obs_EconomicCapitalRatio": 9.615236147466042 }, "2021": { "obs_EconomicCapitalRatio": 12.452497348721183 }, "2022": { "obs_EconomicCapitalRatio": 1.7252599263898558 }, "2023": { "obs_EconomicCapitalRatio": 2.3101133818505715 }, "2024": { "obs_EconomicCapitalRatio": 3.5178811866292525 }, "2025": { "obs_EconomicCapitalRatio": 1.2089199749282789 } }, "0001262823": { "2011": { "obs_EconomicCapitalRatio": 0.8632654186815746 }, "2012": { "obs_EconomicCapitalRatio": 1.7673872630528977 }, "2013": { "obs_EconomicCapitalRatio": 2.313519828661935 }, "2014": { "obs_EconomicCapitalRatio": 1.9211037148664771 }, "2018": { "obs_EconomicCapitalRatio": 0.8578468481324052 }, "2019": { "obs_EconomicCapitalRatio": 0.8041790501234812 }, "2020": { "obs_EconomicCapitalRatio": 0.906469497835784 }, "2021": { "obs_EconomicCapitalRatio": 0.7947629410142738 }, "2022": { "obs_EconomicCapitalRatio": 0.8106507231202377 }, "2023": { "obs_EconomicCapitalRatio": 1.1011409475588807 }, "2024": { "obs_EconomicCapitalRatio": 0.9378427733083907 }, "2025": { "obs_EconomicCapitalRatio": 0.6164497377130742 } }, "0001309402": { "2011": { "obs_EconomicCapitalRatio": 0.24542500073271054 }, "2012": { "obs_EconomicCapitalRatio": 0.19238507100289554 }, "2013": { "obs_EconomicCapitalRatio": 0.414950096399585 }, "2014": { "obs_EconomicCapitalRatio": 0.5919243332848719 }, "2015": { "obs_EconomicCapitalRatio": 0.526190605613486 }, "2016": { "obs_EconomicCapitalRatio": 0.5113655037386442 }, "2017": { "obs_EconomicCapitalRatio": 0.29438501518347043 }, "2018": { "obs_EconomicCapitalRatio": 0.31175079761499724 }, "2019": { "obs_EconomicCapitalRatio": 0.4416364891279984 }, "2020": { "obs_EconomicCapitalRatio": 0.39848768672446727 }, "2021": { "obs_EconomicCapitalRatio": 1.18169673379572 }, "2022": { "obs_EconomicCapitalRatio": 1.1035543591345094 }, "2023": { "obs_EconomicCapitalRatio": 1.0552459342477385 }, "2024": { "obs_EconomicCapitalRatio": 0.4456197592893155 }, "2025": { "obs_EconomicCapitalRatio": 0.5727781878908101 } }, "0001337298": { "2011": { "obs_EconomicCapitalRatio": 0.46873569923790753 }, "2012": { "obs_EconomicCapitalRatio": 0.5531606051966987 }, "2013": { "obs_EconomicCapitalRatio": 0.7269469611578753 }, "2014": { "obs_EconomicCapitalRatio": 0.5579156407705856 }, "2015": { "obs_EconomicCapitalRatio": 0.5934897624288799 }, "2016": { "obs_EconomicCapitalRatio": 0.5699786573542159 }, "2017": { "obs_EconomicCapitalRatio": 0.853033731385962 }, "2018": { "obs_EconomicCapitalRatio": 0.8545172953273359 }, "2019": { "obs_EconomicCapitalRatio": 0.5436240813853512 } }, "0001392380": { "2011": { "obs_EconomicCapitalRatio": 0.0 }, "2012": { "obs_EconomicCapitalRatio": 0.0 }, "2013": { "obs_EconomicCapitalRatio": 0.0 }, "2014": { "obs_EconomicCapitalRatio": 0.0 }, "2015": { "obs_EconomicCapitalRatio": 0.17514504542518838 }, "2016": { "obs_EconomicCapitalRatio": 0.42150170519487207 }, "2017": { "obs_EconomicCapitalRatio": 0.2311431373943365 }, "2018": { "obs_EconomicCapitalRatio": 0.2903524117363617 }, "2019": { "obs_EconomicCapitalRatio": 0.5941894466599246 }, "2020": { "obs_EconomicCapitalRatio": 5.010438779881309 }, "2021": { "obs_EconomicCapitalRatio": 2.4717995124336034 }, "2022": { "obs_EconomicCapitalRatio": 1.0698563696583818 }, "2023": { "obs_EconomicCapitalRatio": 0.782419865367601 } }, "0001371128": { "2011": { "obs_EconomicCapitalRatio": 58.29484208586001 }, "2012": { "obs_EconomicCapitalRatio": 16.58349542459826 }, "2014": { "obs_EconomicCapitalRatio": 0.5690210644108553 }, "2021": { "obs_EconomicCapitalRatio": 4.613969151313351 }, "2022": { "obs_EconomicCapitalRatio": 3.3426549629644606 }, "2023": { "obs_EconomicCapitalRatio": 2.8037816904004442 }, "2024": { "obs_EconomicCapitalRatio": 2.356729547028848 }, "2025": { "obs_EconomicCapitalRatio": 16.33332433055325 } }, "0000007431": { "2011": { "obs_EconomicCapitalRatio": 0.818467771051719 }, "2012": { "obs_EconomicCapitalRatio": 1.0942726129203864 }, "2013": { "obs_EconomicCapitalRatio": 1.1052119585170082 }, "2014": { "obs_EconomicCapitalRatio": 1.1115494146880482 }, "2015": { "obs_EconomicCapitalRatio": 1.02166103708548 }, "2016": { "obs_EconomicCapitalRatio": 1.3476740008616848 }, "2017": { "obs_EconomicCapitalRatio": 1.760306037970634 }, "2018": { "obs_EconomicCapitalRatio": 1.5305498421864336 }, "2019": { "obs_EconomicCapitalRatio": 3.2566368202830485 }, "2020": { "obs_EconomicCapitalRatio": 2.264030605291642 }, "2021": { "obs_EconomicCapitalRatio": 3.58771001699517 }, "2022": { "obs_EconomicCapitalRatio": 2.135376522868203 } }, "0000038264": { "2011": { "obs_EconomicCapitalRatio": 1.0329806069578091 }, "2012": { "obs_EconomicCapitalRatio": 0.7899398737508551 }, "2016": { "obs_EconomicCapitalRatio": 1.3369658225594734 }, "2017": { "obs_EconomicCapitalRatio": 1.2936573782377594 }, "2018": { "obs_EconomicCapitalRatio": 0.9061225493935785 }, "2019": { "obs_EconomicCapitalRatio": 0.7789919723924983 }, "2020": { "obs_EconomicCapitalRatio": 1.1538884137625203 }, "2021": { "obs_EconomicCapitalRatio": 0.9853013703608507 }, "2022": { "obs_EconomicCapitalRatio": 0.6187307762078627 }, "2023": { "obs_EconomicCapitalRatio": 0.4505565261038733 }, "2024": { "obs_EconomicCapitalRatio": 0.37213846234683806 }, "2025": { "obs_EconomicCapitalRatio": 0.8080596209243718 } }, "0000069488": { "2011": { "obs_EconomicCapitalRatio": 1.0381389514900297 }, "2012": { "obs_EconomicCapitalRatio": 1.0982471614752694 }, "2013": { "obs_EconomicCapitalRatio": 1.5779663442097482 }, "2014": { "obs_EconomicCapitalRatio": 1.0448340654628014 }, "2015": { "obs_EconomicCapitalRatio": 1.1050712104667275 }, "2016": { "obs_EconomicCapitalRatio": 1.3997384538756348 }, "2017": { "obs_EconomicCapitalRatio": 2.0145122323067755 }, "2018": { "obs_EconomicCapitalRatio": 1.8813426470530377 }, "2019": { "obs_EconomicCapitalRatio": 2.2670171914412007 }, "2020": { "obs_EconomicCapitalRatio": 2.234243587527368 }, "2021": { "obs_EconomicCapitalRatio": 1.6533807558683955 }, "2022": { "obs_EconomicCapitalRatio": 1.797531523930188 } }, "0001026655": { "2011": { "obs_EconomicCapitalRatio": 0.8608604132301414 }, "2015": { "obs_EconomicCapitalRatio": 1.0261225432597354 }, "2016": { "obs_EconomicCapitalRatio": 1.5457069662038585 }, "2017": { "obs_EconomicCapitalRatio": 2.038686180000626 }, "2018": { "obs_EconomicCapitalRatio": 0.3811072540913451 }, "2019": { "obs_EconomicCapitalRatio": 0.1860788744114522 }, "2020": { "obs_EconomicCapitalRatio": 0.9665552273279091 }, "2021": { "obs_EconomicCapitalRatio": 0.5463679132715609 }, "2022": { "obs_EconomicCapitalRatio": 0.8060269557536746 }, "2023": { "obs_EconomicCapitalRatio": 1.1817584887595467 }, "2024": { "obs_EconomicCapitalRatio": 1.0829256568468935 }, "2025": { "obs_EconomicCapitalRatio": 1.2340741543649976 } }, "0001101302": { "2011": { "obs_EconomicCapitalRatio": 2.7491165994593594 }, "2012": { "obs_EconomicCapitalRatio": 2.6653627657446073 }, "2013": { "obs_EconomicCapitalRatio": 3.113402676837307 }, "2014": { "obs_EconomicCapitalRatio": 1.7470382204545611 }, "2015": { "obs_EconomicCapitalRatio": 2.001756544086691 }, "2016": { "obs_EconomicCapitalRatio": 2.499761364933779 }, "2017": { "obs_EconomicCapitalRatio": 3.6869056226990087 }, "2018": { "obs_EconomicCapitalRatio": 2.734074355112706 }, "2019": { "obs_EconomicCapitalRatio": 4.824371067308623 }, "2020": { "obs_EconomicCapitalRatio": 7.899749187595021 }, "2021": { "obs_EconomicCapitalRatio": 10.252528829437917 }, "2022": { "obs_EconomicCapitalRatio": 1.7535183737791016 }, "2023": { "obs_EconomicCapitalRatio": 3.819572157423702 }, "2024": { "obs_EconomicCapitalRatio": 3.432771056072382 }, "2025": { "obs_EconomicCapitalRatio": 2.9138159001120774 } }, "0001532595": { "2017": { "obs_EconomicCapitalRatio": 0.0 }, "2018": { "obs_EconomicCapitalRatio": 0.0 }, "2021": { "obs_EconomicCapitalRatio": 0.0 } }, "0000314227": { "2012": { "obs_EconomicCapitalRatio": 36.58227159030734 }, "2013": { "obs_EconomicCapitalRatio": 4.878952832500941 }, "2014": { "obs_EconomicCapitalRatio": 5.24015335098959 }, "2015": { "obs_EconomicCapitalRatio": 10.893902688960509 }, "2016": { "obs_EconomicCapitalRatio": 6.300286207146806 }, "2017": { "obs_EconomicCapitalRatio": 1.5030478789208082 }, "2018": { "obs_EconomicCapitalRatio": 1.5930927533821764 }, "2019": { "obs_EconomicCapitalRatio": 1.8430933154497675 }, "2020": { "obs_EconomicCapitalRatio": 6.922906717251226 }, "2021": { "obs_EconomicCapitalRatio": 3.987960578296863 }, "2022": { "obs_EconomicCapitalRatio": 1.0411978255748624 }, "2023": { "obs_EconomicCapitalRatio": 1.96551223898017 }, "2024": { "obs_EconomicCapitalRatio": 2.1470292359354066 }, "2025": { "obs_EconomicCapitalRatio": 2.3255815191838423 } }, "0001071840": { "2012": { "obs_EconomicCapitalRatio": 32.706552675237205 }, "2013": { "obs_EconomicCapitalRatio": 174.28955623584739 }, "2014": { "obs_EconomicCapitalRatio": 32.00351898115899 }, "2016": { "obs_EconomicCapitalRatio": 26.74688687094453 }, "2017": { "obs_EconomicCapitalRatio": 94.77196250958391 }, "2018": { "obs_EconomicCapitalRatio": 41.72706553606827 }, "2019": { "obs_EconomicCapitalRatio": 14.354465949469557 }, "2020": { "obs_EconomicCapitalRatio": 52.10124549238521 }, "2021": { "obs_EconomicCapitalRatio": 30.163879507506234 }, "2022": { "obs_EconomicCapitalRatio": 9.7061071465738 }, "2024": { "obs_EconomicCapitalRatio": 6.193829201423762 }, "2025": { "obs_EconomicCapitalRatio": 8.271155331969494 } }, "0001308027": { "2012": { "obs_EconomicCapitalRatio": 1.9803797398257204 }, "2015": { "obs_EconomicCapitalRatio": 2.778919231593189 }, "2016": { "obs_EconomicCapitalRatio": 10.351619765303129 }, "2017": { "obs_EconomicCapitalRatio": 3.7308811857383533 }, "2018": { "obs_EconomicCapitalRatio": 0.08714768625160174 }, "2020": { "obs_EconomicCapitalRatio": 1.3387441772805952 }, "2021": { "obs_EconomicCapitalRatio": 0.5700547146774205 }, "2022": { "obs_EconomicCapitalRatio": 0.14721267296450652 }, "2023": { "obs_EconomicCapitalRatio": 0.14346362598664772 }, "2024": { "obs_EconomicCapitalRatio": 0.23698738818540735 }, "2025": { "obs_EconomicCapitalRatio": 0.35054254006651825 } }, "0001489393": { "2013": { "obs_EconomicCapitalRatio": 1.4151084027441547 }, "2014": { "obs_EconomicCapitalRatio": 1.4900382362139972 }, "2015": { "obs_EconomicCapitalRatio": 1.6300225505579853 }, "2016": { "obs_EconomicCapitalRatio": 1.4926247052183903 }, "2017": { "obs_EconomicCapitalRatio": 1.7026727710448146 }, "2018": { "obs_EconomicCapitalRatio": 1.1735237199637458 }, "2019": { "obs_EconomicCapitalRatio": 1.1746692422602985 }, "2020": { "obs_EconomicCapitalRatio": 1.039160334370416 }, "2021": { "obs_EconomicCapitalRatio": 1.0115527984501795 }, "2022": { "obs_EconomicCapitalRatio": 1.001507933051565 }, "2023": { "obs_EconomicCapitalRatio": 1.1989866656327328 }, "2024": { "obs_EconomicCapitalRatio": 1.0201268420034355 }, "2025": { "obs_EconomicCapitalRatio": 0.6858348113544311 } }, "0001042187": { "2013": { "obs_EconomicCapitalRatio": 0.5714296705166615 }, "2014": { "obs_EconomicCapitalRatio": 0.3391814297044462 }, "2015": { "obs_EconomicCapitalRatio": 0.4583016602403627 }, "2016": { "obs_EconomicCapitalRatio": 0.5278406481008625 }, "2017": { "obs_EconomicCapitalRatio": 0.4309951786881203 }, "2018": { "obs_EconomicCapitalRatio": 0.33238633083898383 }, "2021": { "obs_EconomicCapitalRatio": 0.5428482214821214 }, "2022": { "obs_EconomicCapitalRatio": 1.2123118520382488 }, "2023": { "obs_EconomicCapitalRatio": 2.8157146744889916 }, "2024": { "obs_EconomicCapitalRatio": 0.6517477133212607 }, "2025": { "obs_EconomicCapitalRatio": 0.6078884785899927 } }, "0001325964": { "2013": { "obs_EconomicCapitalRatio": 22.493014273125006 }, "2021": { "obs_EconomicCapitalRatio": 124.11066425481359 }, "2022": { "obs_EconomicCapitalRatio": 34.89205016257957 }, "2023": { "obs_EconomicCapitalRatio": 26.28715222376341 }, "2024": { "obs_EconomicCapitalRatio": 12.036573744155438 }, "2025": { "obs_EconomicCapitalRatio": 10.167232094101845 } }, "0001530804": { "2014": { "obs_EconomicCapitalRatio": 0.23216984985374312 }, "2015": { "obs_EconomicCapitalRatio": 0.041862906284199475 }, "2016": { "obs_EconomicCapitalRatio": 0.12247701906359186 }, "2017": { "obs_EconomicCapitalRatio": 0.3243116789167706 }, "2018": { "obs_EconomicCapitalRatio": 0.1282515917643454 }, "2019": { "obs_EconomicCapitalRatio": 0.26738229447865736 }, "2020": { "obs_EconomicCapitalRatio": 0.2980248750707583 }, "2021": { "obs_EconomicCapitalRatio": 0.5991924965793767 }, "2022": { "obs_EconomicCapitalRatio": 0.34669182047987734 }, "2023": { "obs_EconomicCapitalRatio": 0.38428424149732565 }, "2024": { "obs_EconomicCapitalRatio": 0.29016321773794146 }, "2025": { "obs_EconomicCapitalRatio": 0.12252377761438202 } }, "0001549145": { "2014": { "obs_EconomicCapitalRatio": 2.602779631596862 }, "2016": { "obs_EconomicCapitalRatio": 1.9211096942138082 }, "2017": { "obs_EconomicCapitalRatio": 0.5747342547575599 }, "2021": { "obs_EconomicCapitalRatio": 28.9178358769749 }, "2022": { "obs_EconomicCapitalRatio": 17.175502525835405 }, "2023": { "obs_EconomicCapitalRatio": 10.771142591731094 }, "2024": { "obs_EconomicCapitalRatio": 12.172611309231886 }, "2025": { "obs_EconomicCapitalRatio": 16.461976915111812 } }, "0001519061": { "2015": { "obs_EconomicCapitalRatio": 0.5082545963516538 }, "2016": { "obs_EconomicCapitalRatio": 0.9822707398812356 }, "2017": { "obs_EconomicCapitalRatio": 1.0603699225812344 }, "2018": { "obs_EconomicCapitalRatio": 0.6694580389125863 }, "2019": { "obs_EconomicCapitalRatio": 0.6442858173008269 }, "2020": { "obs_EconomicCapitalRatio": 0.6933794015667445 }, "2021": { "obs_EconomicCapitalRatio": 0.44773102673168885 }, "2022": { "obs_EconomicCapitalRatio": 0.2159810544712253 }, "2023": { "obs_EconomicCapitalRatio": 0.09109949903062606 }, "2024": { "obs_EconomicCapitalRatio": 0.060660047162396515 } }, "0001604665": { "2017": { "obs_EconomicCapitalRatio": 0.38596753102315345 }, "2018": { "obs_EconomicCapitalRatio": 0.37561511361862315 }, "2019": { "obs_EconomicCapitalRatio": 0.5626102527641046 }, "2020": { "obs_EconomicCapitalRatio": 0.5786108953382062 }, "2021": { "obs_EconomicCapitalRatio": 0.625922748853383 }, "2022": { "obs_EconomicCapitalRatio": 0.6358639836543026 }, "2023": { "obs_EconomicCapitalRatio": 0.7241530877769992 }, "2024": { "obs_EconomicCapitalRatio": 0.8379790013918492 }, "2025": { "obs_EconomicCapitalRatio": 0.7668585509621723 } }, "0001604028": { "2015": { "obs_EconomicCapitalRatio": 1.273025974598838 }, "2016": { "obs_EconomicCapitalRatio": 1.162661883696283 }, "2020": { "obs_EconomicCapitalRatio": 2.842591008013679 }, "2022": { "obs_EconomicCapitalRatio": 3.22180346425185 }, "2023": { "obs_EconomicCapitalRatio": 4.5099881471076415 }, "2024": { "obs_EconomicCapitalRatio": 3.3874661614584705 } }, "0001673985": { "2016": { "obs_EconomicCapitalRatio": 0.7782186599992573 }, "2018": { "obs_EconomicCapitalRatio": 0.7908073461168124 }, "2019": { "obs_EconomicCapitalRatio": 0.5012501390818038 }, "2020": { "obs_EconomicCapitalRatio": 0.4845788000628009 }, "2021": { "obs_EconomicCapitalRatio": 1.1487852416389563 }, "2022": { "obs_EconomicCapitalRatio": 0.8656004837284976 }, "2023": { "obs_EconomicCapitalRatio": 0.6833615329193509 }, "2024": { "obs_EconomicCapitalRatio": 0.6025210438163165 }, "2025": { "obs_EconomicCapitalRatio": 0.34841400786738524 } }, "0001616862": { "2016": { "obs_EconomicCapitalRatio": 1.249245022511231 }, "2017": { "obs_EconomicCapitalRatio": 1.2709666433083144 }, "2018": { "obs_EconomicCapitalRatio": 0.8988817379751548 }, "2019": { "obs_EconomicCapitalRatio": 1.1628496816891973 }, "2020": { "obs_EconomicCapitalRatio": 1.0477989830362657 }, "2021": { "obs_EconomicCapitalRatio": 1.1375315368339611 }, "2022": { "obs_EconomicCapitalRatio": 0.8928272863027281 }, "2023": { "obs_EconomicCapitalRatio": 1.1738772868758283 }, "2024": { "obs_EconomicCapitalRatio": 1.1968963283554306 }, "2025": { "obs_EconomicCapitalRatio": 1.07578092243606 } }, "0001666700": { "2017": { "obs_EconomicCapitalRatio": 1.2982724922533362 }, "2018": { "obs_EconomicCapitalRatio": 0.9766770954550188 }, "2019": { "obs_EconomicCapitalRatio": 1.0763840926952941 }, "2020": { "obs_EconomicCapitalRatio": 1.2281886255149852 }, "2021": { "obs_EconomicCapitalRatio": 1.1716964643545753 }, "2022": { "obs_EconomicCapitalRatio": 1.1391746058297987 }, "2023": { "obs_EconomicCapitalRatio": 1.1769393384782991 }, "2024": { "obs_EconomicCapitalRatio": 1.269255252759582 }, "2025": { "obs_EconomicCapitalRatio": 1.177039000282219 } }, "0001648087": { "2022": { "obs_EconomicCapitalRatio": 0.0 }, "2023": { "obs_EconomicCapitalRatio": 0.0 }, "2024": { "obs_EconomicCapitalRatio": 0.0 }, "2025": { "obs_EconomicCapitalRatio": 0.0 } }, "0001096056": { "2018": { "obs_EconomicCapitalRatio": 1.2084172700636033 }, "2019": { "obs_EconomicCapitalRatio": 1.3399983762345555 }, "2020": { "obs_EconomicCapitalRatio": 1.3587499237343874 }, "2021": { "obs_EconomicCapitalRatio": 1.6715663477419418 }, "2022": { "obs_EconomicCapitalRatio": 1.0053153019909002 }, "2023": { "obs_EconomicCapitalRatio": 0.8248803824588569 }, "2024": { "obs_EconomicCapitalRatio": 1.2139487963598101 }, "2025": { "obs_EconomicCapitalRatio": 1.4140802578124703 } }, "0001707925": { "2018": { "obs_EconomicCapitalRatio": 1.1893866129197774 }, "2019": { "obs_EconomicCapitalRatio": 1.7107372512106584 }, "2020": { "obs_EconomicCapitalRatio": 1.9789271383123104 }, "2021": { "obs_EconomicCapitalRatio": 2.803679476386629 }, "2022": { "obs_EconomicCapitalRatio": 2.641834020623559 }, "2023": { "obs_EconomicCapitalRatio": 3.2039390092777027 }, "2024": { "obs_EconomicCapitalRatio": 3.276524672647183 }, "2025": { "obs_EconomicCapitalRatio": 2.9532857569105055 } }, "0001830033": { "2021": { "obs_EconomicCapitalRatio": 2.5233687441015444 }, "2022": { "obs_EconomicCapitalRatio": 1.736546527421995 }, "2023": { "obs_EconomicCapitalRatio": 0.7715736522402894 } }, "0001758021": { "2021": { "obs_EconomicCapitalRatio": 2.23009434292126 }, "2022": { "obs_EconomicCapitalRatio": 1.2779871240295437 }, "2023": { "obs_EconomicCapitalRatio": 2.1494705882572824 }, "2024": { "obs_EconomicCapitalRatio": 2.5946291453927186 }, "2025": { "obs_EconomicCapitalRatio": 2.1540554003132124 } }, "0001833197": { "2021": { "obs_EconomicCapitalRatio": 4.733556344493112 }, "2022": { "obs_EconomicCapitalRatio": 0.5439158340845507 }, "2023": { "obs_EconomicCapitalRatio": 0.491241265280765 }, "2025": { "obs_EconomicCapitalRatio": 1.1848142238337869 } } } }